CALIFCJRNIA STATE

ATHLETIC CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

December 2, 2010 STATE OF CALIFORNIA-STATE AND CONSUMER SERVICES AGENCY ARNOLD SCHWARZENEGGER, Governor

STATE CF CALIFORNIA California State Athletic Commission 2005 Evergreen St, Ste. #2010 Sacramento, CA 95815 c:Jca www.dca.ca.gov/csac/ DEPARTM!:I\IT 0~ COf~SUMEf, AFFAIRS (916) 263-2195 FAX (916) 263-2197

Members of the Commission Commissioner John Frierson, Chair Action may be taken on any item listed on Commissioner Christopher Giza, Vice-Chair the agenda except public comment. Commissioner Van Lemons, M.D. Agenda items may be taken out of order Commissioner Steve Alexander Commissioner DeWayne Zinkin Commissioner Eugene Hernandez MEETING AGENDA Thursday, December 2, 2010 9:30 A.M. to Close of Business Location 2005 Evergreen St Hearing Room Sacramento, CA 95815

1. Call to Order/Roll Call/Pledge of Allegiance

2. Approval of Minutes a. September 20, 2010

3. Chairman Remarks - Chairman Frierson

4. Executive Officer Report a. Status of Office 1. Sunset Review 2. Strategic Plan c. Personnel Update d. Current Projects e. Budget Update

5. DCA Director's Report

6. Public Comment on Items not on the Agenda - Note: The Commission may not discuss or take action on any matter raised during this public comment section, except to decide whether to place the matter on the agenda of a future meeting. [Government Code Sections 11125, 11125.l(a)]

Break

7. Applicants for Referee and Judge to Appear Before the Commission (Section 18662 of the Business and Profession Code) - Original Application a. Mark Lawley - MMA - Judge/Referee

8. New Promoter Applications for Licensure- Executive Officer a. Brett Roberts - Bamma USA b. Arpine Esmailian - King of the West c. Israel Montes - Battle of the Badges

9. License Reinstatement a. Josh Barnett- Professional Fighter 10. Appeals of License Suspension a. Chael Sonnen

Lunch

11. Subcommittee Report a. Muay Thai Subcommittee Update - Chairman FriersonNice-Chairman Giza

12. USA Boxing - Northern California Report

13. Bout Appeal a. Adam Rothweiler VS Nick Garcia b. Ryan Roy vs. Joe Schilling

14. Neurological/Boxer Pension Fund Report To Legislation

15. Agenda Items and Meeting Dates for Future Meetings

Adjournment

NOTICE: The meeting is accessible to the physically disabled. A person who needs disability-related accommodation or modification in order to participate in the meeting may make a request by contacting George Dodd at (916) 263-2195 or email [email protected] or sending a written request to George Dodd at the California State Athletic Commission, 2005 Evergreen Street, Suite 2010, Sacramento, CA 95815. Providing your request at least five (5) days before the meeting will help ensure availability of the requested accommodation. Requests for further information should be directed to George Dodd at the same address and telephone number.

Meetings of the California State Athletic Commission are open to the public except when specifically noticed otherwise in accordance with the Open Meetings Act. The audience will be given appropriate opportunities to comment on any issue presented.

2 lc::sRc::ICALIFORNIA STATE ATHLETIC: CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 2

Approval of Minutes -20 September 2010 g·"'"',;,c,;.:;;.:,c\i, ,: -· -,._l ~

CALIFORNIA STATE ATHLETIC COMMISSION MEETING MINUTES

Monday September 20, 2010 9:15 A.M. - 2:18 P.M. Junipero Serra State Building I Carmel Room 320 West Fourth Street Los Angeles, CA 90013

Commissioners Present: Chairman John Frierson Vice-Chairman Dr. Christopher Giza Commissioner Dr. Van Lemons Commissioner Steve Alexander Commissioner Eugene Hernandez

Cornmissioner(s) Not Present: Commissioner De Wayne Zinkin

Staff Present: George Dodd, Executive Officer Karen Chappelle, Deputy Attorney General Dale Chessey, Asst. Executive Officer Gil DeLuna, Dept. Consumer Affairs (DCA) Che Guevara, Assistant Chief Athletic Inspector Spencer Walker, Legal Counsel

The minutes reflect the order in which the agenda items were heard.

AGENDA ITEM 1. CALL TO ORDER/ROLL CALL/PLEDGE OF ALLEGIANCE The meeting was called to order at 9:15 A.M. Commissioners present and accounted for: Chairman Frierson, Vice-Chairman Giza, Commissioner Lemons, Commissioner Alexander, and Commissioner Hernandez. Commissioner(s), not present: Commissioner Zinkin.

AGENDA ITEM 2. APPROVAL OF MINUTES FOR JULY 26, 2010 AND AUGUST 18, 2010 Moved, seconded and carried to approve the minutes of the meetings held on July 26, 2010 and August 18, 2010, pending minor changes.

AGENDA ITEM 3. CHAIRMAN REMARKS Chairman Frierson made no opening statements

AGENDA ITEM 4. EXECUTIVE OFFJCER REPORT- GEORGE DODD Status of the Office Executive Officer Dodd opened the meeting by giving a yearly briefing (Calendar year January 2009- December 2009). He explained that overtime for inspectors has been cut until a budget is in place, and that an exemption has been submitted.

Personnel Update Executive Officer Dodd informed that, when the budget is passed, he intends to hire a Chief Athletic Inspector, and a part-time employee for the El Monte office in Southern California. Mr. Dodd introduced the new Assistant Executive Officer, Dale Chessey.

Page 1 l l/16/20!0 12:00 J>M

Status oflnformation Technology Projects Executive Officer Dodd explained the new licensing database and stated that it is set to go live online in the beginning of 2011 .

Budget Update Executive Officer Dodd mentioned that, to date, a budget for fiscal year 2010-2011 was not in place. He also pointed out that, without a budget in place, travel expense claims will not be issued, however all contractors are still honoring standing contracts.

Physician/Officials Training Executive Officer Dodd informed the commission that the officials/physicians training for both Northern and Southern California have been conducted.

Event Cancellations Executive Officer Dodd stressed to the promoters, the impact that canceling on short notice has on the officials and office staff. He also pointed out that there will be future repercussions on any promoter that tends to have this type of pattern with regard to the scheduling of their events.

Executive Officer Dodd announced that the Muay Thai sub-committee meeting will be held on October 18, 2010 at the Van Nuys state building from 2:00 P.M to 5:00 P.M. He also recommended to the commissioners that another sub-committee be formed to evaluate the pension plan and look into the possibilities of including Mixed Martial Arts (MMA).

AGENDA ITEM 5. DCA DIRECTORS REPORT Gil DeLuna, on behalf of the Department of Consumer Affairs' Director Brian Stiger, briefed the commission on the current standing of the hiring freeze within the state. He informed the Commission that the new online licensing database for the department, BreEZe, is on target for completion in February 2014.

AGENDA ITEM 6. PUBLIC COMMENT Marty Denkin recommended to the commission that they implement Rule 279 for use with officials evaluations.

Andrew Madigan briefed the commission on a new organization called the World Series of Boxing.

Jeremiah Williamson requested the reinstatement of his license. Action cannot be taken on any item in the public comment section, therefore Mr. Williamson must work with EO Dodd to be placed on a future agenda.

AGENDA ITEM 7. APPLJCANTS FOR REFEREE AND JUDGE TO APPEAR BEFORE THE COMMISSION Bill Oseguera Executive Officer Dodd gave his recommendation to deny Bill Oseguera's license at this time as a Boxing Judge, and suggests that he enroll into a mentorship program to gain experience in the professional rankings.

John Newburg Executive Officer Dodd gave a verbal recommendation to approve John Newburg with a Professional Mixed Martial Arts Judge license. Moved, seconded and carried to approve Mr. Newburg's license.

Page 2 11/l6/2010 12:00 PM

AGENDA ITEM 8. NEW PROMOTER APPLICATIONS FOR LICENSURE Lords of Combat Moved, seconded and carried to approve a professional promoter's license to Anwar Elmahrek with Lords of Combat after a recommendation from Executive Officer Dodd.

The following promoter licenses have been denied pending appearance in front of commission: Brian Manna, Pongsan Vivo, Israel Montes- Battle of the Badges, and Tuff Promotions.

AGENDA ITEM 9. LICENSE REINSTATEMENT Danny Batchelder - Drugs of Abuse After a brief discussion, a motion was made, seconded and carried to deny Mr. Batchelder a professional athlete license.

AGENDA ITEM 10. LICENSE APPEAL Rickey Funez - Seconds license After testimonies from Inspector Mark Relyea, Event Supervisor Sid Segovia, and Boxing Judge Marty Denkin, as well as extensive discussion, there was a motion made, seconded and passed (4-1) to deny the appeal and increase the fine to the maximum amount of $2,500. Mr. Funez will be eligible to reapply in January 2011.

AGENDA ITEM 11. SUBCOMMITTEE REPORTS Muay Thai Subcommittee Vice-Chairman Giza reiterated the Muay Thai sub-committee meeting and location as previously announced by Executive Officer Dodd.

[Lunch Break - 12:05 PM to 1:00 PM]

AGENDA ITEM 12. APPROVAL OF DRAFTED REGULATOR LANGUAGE Moved, seconded and carried to commence the regulatory process pending minor changes to language.

AGENDA ITEM 13. PROPOSED LEGISLATION Executive Officer Dodd briefed the Commission on the proposed legislation to authorize limiting the number of officials being licensed. Moved, seconded and carried to proceed with legislation.

AGENDA ITEM 14. SUNSET REVIEW Assistant Executive Officer Dale Chessey presented the sunset review report, discussed some historic and current areas of interest and answered questions. Moved, seconded and carried to approve the sunset review document to be sent to the Legislature.

AGENDA ITEM 15. NEUROLOGICAL/BOXERS PENSION FUND REPORT TO LEGISLATION Vice-Chairman Giza and commissioner Lemons requested to give recommendations on the language to be sent to legislation. Moved, seconded and carried to proceed with the legislation process.

AGENDA ITEM 16. STRATEGIC PLAN - UPDATE After a brief discussion and minor changes, a motion was made, seconded and carried to approve the strategic plan pending minor changes.

AGENDA ITEM 17. FUTURE AGENDA ITEMS AND MEETING DATES FOR FuTURE MEETINGS 1. Marty Denkin requested Rule 368, 373, 371 and 379 to be placed on a future agenda for discussion.

Page 3

t - 11/16/2010 12:00 PM

2. Commissioner Lemons referenced an article on mortality rates of head injuries in professional boxing be included in the meeting package and requested it to be placed on a future agenda for further discussion, and the possibility of having two doctors present their research and article material with regard to head trauma and the sport of boxing.

3. Fair Political Practice ruling regarding tickets for Commissioners.

4. Badges for Commission members and representatives.

Future Dates • Commission meeting in Sacramento on December 2, 20 l 0 at 9:30 A.M.

• Commission meeting in Los Angeles on February 1, 2010 at 9:30 A.M.

AGENDA ITEM 19. ADJOURNMENT The meeting was adjourned at 2: 18 P .M. on September 20, 2010.

Page4 CALIFORNIA STATE

ATHLETIC CCJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 3

Chairman Remarks ICALIFORNIAC::SFIC::I STATE ATHLETIC CCJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 4

Executive Officer's Report 2010 Officials Assignments

Judge Referee TK Boxing MMA TV? Adair Gwen Judge/Boxing 13 0 13 0 10 Adkins George Judge/MMA 8 0 2 6 0 Adrian Kris Judge-Ref/Kboxing-MMA 12 3 13 3 0 Arriola Willie Timekeeper 22 5 15 Monay:on Karina Timekeeper 8 7 8 Balewicz Ray Judge-Ref/Boxing/KB/MMA 5 12 14 3 0 Bayless Kermit Judge/Boxing 7 0 7 0 5 Belardo Abe Judge/Boxing/MMA 18 0 6 12 4 Beltran Mike Judge-Ref/MMA 6 9 0 15 0 Burton Terry Timekeeper 6 4 5 C.Caiz Carla Judge/Boxing 7 0 7 0 1 S.Cai~ Sergio Judge/Boxing 7 0 6 0 3 Caiz, SR Raul Judge-Ref/Boxing 3 10 13 0 10 Caiz, JR Raul Judge-Ref/Boxing 3 12 15 0 8 Camgbell Jack Judge/Boxing 11 0 11 0 0 Cantu Jerry Judge-Ref/Boxing 4 11 15 0 10 Cobian Jose Judge-Ref-Boxing/MMA 10 9 15 4 7 Cobian Luis Judge-Ref-MMA 16 4 0 19 8 Collantes Ed Judge-Ref-TK/Boxing/KB 0 12 3 12 2 4 Collins Dan Judge-Ref-TK/Boxing 1 1 11 6 6 3 Connolly: Pat Judge/Boxing 8 0 8 0 3 Corona Ray Judge-Ref/Boxing 8 12 19 1 9 Crebs Tony Judge-Ref/Boxing 7 9 16 0 7 Davis Johnathan Judge/Boxing 12 0 12 0 9 Dean Herb Judge-Ref/MMA 1 13 0 14 7 Delgado Vince Ref/Boxing 6 0 6 0 4 Deluca Max Judge/Boxing 14 0 14 0 10 Denkin David Judge-Ref/Boxing 8 7 15 0 6 Denkin Marty Judge/Boxing-MMA 24 0 19 4 9 Denkin Jackie Judge/Boxing-MMA 15 0 0 15 0 Druxman Barry Judge/Boxing-MMA 6 0 4 0 4 English Steve Judge-Ref/Boxing 10 0 4 6 4

-CJ Feldman Glen Judge/Boxing 1 0 1 0 1 Garcia Debbie Timekeeper/Boxing-MMA 15 4 8 Gordon Stan Timekeeper/Boxing-MMA 5 2 1 Griffin Lester Judge/MMA 19 0 0 19 6 Hamilton Nelson Judge-Ref/ALL 13 9 10 12 6 Hedgei::1eth Wayne Judge-Ref/Boxing 1 12 13 0 11 Hernandez Eddie Judge-Ref/Boxing 3 0 3 0 2 Herzog Jason Judge-Ref/MMA 0 15 0 15 6 Jenkin James Judge-Ref/Boxing-MMA 9 3 11 0 10 Landless Larry Judge-Ref/MMA 8 10 0 18 6 Lebell Gene Judge/MMA 14 0 0 14 5 Liechty John Timekeeper/Boxing-MMA 15 7 12 McCarthy John Judge-Ref/MMA 1 16 0 16 10 McQQY- Jason Judge-Ref/MMA-Boxing 1 14 0 15 2 McKnight Ralph Judge/MMA-Boxing 16 0 5 12 4 Mendoza David Judge-Ref/MMA-Boxing 16 8 17 7 8 Milsap Mike Timekeeper 15 6 8 Montes Veronica Timekeeper 9 6 7 Moret Lou Judge-Ref/MMA-Boxing 7 8 15 0 11 Morro\\'. Steve Judge-Ref/MMA-Boxing 10 0 4 6 6 Newburg John Judge North Norman nmekeeper 16 7 8 Peoi::1les Cecil Judge-Ref/Boxing-MMA 9 7 5 12 0 Peterson Fred Timekeeper 9 8 6 Polanco Alfredo Judge/Boxing 1 0 1 0 1 Rasmussen Bruce Judge-TK/Boxing/MMNKB 14 0 8 6 0 Reiss Jack Judge-Ref/Boxing/MMA 4 20 19 5 11 Rochin Alejandro Judge/Boxing-MMA 17 0 16 1 2 Rosale~ Marcos Judge-Ref/Boxing/KB/MMA 5 19 8 15 7 Rosenthal Josh Ref-KB/MMA 0 11 1 10 5 Russell Patrick Judge-Ref/Boxing 4 11 15 0 10 Sammon Marty Judge-Boxing 5 1 6 0 4 Sandoval Danny Judge-Ref/Boxing 3 0 3 0 1 Schorle Jon Judge-Ref/Boxing/KB/MMA 5 9 8 6 7 SriamQfil Dej Judge-Ref/KB/MMA 2 14 16 0 0

... 1st Quarter FY 10-11

Agency Agency Name Code DCA B~d9-etJtt!~i~f:~s! _To:~:~~;et l T~~~~:~~:dj R:::~)~g_··Jaua~:~r~~:thlyl ' Invoiced

3501 IState Athletic Comm __ $95,691.00 $0.ooJ_____ . $95,691.00 $30,442.50 $65,254.50 $10,147.50 J ___ L ___ . --·-- ·-----~·--

SUBTOTAL !95,6_9!:QQ_, __ _ $0.00 $95,697.00 $30,442.50 $65,254.50 $10, 147.50

■total Invoiced in Quarter

II Balance Remaining

$65,254.50 , 68%

C CALIFORNIA STATE

ATHLETIC C:CJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STA TE ATHLETIC COMMISSION

Agenda Item 5

DCA Director's Report

l c::..,,_ CALIFORNIA STATE

ATHLETIC: CCJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 6

Public Comment

' .' ,- CALIFORNIA STATE

ATHLETIC CCJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 7

Applicants For Referee and Judge to Appear Before the Commission Mark Lawley - MMA Referee/Judge STATE OF CALIFORNIA-STATE ANO CONSUMER SERVICES AGENCY ARNOLD SCHWARZENEGGER, Governor

STATE 0 F CALIFORNIA California State Athletic Commission 2005 Evergreen St., Ste. #2010 Sacramento, CA 95815 c::1ca www.dca.ca.gov/csac/ DEPARTMENT OF CONSUMEF: AFFAIRS (916) 263-2195 FAX (916) 263-2197

Agenda Item 7 December 2, 2010

Applicants For Referee Subject:

Mark Lawley - MMA Referee/Judge

Summary: I have reviewed the documentation that Mr. Lawley has provided to be licensed as a professional referee/judge for MMA. Mr. Lawley has the necessary knowledge to referee/judge MMA. Under rule 543(a) and (f) Mr. Lawley has not demonstrated prior experience in refereeing~udging MMA matches. Mr. Lawley has provided documentation of refereeing 55 matches and judging 33 matches. He has performed in a series of training sessions as a referee/judge to successfully demonstrated proficiency in Mixed Martial Arts.

Rule 543(a) Have two years of documented experience refereeing martial arts or kickboxing matches with a minimum of 100 matches with a minimum of 100 matches referee. It is not necessary that this experience be obtained by refereeing professional contests.

Rule 543(f) Perform a demonstration of competence in judging by judging at least 50 martial arts of kickboxing contests as verified by a representative of the commission.

Recommendation: I recommend that Mr. Lawley license be denied at this time until Mr. Lawyley meets the requirement under rule 543(a) and 543(f). Once those requirements have been met I would recommend that the commission approve his license as an MMA referee/judge. I would also recommend that he not have to appear before the commission for his license and allow the Executive Officer to verrfy the information once received. George Dodd

From: CSAC Sent: Wednesday, November 17, 2010 12:01 PM To: George Dodd Subject: FW: to George Dodd / event list from Mark Lawley

California State Athletic Commission 2005 Evergreen St. Suite #2010 Sacramento, CA 95815 P 916.263.2195 F 916.263.2197

From: Toni Lawley [[email protected]] Sent: Tuesday, November 16, 2010 8:49 PM To: CSAC Subject: to George Dodd/ event list from Mark Lawley

Tachi Palace Gladiator Challenge Lemoore Dec. 3 2009 reffed 1 match

Redhawk Casino Gladiator Challenge Placerville Dec. 12 2009 reffed 9 matches

Playboy Fight Night Visalia March 5 2010 reffed 6 matches

Strikeforce challengers Save Mart Center Fresno reffed 4 matches

V.F.C. Calway Park Fresno May 22 2010 reffed 4 matches/ judged 4 matches

V.F.C.2 Fresno Fair Grounds Fresno July 24 2010 reffed 7 matches/ judged 6 matches

Convicted Artists Reign Traning Center Lake Forest Aug. 14 2010 reffed 6 matches/ judged 6 matches

Battle at the Ballpark Marysville Aug. 21 2010 reffed 1 match/ judged 4 matches

Central Valley Regionals Chukchansi Park Fresno Sept. 18 2010 reffed 4 matches

Central Valley Regionals Tower District Fresno Oct. 10 2010 reffed 5 matches/ judged 5 matches

V.F.C. 3 Kerman Oct. 17 2010 reffed 6 matches/ judged 4 matches

Strikeforce Challengers Save Mart Center Fresno Oct. 22 2010 reffed 2 matches/ judged 4 matches

I will be reffing at the Tulare Fair Grounds on Nov. 26 2010 The amount of matches is unknown at this time. I have shadowed Jason McCoy on many events thruout the year to help improve and learn as much as possible.

I know I have not met the required 100 matches but I have been invoved in Mixed Martial Arts for many years and feel my experience in M.M.A. carries over to my reffing ability. I have fought in the cage, cornered, coached and judged outside the cage. I ran a cage fight team for 7 years and understand the sport well. I have been thru Big Johns C.O.M.M.A.N.D. course for reffing and passed the course on the first attempt. The best way I can improve my reffing skills is to get in the cage and ref. CAMO is great but they dont have enough events in my area to really keep roe busy like I need to improve. Getting my license would give me more chances to work as a ref, improve my reffing skills and I hope to help improve the quality of M.M.A.

1 I am prior military and have been working as a Police Officer for the state of California for the last ten years. I have been involved in Mixed Martial Arts since 1982. I haved trained in Boxing, Kickboxing, Shootboxing, Karate, Judo, Jui-Jitsu, Kali and Jeet Kune Do.

I am a 4th degree black belt in Japanese Goju-Ryu Karate.

I am a certified weaponless defense instructor per P.O.S.T. (Peace Officers Standards and Training).

I am a level 1 certified Army Combatives instructor.

I am a certified M.M.A. referee through Big John McCarthy and C.O.M.M.A.N.D.

I am a Mixed Martial Arts Referee and Judge for C.A.M.O.

I ran a Mixed Martial Arts school and fight team from 2002 to 2009 with a team record of 49 wins and 13 losses. I have coached, cornered and fought in the cage myself with success.

With my experience in Mixed Martial Arts and my strong work ethic I think I would make a valuable pro referee. I would continously strive to improve my skills as a referee and improve Mixed Martial Arts as a whole.

Thank you,

Mark Lawley J / .1,,, ,J .i ) I v•v ·1YlZ-, -f({J;,.;~ - - / THIS IS TD CERTIFY THAT Mark Lawley

H A S S U C C E S S FU L LY M E T T H E .R E Q LJ I R E M E N T S

t ,. . • . •. . . F □ R THE ct···aMMA.ND···· .. ~- ·.. •. . ' ..- PROGRAM

AND IS NOW CERTIFIED AS A MIXED MARTIAL ARTS REFEREE

Valencia, CA October 2 7, 2009 ------~----·------COURSE LOCATION -~ DATE )

(~/ ~ -·- --/ Jtt , A - -JOHN MCCA~EAD INSTRUCTOR

.., Sacramento Regional

11 P~~li~j:;arety Training Geuter

i_ ,.····.:-· ·11·")t'-. . - J.. t . ·_"'tt,'\tJ'-l~_-•-,~,~ n_ii;::·~ ._-~, ~ \t._ • ., . -. ~ ·- \'· ij.""¥{'.._11•9·· I i.l: ~"% · · \ ,,t•.c~~" ;;ct"" ~'-\'.,';ijf.-@~te of ~~lit\f)I ___ _ .~- '.flJo111,,

/1,',:•i .··t' ,{•t : . . t·\;,~-?~\;,'• .... •'·•., i ... :a. . 1 l\ ~,•••· .'. ·. ·. .,·._:-!,,).,, . ' ✓,, /i.·\.,\J. •'lt;,;.:"l\,,c~-:'i~ ! - · 1/,-,~_11:,;;:_,• .. , • l , · : f , . ~ ... , / I _. 'I.' ,i/ .\ 1 1 ; 1 .J!;, \ ~ - , i.,~ ' ,-1 l / ' ' ' , \•. _., , ,_ 1 . .. i. "';,,, • ,,_..... · ii , ., '• ,, . a,~,\\,;, ":, '·,· £.a.,,r,,. ,,.. .,' e"'' ~:1 , , , I 1· • ' , , , 1 '•' ,· '.1 , ·,• ,' 11 \ • / \ , ,, ~ I, ,,\' .I 1· l ''1,;••,·,'.';,' - ~ t • r ...., _;L,,,"I'' ' \ ! ,"I~, I' , r I ,I '1 ;r ,fill{ J , I ' ~• •~1 j , .; \; • ..,. . 1 . i ( : ~ , . .,.·,v .. -.,-~. . . ' , . , . ,. .. i ,. : : ( /\:-J'.· i ·-;~ 1/' .'~I -~h~s,ls~t~f;ctorily coriiplctJd 3 Jo.·111;,1~ 1111 ,~: R . 1 I I ' < , L _ .1 ,, . , 1 ./•' 11 •: ,:· r :·. : m: •. ~- . :' -.,r::,'1111 ,.~ •. : it, 1 • .1 1 ... ·, . ;· --- ,~~\1 . / .1:-:-· ·. • >I.:·· 1 • . \ J:. .. .'~.:, .: : · . r 1 ·" • _;r 1 · ~- Ir · 1 • I' 1 '\ 1•·-- , l , ,,.,_1J. - • ,--f:....,~. i~ , • • r' \ ~ . • ' - r \1, . , , , ' i --· .. . ·-·. \~. . ---- J • ' \ 1\ \ £ l ! ' ~t, l' I 1 1 1 //i: }: ':;\ ontl:f:i,~ DefeDs C\ i,r-lSt~ .. 'tfo:t ,;,' "! wet,~p---· 1 1 ~\ ~t\/ i J ,C "\ ~ ,"' '1 I ~- ~ifi:1 \ ~ I ' 1i ,< ~ 'h • ; • ~,t--.:t ' , ", l ~ I I ~ 1,i ·) .· /u - _.. , .. _, ' .. ,:•,,,JJ.:;•\\ 1\ t .. fl, , •i\ ,, 1 ,· .. • '• ~ / t' , ,.i> \, j~.. •• '..:.r-:::-~f-r :, --~ ,, I I ( ~ ,,,. 1 ! r -· I 'I ,,:,.) l ' • r, ( · . ·, i l d /\J( ~ ( l ' · • ,,,::1 /.\ ,;;_ ~- \~ \ I 1.- • fi l. /\/ 1 ' i \ ' ' . I t! · I V/ ,lj • · ,/, J · ->}11-~. If. \\\ , I ' 1 • ·- , • \ ~- 1 . , · ,.,,:.,:,.:,•,~~~: ..- · .. . . . :·'-'~P(lSXEei,tification #2~170?21635-;090. ~~ ··,>,,\ \ ., t· i 'c,' ·:.- I:- ... ,' ,./ -~-~c::::~~\ \ I / .-·. ' ' ' ' . \,},'.):',:.f (t' ·_·;.r:./' STC Certification #0218-00. 80.. 8. _~_, ·\;.~,t{i~\_1,;:l.,, .. ( .. :;\ -. I;

\~~-,::?P~µ consisting of 80 hours of instritction' \Y/ ~ , th day of Septem her, 2009

Leo Green Training Program Coordinator

}lmerican c.R_jver Co(fege / Los (Rios Co1nniunity Co{fege

:) .... , ...... , .. N ~ .... - :;d,a:,t'_ ,r~r ,, -~,_$11._Ll\lHF LUU I b-aii ·--7 I I I} ~

...... ~ •. !fl_. -~.. -~.a,_: ::::·~t@L,:·· -. 1 ~wr

.d,.,__, ... :THIE LE\''ELD'.F: ~::

•··-~ -oa fhrl• ,..4: !*' ct ■,,01: .,½- · · ~,~, '.·'.. l f.-.·- H••-..~~~~u,ii~'°?tln•e to ,111ahl•1 ,•ad jdwt1ID!P ·lllmaab,o.11rt h:lit1III• ID ti• _.,11 of Ka:ralt:e .. :~~~;}~:t~/ . . ~:-,. -- ···· ;fl 'Jr> ·'c_~- ~1-l )~ - To Mr. George Dodd, Executive Officer of the California State Athletic Commission

Dear Mr. Dodd

This letter is to inform you of my association and dealings with Mr. Mark Lawley who is applying for a license as a referee for Mixed Martial Arts.

Approximately one year ago Mr. Lawley took and successfully passed my refereeing course in Valencia California. My course consists of three days of at least 12 hours classes that focus on the sport of MMA along with the techniques used by the fighters. The mechanics that a referee must use and adhere to for proper positioning, communication, foul administration and the safety of the fighters. At the end of the course the participants are given three separate tests, which they must pass with a score of 90% or better. Mr. Lawley passed my course and moved on to refereeing for the CAMO organization. I have observed Mr. Lawley work as a referee for the CAMO organization, during the prelims of a Strikeforce Challengers show in Fresno California. During the show Mr. Lawley performed well and applied many of the techniques that would allow a referee in MMA to be successful.

I believe that Mr. Lawley has shown that he is ready to take on the position of a licensee for MMA in the state of California.

Sincerely,

John McCarthy Page 1 ot J

George Dodd

From: Marcos Rosales Sent: Friday, November 19, 2010 12:31 AM To: George Dodd Subject: Letter of Reference Mr. Dodd,

I am sending this e-mail on behalf of Mr. Mark Lawley. Mr. Lawley has informed me of his interest in officiating for the CSAC. I have known Mr. Lawley for approximately one year, and worked with him at several CAMMO shows. During this time I have observed him to be very eager to learn and professional. He presents a positive attitude, and I think he would be an asset to the CSAC.

Repsectfully Submitted,

Marcos Rosales

11 /?.?./201 0 lc::sRc::ICALIFORNIA STATE ATHLETIC CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STA TE ATHLETIC COMMISSION

Agenda Item 8.a New Promoter Applications For Licensure Brett Roberts - Bamma USA STATE OF CALIFORNIA-STATE AND CONSUMER SERVICES AGENCY ARNOW SCHWARZENEGGER, Governor

STATE OF CALIFClF!NIA California State Athletic Commission 2005 Evergreen St., Ste. #2010 Sacramento, CA 95815 oca www.dca.ca.gov/csac/ DEPARTMENT o:: CONSUMEF AFFAIC!E (916) 263-2195 FAX (916) 263-2197

Agenda Item 8.a December 2, 201 O

New Promoter Application for Licensure

Promotion Name: Bamma USA

Owner: Brett Roberts

Items included for licensing:

1 Photo of each applicant - Completed Personal Resume - Completed

Copy of Form BC11 8016 (Fingerprints) - Completed Bond/Assignment of Saving -Will Need Update

Financial Statement of each applicant - Completed Article of Incorporation/Minutes N/A

Summary:

The event was held 9/24/2010 at the Commerce Casino in Los Angeles, CA

Box Office Report: Gross Gate: $14,825.00 Live Gate Tax: $1,000 TV: $0 Neuro: $463.00 Purse: $240.00

Capacity: 1,150. There were 352 tickets sold, with 420 given out as comp. Total in attendance was 772. The total of unsold tickets was 378.

Recommended: After review the documentation for licensure and the event supervisors report. I would recommend that the Bamma USA be given a permanent license after they updated the bond requirement to $50,000 and provide all necessary documentation for renewal of her license. Original temporary license was issued on January 27, 2010. CALIFORNIA STATE

ATHLETIC:: C::CJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 8.b New Promoter Applications For Licensure Arpine Esmailian - King of the West STATE OF CALIFORNIA-STATE AND CONSUMER SERVICES AGENCY ARNOW SCHWARZENEGGER, Governor

STATE OF CAI..IFORNI.A. California State Athletic Commission 2005 Evergreen St., Ste. #2010 Sacramento, CA 95815 oca www.dca.ca.gov/csac/ DEPARTMEN7 OF CONSUMEF: AFFAl~if (916) 263-2195 FAX (916) 263-2197

Agenda Item 8.b December 2, 2010

New Promoter Application for Licensure

Promotion Name: King of the West

Owner: Arpine Esmailian

Items included for licensing:

1 Photo of each applicant - Completed Personal Resume - Completed

Copy of Form BC11 8016 (Fingerprints) - Completed Bond/Assignment of Saving -wm Need Update

Financial Statement of each applicant - Completed Article of Incorporation/Minutes NIA

Summary:

The event was held 5/6/2010 at the Circus Disco in Hollywood, CA.

Box Office Report: Gross Gate: $25,785 Live Gate Tax: $1,283.30 TV: $1,000.00 Neuro: $255.00 Purse: $890.00 Promoter: $320.00

Capacity: 1,373. There were 425 tickets sold, with O given out as comp. Total in attendance was 425. The total of unsold tickets was 948.

Recommended: After review the documentation for licensure and the event supervisors report. I would recommend that the King of the West be given a permanent license after they updated the bond requirement to $50,000 and provide all necessary documentation for renewal of her license. Original temporary license was issued on December 17, 2009.

1,,..c CALIFORNIA STATE

ATHLETIC:: C::CJMMl!S!SICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 8.c New Promoter Applications For Licensure Israel Montes - Battle of the Badges STATE OF CALIFORNIA-STATE AND CONSUMER SERVICES AGENCY ARNOW SCHWARZENEGGER, Governor

STATE CF CALIFORNIA California State Athletic Commission 2005 Evergreen St., Ste. #2010 Sacramento, CA 95815 c:::1ca www.dca.ca.gov/csac/ DEPARTMENT OF CONSUMER AFFAIRS (916) 263-2195 FAX (916) 263-2197

Agenda Item 8.c December 2, 2010

New Promoter Application for Licensure

Promotion Name: Battle of the Badges

Owner: Isreal Montes

Items included for licensing:

1 Photo of each applicant - Completed Personal Resume - Completed

Copy of Form BC11 8016 (Fingerprints) - Completed Bond/Assignment of Saving - Completed

Financial Statement of each applicant - Completed Article of Incorporation/Minutes N/A

Summary: The event was held on August 28, 2010 at the Sacramento Memorial Auditorium. All the necessary documentation. was provided to the lead inspector prior to the event. The event supervisor report did not indicate any problems with the facility, security, or any problems working the promoter. Although the promoter was not happy with the official fees he did make all necessary payments as required.

The event lead also indicate the John Schorle volunteered his time for the cause and it was much appreciated.

Recommended: After review the documentation for licensure and the event supervisors report, I would recommend that the Isreal Montes be given a permanent license as an amateur promoter in the State of California. CALIFORNIA STATE

.ATHLETIC:: C:: Cl MM ISSI Cl N

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 9 License Reinstatement Josh Barnett - Professional MMA Fighter lc::sRc::ICALIFORNIA STATE ATHLETIC CCJMMISSICJN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 10 Appeals of License Suspension Chael Sonnen - Professional MMA Fighter

------~,').t?-;;- :=; -r ;... i i:. C 1· C ;.. '- ; f- W rl N • P , ' ~ .. F!l~C.. ;:_.i:, ~:-,.,:·., .. ,.,,.:_::.-_:?..F'-.i ,-.-.,.,;<..:r:.. ~:-~u•.1 f;F~h..i'.:JJ · California State Athletic Commission d~.. a 2005 Evergreen Street, Suite 2010, Sacramento, CA, 95825 P 916-263-2195 F 916-263-2197 www.dca.ca.gov/csac

September 16, 2010

ChaelSonnen

Notice of Suspension and Fine

Dear Mr. Sonnen:

The results of your steroid test taken on August 6, 2010 were received on September 2, 2010 and they were positive. Attached are the results from the Lab.

Title 4 California Code of Regulations, Section 303 states in part:

The administration or use of any drugs, alcohol or stimulants, or injections in any part of the body, either before or during a match, to or by any boxer is prohibited.

Based on the positive laboratory findings, your California license as a Mixed Martial Arts athlete is herby suspended for 1 year, beginning on September 2, 2010 .and you are fined $2,500.

Per Business and Professions Code section18842, you have a right to appeal this denial before the Athletic Commission. You must submit your appeal request, in writing, within 30 days of the date of this letter. Upon receipt of your request, your appeal will be included on the agenda for the next available commission meeting.

If you have any questions, please feel free to contact me at any time (916) 263-2195.

Respectfully,

)~ J-..e.-;--C\t--~

George Dodd Executive Officer California Athletic Commission 2005 Evergreen St. Suite 2010 Sacramento, CA 95815 Office (916) 263-2195 Fax (916)263-2197 UCLA OLYMPIC AhlAL\'TIC.b..L LABORATORY DEPARTMENT OF PATHOLOGY AI\ID LABORATORY MEDICINE 2122 GRANVILLE AVENUE LOS ANGELES, GA 90025 (310) 825-2635 FAX (310) 206-9077

LABORATORY/SAMPLE INFORMATION 0>/V>/10 Sample Collection Date Sample Collection Time

TEST CONDUCTED FOR THE CALIFORNIA STATE ATHLETIC COMMISSION Anabolic Steroids and Masking Agents I~ 1'1 !Bh 1919 leol I SAMPLE CODE NUMBER

Specific Gravity and PH levels within range? ~ YE~ ____ NO Specific Gravity: Greater than or equal to 1.005 PH: Not less than 5.0 and not greater than 7.5

~~~O&A~Collectionite Name - City, State ~ Sport

\'v\ J A.21, Event Name ~"L

Collector Signature

Declaration of any recent blood transfusions, as well as any medications and other subs~tamins, minerals, herbs, and other dietary supplements taken during the preceding three (3) days (enter "NONE" it none declared and draw a line through an) unused spaces) (attach additional information if necessary):

Name Dosage Date Name Dosage Date of Substance Last taken of Substance

tD

Consent for research (optional): By checking "I Accept" and signing in the space provided, I agree that this sample may be used f< anti-doping research purposes. When analyses is completed and this sample would otherwise be discarded, it may then be used by ar WADA approved laboratory for anti-doping research of any type provided that it can no longer be identified as my sample.

_ I Accept ,/41 Decline

COMPLETED BY DONOR: I declare under penalty of perjury under the laws of the State of California that the foregoing information is true and correct; further realize that any intentional misrepresentation may result in disciplinary tion against my license. I certify that I provided rr specimen to the collector; that I have not adulterated it in any manner; ea specimen bottle used was sealed with a tamper-evideI seal i't_my presence; and that the information and 1mbrs provi d on 1s form and affixed~o ~ach specimen bottle are correct. ~ (XV\ ~Lr o /I've ·· 8 1~ ( ( (J te : t 7 o M Donor Name (Please print clearly) Donor Signature Date Time J

COMPLETED BY DONOR'S WITNESS: I assisted the Donor in completing this form and declare under penalty of perjury under the laws of the State of California, that ti' foregoing information is true and correct; further I realize that ny intentional misrepresentation may result in disciplinary actic a~nst my license. . a /[ / ?/, \f'L 4 J o u vt,e, tfV~ /)J &/J lo'.( 7() r"v\., D te Time

{. WHITE - DopinQ Control Officer YELLOW - Laboratory PINK - Donor /l-.- UCLA OLYMPIC Aft~ALYT!CAL LABOF.t>.TORY -<~' DEPARTMENT OF PATHOLOGY A.1\1D LABORATORY MErnCU\IE 2122 GRANVIL:..E AVENUE LOS ANGELES, CA 90025 (310) 825-2635 FAX {310) 206-9077

LABORATORY/SAMPLE INFORMATION

Sample Collection Date Sample Collecto

TEST CONDUCTED FOR THE CALIFORNIA STATE ATHLETIC COMMISSION Anabolic Steroids and Masking Agents

SAMPLE CODE NUMBER

Specific Gravity and PH levels within range? ___::_:-_:-_ ..... viriE::ss~--:_-:_:::::: ➔1~.wo'---? ~~~ Specific Gravity: Greater than or equal to 1.005 PH: Not less than 5.0 and not greater than 7 .5 0-\\~~ 0£,:~~ ~ Collection Site Name - City, State Sport ~l'- ~~JI~ Event Name C~me (Plea~learly)

Collector Signature

Declaration of any recent blood transfusions, as well as any medications and other substances, including vitamins, mi s, herbs, and other dietary supplements taken during the preceding three (3) days (enter "NONE" if none de aw a line through any unused spaces) (attach additional information if necessary):

Name Dosage Date Name Dosage Date of Substance Last taken of Substance Last taken ----, - Consent for research (optional): By checking "I Accept" and signing in the space provided, I agree that this sample may be used fo anti-doping research purposes. When analyses is completed and this sample would otherwise be discarded, it may then be used by an­ WADA approved laboratory for anti-doping research of any type provided that it can no longer be identified as my sample.

_ I Accept ?(', Decline

COMPLETED BY DONOR: I declare under penalty of perjury under the laws of the State of California that the foregoing information is true and correct; further realize that any intentional misrepresentation may result in disciplinary action against my license. I certify that I provided m· specimen to the collector; that I have not adulterated it in y m r; each specimen bottle used was sealed with a tamper-eviden seal in my presence; and that the information and umber. pro I on this form and ~i1d to each specimen bottle are correct.

S o Y1 A. 0_. A ---+--'----- ~/{,/IO ~ Donor Name (Please print clearly) Donor Signature Date Time

COMPLETED BY DONOR'S WITNESS: I assisted the Donor in completing this form and declare under penalty of perjury under the laws of the State of California, that th1 foregoing information is true and correct: further I realize that any intentional misrepresentation may result in disciplinary actio1 against my license.

Witness Name (Please print clearly) Witness Signature Date Time WORLO IJ ANTl•DOPJIIU UCLA Olympic Analytical Laboratory AOEIICY UCLA School of Medicine play 11110 ACC~IO '1'11D 2122 Granvllle Ave. Los Angeles, CA 90025 ACCREDITED ISO/IEC 17025:200:i Phone (31 O) 825-2635 Fax (31 Q) 206-9077 Chemical Testing Certificate: 1420.01 CONFIDENTIAL DRUG TESTING REPORT CSAC55

California State Athletic Commission Attn: Sarah Waklee 2005 Evergreen Street, Ste, 2010 Sacramento, CA 95815 Fax ; · ( 916 ) 2 6 3 - 21 9 7

UCLA code: RKL Sport: MMA Number of samples: 8 Date of laboratory receipt; OB/10/10 Date of analysis; OB/13/10

The laboratory analyzed the urine specimens listed below using method 1001 anabolic and masking agents.

The specimen condition and custody (C) is acceptable if indicated by 1y1,

UCLA Code Specimen# Results C

Y SEE LETTER OF SEPTEMBER 02, 2010

Brian Ahrens Certifying Scientist Signature Date

This report shall not be reproduced, except in full, wi t.hout the writ-ten approval of the laboratory, Page 1 of 1 Sep. 3. 2010 6:18PM No. 4288 P. 4

■ wanioANTl•DOPIIIO UCLA Olympic Analytical Laboratory AO!NCY UCLA School of Medicine Jllitlrw AC:CA&Dl'f ll ACCltEDITEO 2122 Granville Ave. Los Angeles, CA 90025 ISO/IEC 17025:2005 Phone (310) 825-2635 Fax {31 O) 206-9077 Chemical Testing Certificate: 1420.01

CONFIDENTIAL DRUG TESTING REPORT CSAC55(RKL09)

September 02, 2010

California State Athletic Commission Attn: Sarah Waklee 2005 Evergreen Street, Ste. 2010 Sacramento, CA 95815 Fax: (916} 263-2197

Dear Ms. Waklee:

This is a supplemental report for ti~~•~~~~ .• UCLA RKL09, MMA, collection date August 06, 2010 and date received August 10, 2010.

Urine specimen number CSAC 2487996 = UCLA RKLO9 has T/E ratio of 16 .. 9 ..±. 17% (k=2) . The threshold T/E ratio is 4. 0. We recommend carbon, ~ isotope ratio analysis and/or longitudinal follow-up.

Brian Ahrens Certifying Scientist S1.gnature Date I

This report shall not be reproduced( except in full, without the written approval of the laboratory. Page 1 of 1 Se 1,. 14. 2O'r O 10 : 27 AM ~Jc.4326 G

WORLD UCLA Olympic Analytical Laboratory II ANTl·OOPIHO AOllHCY

UCLA School of Medicine ACGREDfl'ED 2122_Granville Ave, Los Angeles, CA 90025 ACCRED(Teo Phone (310) 826-2635 Fax (310) 206-9077 ISO/IEC 1'7025:2005 Chemical Testing Certificate: 1420.01 CONFIDENTIAL Carbon Isotope Ratio Report- CSAC55 (RKL09)

September 14, 2010

Califo111ia State Athletic Commission Attn: Sarah Waklee 2005 Evergreen Street, Ste. 2010 Sacramento, CA 95815 Fax: (916) 263-2197

Specimen number: "'2'4'8:iJ,9)%· UCLA Code: RKL09 Sport: MMA Collection date: 08/06/10 Date Received at Lab: 08/10/10 Date of Analysis: 09/07/10 Condition and custody of sample:. Acceptable

Analysis: The urine sample was analyzed using method 8001, steroids by carbon isotope ratio by GC/IRMS.

Analytical Findings:

IRMS Laboratory Result: !::, (PdioIJEtio) I::.. (Pdiol-Andro) Result* 7.0± 0.9 5.9 :± 0.8 Adverse

* Where "Inconclusive" or "Negative" indicates results are consistent with endogenous origin and "Adverse" indicates results are consistent with administration of a steroid.

Unit of measurement for the two values is 613 C [0/ 00). The :value after the± is the unce1tainty of measurement (k=2).

Brian Ahrens Certifying Scientist Signature Date

This report shall not be reproduced} except in full, without the written approval of the laboratory. Page 1 of 1 LAW OFFICES OF H D WARD L. _J AC D B 5

SEPTEMBER 29, 2010

VIA E-MAIL AND REGULAR MAIL

George Dodd California State Athletic Commission 2005 Evergreen Street, Suite 2010 Sacramento, CA 95815

Re: CSAC v. Chae! Sonnen, August 6, 2010 Drug Test, UFC 117

Dear Mr. Dodd:

Please be advised that I represent Chae! Sonnen in the above-referenced matter. Please direct all future correspondence regarding this matter to me.

Chael Sonnen hereby requests an appeal hearing in the above-referenced matter. Mr. Sonnen requests that this matter be placed on the calendar at the CSAC's December 2, 2010 Commission meeting.

Should you have any questions regarding this matter, please do not hesitate to contact me.

cc: Chael Sonnen (via e-mail)

2815 Townsgate Road, Suite 200 Cell. 818.422.0508 [email protected] Westlake Village California 91361 fax. 805.418.9899 www.atl1letes1awve,.co~: Tel. 805.418.9892 Tel. 818.292.8735

\,....-\.0 LAW OFFICES OF HD WARD L.-' AC: D B 5

SEPTEMBER 29, 2010

VIA E-MAIL AND REGULAR MAIL

George Dodd California State Athletic Commission 2005 Evergreen Street, Suite 2010 Sacramento, CA 95815

Re: CSAC v. Chael Sonnen, Auqust 6, 2010 Drue Test. UFC 117

Dear Mr. Dodd:

I am in receipt of your September 16, 2010 letter to Mr. Sonnen, in which you advise of Mr. Sonnen's alleged positive test.

Please provide me with the following documents related to the "A" and "B" / sample tests for the urine sample identified as specimen number CSAC 2487996 I UCLA RKL09: M

1. List of laboratory staff involved in the test, including signatures and/or initials and position title(s);

2. Urine integrity test results (if completed);

3. Chain of custody documentation for sample container;

4. Transportation chain of custody (e.g., courier documentation, laboratory receipt of container);

"A" sample container chain(s) of custody;

6. "A" Sample Screening Results, including:

a. Relevant aliquot chain(s) of custody; and

b. Screening procedure data, including chromatograms (or other relevant data), for Negative control urine, Positive control urine (with concentration indicated, if relevant), and Sample urine aliquot(s);

7. "A" Sample Confirmation Results, including:

2815 Townsgate Road, Suite 200 Cell. 818.422.0508 [email protected] Westlake Village. California 91361 Fax. 805.418.9899 www.athleteslawyer.com Tel. 805.418.9892 Tel. 818.292.8735 George Dodd September 29, 2010 Page 2

a. Summary of the analytical principles of the confirmation method,

b. Aliquot chain of custody

c. Sequence verification data

d. Confirmation procedure data, including chromatograms (or other relevant data), for Negative control urine, Positive control urine (with concentration indicated, if relevant), Standard(s)/calibrator(s) (if relevant), and Sample urine aliquot(s); and

e. "A" sample report, including pH, Specific Gravity, and other urine integrity test results (if applicable, including abnormal appearance of sample) performed in laboratory.

8. "B" Sample Confirmation Results, including:

a. Summary of the analytical principles of the confirmation method (if different from the "A" confirmation method),

b. Aliquot chain of custody

c. Sequence verification data

d. Confirmation procedure data, including chromatograms (or other relevant data), for Negative control urine, Positive control urine (with concentration indicated, if relevant), Standard(s)/calibrator(s) (if relevant), and Sample urine aliquot(s); and

e. "B" sample report, including pH, Specific Gravity, and other urine integrity test results (if applicable, including abnormal appearance of sample) performed in laboratory.

In addition, request is made for the following documents that are in the possession, custody or control of the California State Athletic Commission:

1. All documents that evidence, reference or relate to communications between the California State Athletic Commission (hereinafter "CSAC") and Chael Sonnen, or any of his representatives, agents, or managers, related to the license obtained by Mr. Sonnen from the CSAC to fight at the UFC 117 event. George Dodd September 29, 2010 Page 3

2. All documents that evidence, reference or relate to communications between the CSAC and Chael Sonnen, or any of his representatives, agents, or managers, related to medications used by Chael Sonnen.

3. All telephone logs that evidence, reference or relate to communications between the CSAC and Chael Sonnen, or any of his representatives, agents, or managers, prior to August 6, 2010.

4. All documents that evidence, reference or relate to communications between the CSAC and the UFC, or any of its representatives, related to the license obtained by Mr. Sonnen from the CSAC to fight at the UFC 117 event.

5. All documents that evidence, reference or relate to communications between the CSAC and the UFC, or any of its representatives, related to medications used by Chael Sonnen.

6. All documents that evidence, reference or relate to communications between the CSAC and Dr. Jeff Davidson related to the license obtained by Mr. Sonnen from the CSAC to fight at the UFC 117 event.

7. All documents that evidence, reference or relate to communications between the CSAC and the Dr. Jeff Davidson related to medications used by Chael Sonnen.

Should you have any questions regarding this matter, please do not hesitate to contact me.

Very truly yours,

cc: Chael Sonnen (via e-mail) LAW OFFICES OF H D WA R D L. _J A C D B 5

SEPTEMBER 30, 2010

VIA E-MAIL AND REGULAR MAIL

George Dodd California State Athletic Commission 2005 Evergreen Street, Suite 2010 Sacramento, CA 95815

Re: CSAC v. Chael Sonnen, August 6, 2010 Drug Test, UFC 117

Dear Mr. Dodd:

As a supplemental request for documents, request is made for the following documents that are in the possession, custody or •control of the California State Athletic Commission:

1. All documents that evidence, reference or relate to / communications between the California State Athletic Commission MU (hereinafter "CSAC") and Chael Sonnen, or any of his representatives, agents, or managers, related to the license obtained by Mr. Sonnen from the CSAC to fight at the UFC 104 event.

2. All documents that evidence, reference or relate to communications between the CSAC and Chael Sonnen, or any of his representatives, agents, or managers, related to medications used by Chael Sonnen in or about 2009.

3. All telephone logs that evidence, reference or relate to communications between the CSAC and Chael Sonnen, or any of his representatives, agents, or managers, in or about 2009.

4. All documents that evidence, reference or relate to communications between the CSAC and the UFC, or any of its representatives, related to the license obtained by Mr. Sonnen from the CSAC to fight at the UFC 104 event.

5. All documents that evidence, reference or relate to communications between the CSAC and the UFC, or any of its representatives, related to medications used by Chael Sonnen in or about 2009. 2815 Townsgate Road, Suite 200 Cell. 818.422.0508 [email protected] Westlake Village, California 91361 Fax. 805.418.9899 www.athietesiawyer.com Tel. 805.418.9892 Tel. 818.292.8735 George Dodd September 30, 2010 Page 2

Should you have any questions regarding this matter, please do not hesitate to contact me.

cc: Chae! Sonnen (via e-mail) j I(' l11· '''7/"fi d~x .._,, -· .-i. ' .,_, , ' 8731 5762 0020 Express m Plssss print and press hard. 4a Express Package Service ·1om,,11.. ,.,., Packages up to 150 lbs. Sender's FedEx edEx Priority Overmgh1 ,-, FedEx Standard Overnight FedEx First Overnight Account Number 3451-3222-8 zj1uo. busme~s mornmg • Ff1oe1· L Nekt ousIness a1te1rn;ion • E.11r11estnextous1nassmommg ,9/ iG?/ ID 11tmems w,H Ile debverao on Munoa~ ~Bturclev Delivery NOl eva~eblt debvervtoselecuocauom:· urnuss SATURDAY Dellvory 15 i;eIectec tier's , FedEx2Day 1 · FedEx Express Saver 18 Phone( 9 j 6) 263-2 l 95 ~11condbusioessoa1'•1nurso1:1v __J Thudbusmessot1y• [ CSAC shlpmentswillbedebveredunMond11y SD1uroayUeb'1eryNOTav111leblt Lmtess SAlURDAV OelNBIYIS sslectad 4b Express Freight Service -,,.,.~,"'.""' Packages ovar 15/J lbs. ,pany CALIF"ORl'HA STAIE ATHLETIC COM FedEx lDay Freight u Next uusm11ss oav- Fmlav shI11ments wil, ue delivered on Monday Ullll!S~ SATURUAY FedExlOayfn11ght &ookmgNL ress 2005 EVERGREEN ST STE 2010 lJ11J1verv1sseIoc11d 011pl/F1oor/Sum1/Rooni :--1 FedEx3Day Freight -' 11111d tms1noS5 ooy- S111urday Deliverv NOl 8V8lIBbl~ _.s.,,·.cA,.,Co<.1-R:uAD..LM_.E....,_l\.:,.I_.T_,O.,______S_t_at_e __c~· ~A~_ZI_P_~9_5_8~1~5_:-_3_8_9~7 - 5 Packaging ·D•ci•"'"'"'""'"""' "r-;(FedEx Ii FedEx Pak' n FedEx LJ FedEx :1 Other 1r Internal Billing Reference /hvelope" ._._, ~~~:~;;:~1~m11Jll'BKand - Box Tube 4 c111111cte1swiHappeeronlflVOIC~ 6 Special Handling and Delivery Signature Options

Phone I 1 1 SATURDAY Delivery .___J NO] UVfUIOIIIO 1orf-od6: Stanuard 0vern1gtJt, h1db 6:prnss Saver, or Fedf:x 3D ay Frmgh'

Indirect S1onature ,-- No Signature Required Direct Signature □ llnoona1s11veifebloa1rac1ptenh ~! f'atKB\IBffiBybelBltwrthoUI ~ ~omeonoet1ec1p1onlsadd1es:, edoress,aomaoneataneI11hoormg ootammgas111n111urelordobv11rl' may 1i1g11 lor deh'191'/. tt:u app!ie: aodressmov1ugnlordohvary.f-or HOLD Weekday res1danbal dehverius only. Htti app/11:: Fedbclotatmnadoross Does this shipment contain dangerous goods? 11vuu,1h\1: □ REOUIREO. Nffi m1 Crne ho}. must ti;; clun:km, fadb:FirstOvom1ghL HOLD Saturday I! X:;erenached !; i~:per'sOeclarauon ,, Ory Ice f-edfJtloc1111onadtiress ~No - Slupper'sUeclaratm1, '--' nouequire[l L Drv1co,!l,UN1845 ---x---•o n REOUlREO. Av111tot,1u ONlYlt1: Uang111ous goodst111clud1ng dry1cel cannmiJe shipped 111 Farlb: patkagm~ LJ FadEitPnomyO'lamigt,tand or placed m a FedEx Express Drop 60~ !I Cargo Aircraft Only f&d£x2Daytoselactlocanons 7 Payment Bill to: State~IP Sender Enter FedEx Acct No. or Credit Card No. below. --­ Atct.No.111Secoo11 W.llbBbilled ·□ Recipient O Third Party O Credit Card . 0 Cash/Check fedb:AcctNll 0426389202 CredrtCatdNc, Total Packages Total Weight Total Declared Value1 l ____ lbs _____ ro 10ur~abUrty 1s hmned toSIOO unless you oecl111e a higher vaiuc:. See bock tor details. By USll\g trusAnlillyou agreetotha nMce condll!Ollli on tne tiackolth1sAirb1II eno 1n1he cu1rentfedExSer11ce Guide,mclulli\Qtenns 1ha1!1m1tourllllbillty

Rev. Da1a 2/10 • Pan 1158219 • ©1934-2010 fedh • PRINTED IN U.S.A SRS --~------· ------....------·· ------·---·----·------·------·-· ---- CALIFORNIA STATE ATHLETIC COMMISSION EVENT INFORMATION ---

NAME OF EVENT: UFC 117 DATE OF WEIGH IN: August 6 th , 2010 RULES MEETING DATE/TIME:

DATE OF EVENT: August 7th , 2010 TIME OF WEIGH-IN: INSPECTORS' REPORT TIME: 1 :30 LOCATION OF EVENT: Fighter Report time: 2:00 Oracle Arena Inspector Report time: 1 :30 7000 Coliseum Way OFFICIALS' REPORT TIME: 3:00 Oakland, Ca LOCATION OF WEIGH-IN:

FIRST BOUT: 4:20PM WEIGH-IN INSPECTOR(S): DRUG TESTING:

EVENT SUPERVISOR: Frank Munoz Event Officials: Event Physicians: Event Inspectors: R - Marcos Rosales Frank l\1unoz R - Josh Rosenthal W-IN PHYS.: Dr. Gary Furness Rich Novoa R - Herb Dean W-IN PHYS.: Joe De La Gue,Tara J - Nelson Hamilton EVENT PHYS: Dr. Gary Furness David Pereda J - Susan Thomas - Gitlan EVENT PHYS.: Dr. Smith Ketchum Gilbert Urbano J - Dan Stell EVENT PHYS: Dr. Cesar Banda iviike Guzman J - Jon Schorle EVENT PHYS: Dr. Diego Allende Kevin Highbaugh J - Alejandro Rochine Tim Huff TK - Terry Burton TK - Valinda Stell Brandon Saucedo Sarah \¥/ aklee Heather Jackson Nichole Bowles Che Guevara 'George Dodd Elizabeth Parkman Dale Chessey

t)C:)A

S----~ WHO'S WHO

RNDS/ I BOXER/MMA MRI EKG.. qAR,Pld I LAB MINS ATHk~TE . ·. ~iJMM . · suMM,.. ,_, ·,_,,., •

PHIL 3 X 5 I DAVIS OK OK ~ N1!'P.i1) OK I I OK I OK I OK I OK 6-0 1/7/10 1/7/10 I 71~:10 I 1/7/10 7 /30/10 7/25/10 7 /25/10 7/22/10 BOUT APPROVED RODNEY Yo NC 101-661 OK OK OK WALLACE ✓ ~-1 OK OK OK OK OK OK 09/30/2013 I I I I I I No 9-2 7/15/10 vv--f- I 2/~7~10 I 11/17/9 7/13/10 11/9/9 7/1/10 2/16/10 6/30/10 7/8/10 3X5 DENNIS WA 103-031 OK OK OK OK HALLMAN\ OK OK OK OK OK I OK 11/29/2013 7/7/10 ~-1 I 7/16/10 I 7/16/10 I 7/19/10 I 42-13-2 I I I 7/7/10 BEN \/ OK OK SAUNDERS I f'IUA> INC 103-3881 OK I ~,,,J I OK I OK I OK I OK I OK I OK 8-2-2 12/11/2013 7/7/10 . I Ji' I 3/~2~0 I 3/5/10 7/7/10 5/16/07 6/18/10 3/12/10 3/12/10 7/8/10 3 X 5 I CHARLIE OK OK BRENNEMA~N&fflJ I NJ 101-051 I OK I ~ 1 OK I OK I OK I OK I OK .,:~i:w I ,z-, 09/03/2013 7/13/1 o • _ _ I 3~~0 I 3/4/10 I 7/fs~o I 3/5/10 6/18/10 7 /13/10 7 /13/10 7/14/10

JOHNY NV 103-0591 OK 1 OK OK OK ~ ~ HENDRICKS1- I 12/01/2013 7/13/10 I ~- · I OK I OK I OK I OK I OK I I OK 8-0 I! , r-/ 7 /6/10 4/26/10 7 /1/10 8/26/08 6/18/10 7/6/10 I 7/7/10 7/6/10 3 X 5 I CHRISTIAN OK MORECRAF~ I ~IEED I OK I _ ·1 I OK I OK I OK I OK I OK I OK I OK BOUT 7/7/10 ~ Neiffl" 7/28/10 7/19/10 7/22/10 8/2/10 8/4/10 7/14/10 7/28/10 7/19/10 APPROVED 6-0 ' I Yo No STEFAN ✓ Ir-1 NC 114-5671 OK I OK · 1 OK OK I OK I OK I OK I OK I OK I OK ST1~~iE 04/20/2015 10/21/9 10/24/9 I 10~2~/9 I 10/20/9 I 0/20/9 10/20/9 10/21/9 10/20/9 10/20/9 7/14/10 3X5 I OK RICKY VI IWA 101-0061 OK I . . I OK I OK I OK I OK I OK I OK I OK . STORY 08/28/2013 7/7/10 Nfffl1J 12/28/9 7 /16/10 1/27/9 sour 10-3 r- ,/1 v~rL I 12~2~/9 I 7/1/10 7/12/10 7/25/10 7/12/10 APPROVED y rJ DUSTIN \/1 ~INV 102-6621 OK I ; · 1 OK OK OK OK N c1 HAZELETT 11/13/2013 7/21/10 ~ OK I OK I OK I I OK 12-5 ,,, ,k# I 12~1~,9 I 12/14/9 7 /7/10 9/29/6 I 7/1/10 7/7/10 I 7/7/10 7/7/10 3X5 I TIM H 105-206 OK OK OK BOETSCH I OK I OK I OK I OK OK I OK BOUT 03/06/2014 7/13/10 ~-1 7 /7/10 7 /20/10 7 /16/10 1/30/8 6/?8~10 7/7/10 7/7/10 7/8/10 APPROVED 11-3 f.J{')(_ I I I YD TODD OK OK OK OK N D BROWN OK I I OK 11-1 ~~ m;tffl I 8~~0 I 8/2/10 I 8~~0 I 8/2/10 I 8/4/10 8/2/10 I 8/2/10 7 /28/10

2 ~~ RNDS/ I BOXER/ MMA I STATUS I fEP IU/t:X~ I APRAY,li.'fbl::f I Ct!!W''H;:f::tA

3X5 OK OK OK OK DOS-SANTOs-1 ~ IILAC 102-2201 OK 1 ·~) I I OK I OK I OK I OK I I OK ,~-ut~!lQ ... · 11-1 10/24/2013 7/26/10 . ,,, I 7/2/10 7/2/10 7/2/10 12/29/9 6/18/10 7/2/10 I 7/2/10 7/2/10 APPROVED y [] OK OK No ROY \/, ~ I FL 106-8851 OK I . I I OK I OK I OK I I OK I OK I OK I OK N~~~~N 04/25/2014 7/10/10 ~ 2/22/10 2/22/10 7 /12/10 4/28/9 6/18/10 7/12/10 7/12/10 7/12/10 3X5 THIAGO N~IILAC 102-2111 OK I • I OK OK If~;) c 1J 11 OK OK OK I OK I OK I OK I OK laU'f-·. A;:1s l, 10/24/2013 6/15/10 ~J . I 2/15/10 I 2/15/10 I 6/15/10 I 6/9/10 3/18/10 5/17/10 5/17/10 7/15/10 APPROVED y [J OK OK OK OK No FITCHJOH v / I ~I· NV104-29 6 1 OK I ~ I OK I OK I OK I OK I I OK 22-3 01/30/2014 7/29/10 A -~'-~ I 12/3/9 I 12/8/9 7/8/10 2/18/10 6/18/10 I 7/14/10 -- 3X5 . RAFAEL / I ~NV 102-6531 OK 1· I OK OK OK OK . I OK I OK I OK I OK I I OK Dos1:~Jo's , 1111312013 1128110 ~~ I 8/2/10 8/2/10 8/2/10 11/12/8 6/21/10 8/2/10 I 8/2/10 8/2/ I 0 APPROVED Yo OK OK OK OK CLAY /I ~1NEAC101-4661 OK I I I OK I OK I OK I I OK -N rJ 1 GUIDA 09/22/2013 7/22/10 JSiiil? 2/24/10 2/22/10 7 /12/10 10/5/6 I 6/~8~10 7 /6/10 I 7/6/10 7/14/10 26-11 A • .r / I 3X5 RICARDO ,. OK OK ALMEIDA 0-,:lEEtrl NJlOl-613 I OK I ~ 1 I OK I OK I OK I I OK I OK I OK I OK \§Q\)T' 12-3 09/29/2013 7/16/10 A uc, 2/17/10 2/17/10 7/16/10 10/4/7 6/18/10 2/17/10 6/30/10 7/15/10 APPROVED y [] OK OK N [J H~i~svl~I NJ107-31!( ~,A~) I I OK I OK I OK I OK I OK I I OK I OK 44-7 05/06/201 ~ ✓ -1 3/17 /10 3/17 /10 7 /22/10 10/20/3 7/1/10 4/30/9 6/30/10 7/14/10

~ t'.,<'.:" I CHAEL v1' CLEAR IOSAC103-3571 OK I OK. I OK OK OK OK OK OK OK BOUT I OK I OK I I I I I APPROVED \~~1~~1N 12/10/2013 6/29/10 10/24/9 1/13/10 1/25/10 10/9/9 9/21/04 10/5/9 10/1/9 I 10/1/9 6/28/10 Yo N D OK OK ANDERSON/I . IILAC102-221 I OK I j I OK I OK I OK I OK I OK I OK I OK S'f.S s~~~t \ ~ 1012412013 1112110 ~., 7 /12/10 7 /12/10 7 /12/10 5/18/07 6/18/10 I 7/12/10 THIAGO ~\\'- OK OK OK TAVARES 1~ INV 104-3021 OK I . j OK OK OK OK I OK I OK ::::ir 0113012014 112s110 ~ I 7/13/10 I 7/15/10 I 7/14/10 I 7/22/10 7/12/10 14-3-1 I I

NOTES: 1 2.

WWW.ABC.MIXEDMARTIALARTS.COM SUSPENSIONS

3 ►0 BOUT RED BLUE ROUNDS/ REFEREE JUDGE JUDGE JUDGE INSPECTOR INSPECTOR NO. CORNER CORNER MINUTES RED BLUE 1 Ben Dennis Sarah 3 X 5 Rosales Hamilton Rochin Susan Tim Huff Saunders Hallman Waklee 2 Stefan Christian 3 X 5 Kevin Joe De La Dean Stell Susan Rochin Struve Morecraft Highbaugh Guevara 3 Tim Todd 3 X 5 Dave Rosales; Nelson Stell Schorle Gil Urbano Boetsch Brown Pereda 4 Johny Charlie Brandon Mike 3 X 5 Rosenthal Stell Schorle Rochin Hendricks Brenneman Saucedo Guzman 5 Phil Rodney Sarah 3 X 5 Dean Schorle Rochin Susan Tim Huff Davis Wallace Waklee 6 Dustin Rick Kevin Joe De La 3 X 5 Rosenthal Nelson Susan Stell Hazelett Story Highbaugh Guevara 7 Roy Junior Brandon Mike 3 X 5 Rosales Schorle Stell Rochin Nelson Dos Santos Saucedo Guzman 8 Matt Ricardo 3 X 5 Sarah Rosenthal Nelson Rochin Susan Tim Huff Hughes Almeida Waklee 9 Glay Rafael 3 X 5 Dean Susan Stell Schorle Brandon Joe De La Guida Dos Anjos Saucedo Guevara 10 Jon Thiago 3 X 5 Dean Susan Rochin Nelson Kevin Mike Fitch Alves Highbaugh Guzman 11 Anderson Chae! 5 X 5 Rosenthal Nelson Schorle Stell Dave Gil Silva Sonnen Pereda Urbano

Red Corner Sup: S0vv-p,._ ~ Blue Comer Sup: \i ~ \-\J \,G- Pay Out: N,c~\Q. J \~~If'

4 ~ California State Athletic Commission 2005 Evergreen St Suite 2010 Sacramento, CA 95834

1facsimile transmittal

To: Karen Chappell Fax: 213-897-2804

From: George Dodd Date: 10/5/2010

Re: Chael Sonnen Documents Pages: 23

Cc: [Name]

D Urgent D For review D Please comment o Please reply D Please recycle

Notes: Karen if you need anything else please let me know.

George UG/2fi/2010 21: :J:.J FAX

GTATE OF OA\,IFDRNIA-STATE AND CONSUMF.R SERVICES AClENCY

t1"!'J:i.'flii i:;i,,. CALlFDANIA California State Athletic Commission :,;c,_.•>-, .. ,.,,;, ·a 2005 Evl:lrgrnon Streat Suite 2010 'd i': :., ..... ," - Sacmmento, C/o, 95815 www .doa,ca,gov/csac/ (916) 263-2195 FAX (91 Cl) 263·2197

APPLICATION FOR PROFESSIONAL ATHLETE

BOXING MIXED MARTIAL ARTS KICKBOXING You must submit all the itams llsted below before your application Is procassed. Your a llcatlon wlll be considel'ad 11Pendln "If an Information la not comp~e_t_a_d_.-----, $60 Application Fee. Ona (1) passport siz11d photograph (2"x 2,'), Neurological Examination Report (by llcana1.td OFFICE USE ONLY physician specializing in neurology Hnd/or niurosurgary). Dahi of Applloatlon: ______Physical Examination Report by licanaad physician, Date License Approved: ______Ophthalmolo9lc Examinatlcm by flcenHd Lloense # and Exp. Dale: ----,;c:'""'--~------0 hthalmologist. Federal ID# and Exp. Date (Boxers only) : ______P Amount Rec'd· _____ Method of Payment: Negatiw HIV, HCV Antibody (Hipatltls C), and : Receipt#: · Receipt given by: ----- HBV Surface Antigen (Hepatlths B} test results , P/E E:xp. Date: ______HIV Exp, Date: __ . must be submitted on the letterhead of :a : HSV Exp. Dale: ---c----- HCV Exp. Date; --- CLEA certified .laboratory In the United States. , Ophthalmologic Exp. Date: ______EKG Examlnat1011"' Neuro Exp. Date:------~------EKG Summary Report"' EKG Exp.Date:~--=---~------MRI Diagnostic Report"' MR! Diagnostic Report Date: ______MRI Summary Report"' "Baseline examinations. Only when ordered,

Section 1. Plaa$8 print tha following Information: Social Si,curlty Number;

Latit So "-'\t,r,,,,.

Telephone numbar:

Age; Birth Data: Hsi? Waight: '.~amale (MM / DD/ YYYY): ~eone ]LFt. ~In. "'t_..GC,pounds

Section 2. Please print the following information;

Havfl you over ua11d any other nome(9)7 YES ~yes, lllll mtmajs): ----~------Have you aver baen disqualified in any competition? YES O,oti, please explain: ______

Has your license ever been d~suspended or revolted In any .state or country for madlcal reasons (OTHER THAN HIV, HBV, OR HCV )? YES.~ yes, p!Ba&a axplaln: ______06i29i201(1 21:33 FAX [41003

APPLICATION FOR PROFESSIONAL,s;LETE APPLICANT NAME: C k, ~ ' ft~ ('\, Section 3. Please print th8 following Information: Section 4. Please print the following information:

Professional boxing record: Professional martial arts record: Wins: ___ Wins by KO/TKO: ___ Losses; ~ickboxlng C~•tGlt~~~--~--,Mixed Martial Ari$ ,,- Losses by KO/TKO: ___ Wins: :t. '9 Wins by KQ/fK~~~~i.~ Losses; 4 0 Los!!eS by KOtrKCJSf :5:S,=tt= Arnataur boxing record: Amattlur martial arts record: Wins: ___ Wins by KOffKO: ___ Losses: l

Section 5. Please print the following Information: 'fl1i' If you are now or have ever been licensed by the California State Athletic Commission, anothfli;,''ithlatlc commission, or any similar governmental authority, provide the following Information for eac~ license, llstlng 1h11 moat recent first:

STAil:IOTHER COMMIIIIIION/•GOVERNMENTAL AUTHORITY '

Ha& your llc11na11 ever been suspended, revoked orflnliKI by l~~m.Jlt.~Athletlc Commlaalon, another athletic commission or any similar governmental authority? YES ~fY~~lde the following Information:

TYPE OF LICE:NSE ACTION TAKliN REASON FOR ACTION ·oATE OF ACTION •

~~- ..,. Ar11 there charges pending against~ the California Statt Athletic Cor.:nmlsslon, anothor athletic 0ommlsslon or any similar governmental authority? YES ~ YES, prov,lde the following information:

OF!=ENSE DATE OF OFFENSE GOVERNMENTAi..•• AUTHORITY HEARING DATE

Have you b(ien convicted of a crime In the past 10 yearg? Y~s@tvcs, provide the following Information: ,,-'~ OFF!:NSE DATE OF CONVICTION ' CITY, STATE:, COUNTRY SENTENCE ,.. ~. ~ro there any charges pending against you by a~uif·enforcement agency7 YE~YES, provide lh11 following mftirmallon: ~-

OFFENSE DATE OF OFFENSE CITY, STATE, COUNTRY HEARINCl OR TRIAL DATE

2 06/2fl,'2010 21: ~14 FAX @004

APPLICATION FOR PROFESSIONA~LETE APPLICANT NAME: ~ ,,..,\ t'\I\C. ·"' Section 6. Please Print the Following Information:

Name ~------~----Ralat ionshlp Address ______PhoneNumber. City ______state ______zip Code ______- Country ____

AUTHORIZATION TO RELEASE INFORMATION

Authority to provide the California State Athletic Commission with this Information is established pursuant to Sections 18640, 18642 and 18643 of the Business and Professions Code. Disclosure of your saclal security number Is mandatory pursuant to Section 30 of the Business and Professions Coda and Pub. L.94-455 ( 42 USCA 405 ©©authorizes collection of your social seourity number. Your social security number will be used exclusively for tax enforcement purposes, and for purposes of compliance with any judgment or order for family support In accordance with Section 17520 of the Family Code. The social security number Is also used to report and credit boxer pension fund payments in implementing Sections 18880, 18881, 18882, 18883, 18884, 18 887, and 18888 of the Business and Professions Code. If you fail to disclose your social security number your application for Initial or renewal license will not be processed AND you will be reported to the Franchise Tax Board, which may assess a $100 penalty against you.

All Items in this appllcation are mandatory; none are voluntary. Failure to provide any of the requested Information will result In the application being rejected as incomplete, The information provided wlfl be used to determine quallficatlon for licensure, Information on your application and physical examination report may be released to law enforcement agencies. Applicants have the right to review their application subject to the prov! slons of the Information Practices Act. The Executive Officer is the custodian of records. -· ... APPLICANT~DE~C,c'-L~A~RA~Tl,..,....O-,;..N"""------1

This Item ls VOL.UNTARY. You do not have to ch&ol< this box,

[ J I hereby authorize the California State Athletic Commission to release my telephone number 10 any commission licensee for contact u oses. This authorization shall bo valld durln the licanse ear In which this a Ucation is si ned.

Daec.mtar 2007-27

3 .0 c\. 14. 20 0 9: , 9: 52 AM No. 4097 1jP 6

·O'!'/',TII O" &IA~lllllJRNIA California State Athletic Oomrnlsulon 2006 Evergreen St., sie. 2010 Sacramanm, CA 96816 www.doa.oa.gov/csec/ t1m,'R1MtNl OJI COMiUMe~ IIFf-AIHl!. (916) 20).2195 F~ (915) 263-2197

Authorization to Use and Disclose Prot.ected ·Health Information

The Oallfomla Sbite Athletic Commission is a public health authority, as defined in 45 CFR 164.501, oxompt from HIPAA, end le authorized by 'California Business and Professions Code Sections 18800 et seq. to collection information about the applloanfe mental and physical health.

I hereby authorize my personal physlalans and other healthcare providers and all hospitals or similar ltmltutlons or organ1%8tlon11 to furnish to the California State AthleHo Commission or its successors ooplas of all my medical reoorda, hospltal records. records of-treatment for drLJg and/or alcohol abueo or dependency, or other information requested by that Commission In oonnec:tlon with this applicaUon or any further or fUture Investigation by that Commission necessary lo determine my fltnese ·for lloensure.

I further authorize the Commission or its suoceaaore to release any medical er other personal Information with re•peot tc my applioation or licsrisure to the organizations, lndlvlduale or groups listed above and to other regutalory bodlGa. The Commlaslon Will release this information only lo those athletic ~mmleelons (or slmilar regulatory bodies) that have a J'lijEfd to know, ee determinad by the Commission. Thie disolosure or r"oordu I& requited for official use, Including Investigation of my fltnHs for lloensure by the Commission. I understand that the realplent of my Information Is not a health plan or haalth care provloer and the released Information may no longer be protected by 1tScleral prlvaoy regulations, I undemand that I have a right to receive a copy of this authorization If l request It. I may lnti:,ect or obtsin a copy of the protected health lnfonnationthat I em being asked to disclose.

I understand -that I llave a right to revoke this authorization by eendlng written notiflcaHon to the California State Athletic Commission, 2005 Evergreen St., Suite 2010, Sacramenlo, Ce!lfornla 96815. I un

This authorization .shall remain valid for one year from the date a license Is l6SUad to me. A copy of this aulhorizatian shall be as valid as the orlglnal.

Applicant en.- Name Signature St D. : 2(: 'i C 6 : 18 P~i N0. 4288 D 1

UCLA OLYMPIC ANALYTICAL LABORATORY 2122 Granville Avenue Los Angeles, CA 90025-6106 Tel: (310) 825-2635 Fax: (310) 206-9077

DATE: ~ o

TO: Ca. J ~ ,{uv::Lr\ 1· Oi ,s,z;vf~e

,J,Hn ·, Seu-ab i2 g k I~-L

FAX#; qI 0 -- 2. 63 2 [ lt J

FROM: SaNc;.tr:n

NUMBER OF PAGES (including cover page): ---'-L-+-r _.,----1,1-~p______

MESsAGn:, Dv:4 r,.,, h·1; ~fO o. ~ c,s H s s <')l , ~p

This message is intended only for the party to which it is addressed. It contains confidential information. If you have received this message in error, please contact the sender at one of the above numbers immediately. Thank you. CONTESTANT'S NAME I REMARKS

Dennis Hallman Ben Saunders

Christian lVlotecraft ------·-" Stefan Struve Todd Brown

Tim Boetsch

Charlie Brenneman Johny Hendricks

Rodney Wallace

Phil Davis Rick Story

Dustin Hazelett Junior Dos Santos Roy Nelson Ricardo Almeida

Matt Hughes -·------+------1 Rafael Dos Anjos Clay Guida Thiago Alves Jon Fitch

ChaelSonnen - 1- c\ ~ L--L\ J.... \ \~L- ~ Anderson Silva

'\ ) ' WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

REPORTING AND EVALUATION GUIDANCE FOR TESTOSTERONE, EPITESTOSTERONE, TIE RATIO AND OTHER ENDOGENOUS STEROIDS

1. Introduction:

This guide has been prepared to ensure that Laboratories can report, in a uniform way, the presence of abnormal profiles of urinary steroids resulting from the administration of testosterone or its precursors, androstenediol, androstenedione, dehydroepiandrosterone (DHEA) or a testosterone metabolite, dihydrotestosterone or a masking agent, epitestosterone. It also provides guidance to the Testing Authority on how to conduct the evaluation of Adverse Analytical Findings reported by the Laboratories.

It is proven that administration of these steroids alters one or more of the parameters of the urinary steroid profile. Elevated levels of urinary metabolites, which are part of the "steroid profile", e.g. testosterone, epitestosterone, dihydrotestosterone, androsterone, etiocholanolone, DHEA as well as other specific metabolites are not consistent with normal endogenous production an:l result from the intake of these steroids. Increased ratios of specific pairs of steroid metabolites are also indicative of the administration of these endogenous steroids.

It is emphasized that the following requirements shall be applied by all Laboratories in their routine practice.

2. Specific requirements for GC/MS measurement of TIE value, concentration of testosterone, concentration of epitestosterone:

The TIE value is given by the pealc area or peak height ratio of testosterone and epitestosterone (equivalent to the glucuronide) obtained by measuring the ion at m/z 432 by GC/MS analysis in a Single Ion Monitoring mode (SIM). The TIE value is usually measurable regardless of the concentration of both steroids. Whether measured from the Screening Procedure or the Confirmation Procedure, it must be corrected using an appropriate standard (e.g. calibration curve, quality control sample(s) or authentic standard solutions of both testosterone and epitestosterone). The concentration of testosterone and epitestosterone (equivalent to the glucuronide) should be estimated but should not be used to determine the TIE value. In the case of high TIE values, the concentration of epitestosterone is frequently low and it may not always be possible to measure epitestosterone precisely. In such cases, only the concentration of testosterone (equivalent to the glucuronide) is to be determined.

The Screening Procedure which is normally conducted on a single aliquot shall be carried out including, together in the same batch, a control sample where the T/E value, concentrations of testosterone and epitestosterone are known.

Reference ranges of the various parameters of the urinary steroid profile have been described for populations of both males and females. It filould be borne in mind that there is significant

Page 1 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004 variation between individuals . A normal level for one individual may in another be elevated and be consistent with doping. The Laboratory will adapt its testing procedures to the Sample tested; for example, female or male, Asian or Caucasian (when the information is provided). The concentration of urinary steroids such as testosterone and epitestosterone varies greatly between individuals and also depends upon the specific gravity of the urine Sample; only values corrected for a specific gravity value of 1.020 can be compared.

It is recommended that a urine Sample in which any one of the following criteria is met during the Screening Procedure, be routinely submitted to the IRMS analysis: i) TIE value eqml or greater than 4; ii) concentration of testosterone or epitestosterone (equivalent to the glucuronide) greater than 200 nglrnL I; iii) concentration of androsterone or etiocholanolone ( equivalent to the glucuronide) greater than 10,000 nglmL 1; iv) concentration of DHEA (equivalent to the glucuronide) greater than 100 nglmL 1.

It is recognised that other parameters may justify a need for IRMS study and the reason should be documented.

Any result that will be used to support an Adverse Analytical Finding shall be confirmed and quantified.

Confirmation of elevated TIE values, concentration of testosterone, epitestosterone or any other steroid metabolite under consideration is to be performed in triplicate. The confirmation of the identity of any steroid reported with abnormal properties must be made (refer to technical document TD2003IDCR). Appropriate calibration (e.g. calibration curve, deuterated standards, quality control samples) is to be included in the protocol of the Confirmation Procedure.

Confirmed elevated concentration of steroids will be reported as such together with the value adjusted for the specific gravity of the urine Sample using the following formula:

Concentration1.020 nglmL = (1.020 - 1) I (Specific gravity oftheSamp/e-1) • Concentration measured ng/rnL

The urine Sample is not collected under sterile conditions, and where the circumstances are favourable, the microbes present in the Sample can cause changes to the profile of the urinary steroids. Initially there is cleavage of the glucuronides and sulfates followed by modifications of the steroids' structure by oxido-reductive reactions. To report an Adverse Analytical Finding of an elevated TIE value, testosterone or epitestosterone concentration or any other endogenous steroid parameters, the concentration of free testosterone and/or epitestosterone in the specimen is not to exceed 5% of the respective glucuroconjugates. Elevated amounts of 5cx- and 5.B-androstan-3,17- dione in the free form also indicate microbial degradation.

1 Concentrations adjusted for a specific gravity value of 1.020

Page 2 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

3. Isotope ratio mass spectrometry:

When a parameter of the steroid profile indicates a need to further study, its 13 C/12C value expressed in delta units per mil (d 0!00) or that of its metabolites will be measured and compared to that of urinary reference steroids within the sample not affected by administration. Depending upon the nature of the endogenous steroid suspected to have been administered, the metabolites analysed could be testosterone, epitestosterone, androsterone, etiocholanolone, the androstanediols, DHEA, or other relevant metabolites while the urinary reference steroid usually analysed by the Laboratories is one of, pregnanediol, pregnanetriol, cholesterol, 11- hydroxyandrosterone or 11-ketoetiocholanolone. The instrumentation should be calibrated with an appropriate Reference Material

The results will be reported as consistent with the administration of a steroid when the 13 CJ12C value measured for the metabolite(s) differs significantly i.e. by 3 delta units or more from that of the urinary reference steroid chosen. In some Samples, the measure of the 13 CJ12C value of the urinary reference steroid(s) may not be possible due to their low concentrafon. The results of such analyses will be reported as "inconclusive" unless the ratio measured for the metabolite(s) is below -28%0 based on non-derivatised steroid.

4. Reviewing and evaluating test results:

The following actions should be requested by the Testing Authority in agreement with the Laboratory:

• Isotopic ratios (13 C/12C) of the relevant metabolites should whenever possible be measured each time an· elevated parameter of the steroid profile is estimated from the Screening Procedure or Confirmation Procedure and reported to the Testing Authority as having been determined. If the Laboratory does not have the capability to conduct such testing, the Samples are to be securely transferred ensuring the Chain of Custody to another Laboratory with the requisite capability.

• The results of the IRMS analysis and/or of the steroid profile measured by GC/M.S shall be used to draw conclusions as to whether a doping violation may have been committed. If the IRMS study does not readily indicate exogenous administration, the result should be reported as "inconclusive" and if necessary further longitudinal studies performed.

• When available, the athlete's previous tests on record at the Testing Authority should be accessed and the corresponding steroid profile data requested from the relevant Laboratory. These results should be examined and considered together with the existing evidence (longitudinal study).

Page 3 of 11 'C t (L WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

• If, for any reason, an IRMS analysis cannot be carried out satisfactorily ( e.g. insufficient volume of mine, amount of analyte too low to enable a valid measurement) or the examination of previous test results raises suspicions due to unstable profile values, up to three further unannounced tests should be carried out, preferably within a three months period following the report of the suspicious analytical result. There should be a minimum total of three results, other than the abnormal Sample, of either past or post data. A Sample in which the elevated parameter is again measured is to be analysed by IRMS as described above. In difficult cases longer monitoring may be required.

5. Evaluation of longitudinal studies:

In males, the individual TIE values have been shown to vary from their mean value by less than 30% (screening values). In females, a low concentration of some urinary steroids such as epitestosterone and testosterone, close to the limit of detection using current analytical methods occurs. Normal variation of up to 60% may be expected. The individual basal TIE value should be determined from at least three test results, excluding the suspicious result under consideration. The mean, standard deviation and coefficient of variation (expressed in percent) should be calculated for those three basal values. If the suspicious test result, when compared to the basal value using appropriate statistical evaluation is found to be significantly different, that will constitute a proof of the administration of a source of testosterone. It is understood that the basal value may be calculated from previous screening test results. The comparison of screening results and confirmed results is acceptable.

The same reasoning applies to any other parameter of the steroid profile which has been estimated to be in an amount exceeding the ranges of values normally found in humans.

6. Other parameters:

Other parameters such as the ratio of urinary testosterone to Lutenising Hormone (T/LH) and the androsterone to testosterone ratio (A/T) may be used to provide extra information to help determine the use of some substances especially injected testosterone and many of its esters. A high T/LH ratio may be used as ancillary evidence. The A/T ratio which has markedly changed from the "normal" value found for an individual during a longitudinal study may indicate which type of substance has been used. A change to high value can indicate testosterone use and a change to low values may indicate the use of testosterone precursors such as DHEA. However, any administration of testosterone and of its precursors, arrlrostenedione or DHEA will not necessarily alter the excretion of LH and epitestosterone glucuronide.

Page 4 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

7. Examples of specific urinary metabolites potentially altered by the administration of "endogenous steroids";

Urinary steroid Steroid administered

Testosterone ( G) Testosterone, androstenedione, DHEA Epitestosterone (G) Epitestosterone TIE (G) Testosterone, androstenedione, DHEA Androsterone ( G) Testosterone, DHT, androstenedione, DHEA and androstenediol Etiocholanolone (G) Testosterone, androstenedione, DHEA and androstenediol DHEA (G) (S) DHEA 6a-OH Androstenedione (G) Androstenedione 6P-OH Androsterone (G) Androstenedione 6P-OH Etiocholanolone(G) Androstenedione 6P-OH Epiandrosterone (S) Androstenedione 7P-OH DHEA/16a-OH Androsterone (S) DHEA 7-OH DHEA, 7 keto DHEA 7 keto DHEA

* G indicates the glf,lcuronide and S indicates sulphate conjugation.

The official text of the technical document Reporting and Evaluation Guidance for Testosterone, Epitestosterone, TIE Ratio and other Endogenous Steroids shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail.

8. References:

Aguilera R., M. Becchi, H. Casabianca, C.K. Hatton, D. H. Catlin and B. Starcevic, Improved method ofdetection oftestosterone abuse by gas chromatography /combustion/ isotope ratio mass spectrometry analysis ofurinary steroids, J. Mass Spectrom. 31 (1996) 169

Aguilera, R., Catlin, D.H., Becchi, M., Phillips, A., Wang, C., Swerdloff, R.S., Pope, H.G., and Hatton, C.K. (1999). Screening for exogenous testosterone by isotope ratio mass spectrometric analysis ofone pregnanediol and two androstanediols. J. Chromatogr.B. 727:95.

Aguilera, R., Chapman, T.E., and Catlin, D.H. (2000). A rapid screening assay for measuring urinary androsterone and etiocholanolone 813 C (° Ioo) values by gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Commun. Mass Spectrom.14: 2294.

Aguilera, R., Chaprmn, T.E., Starcevic, B., Hatton, C.K., and Catlin, D.H. (2001). Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on

Page 5 of 11 ,?f \ n WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

urine dials: controls and athletes with elevated testosterone/epitestosterone ratios. Clin. Chem. 47: 292.

Aguilera R, Hatton CK, Catlin DH, Detection of epitestosterone doping by isotope ratio mass spectrometry. Clin Chem. 2002;48( 4):629-36.

Ayotte C., Charlebois, A., Lapointe, S., Barriault D. and Sylvestre M. : Validity ofurine samples: microbial degradation. Recent advances in doping analysis. Proceedings of the 14th Koln Workshop on Dope Analysis, Institut fur Biochemie, Koln, Germany, March 17-22, 1996, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln, pp 127-137 (1997).

Ayotte C., D. Goudreault, A. Lajeunesse, M. Cleroux, Y. Richard, A. Charlebois, J. -P. Couture and A. Fakirian: GCICIIRMS and GCIMS in "Natural" Steroids Testing, in Recent Advances in Doping Analysis (9), Proceedings of the 19th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (2001) p. 133

Ayotte C., Evaluation of elevated testosterone/epitestosterone values in athletes' urine samples, IAF New Studies in Athletics, 12:2-3 (1997) p. 87 and reference cited

Ayotte C.: The integrity ofurine samples: the effects oftemperature and bacteria on the validity of the analytical result. Proceedings of the IAF Seminar 1995, Paris, France, October 10-11, 1995, in " Harmonisation of Doping Issues in the IAAF ", p. 127-13 8 (1997)

Baenziger J. and L. Bowers, Variability of TIE ratios in Athletes, Proceedings of the 11 th Cologne Workshop on dope analysis, 111 to 12th March 1993, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth eds, Sport und Buch Strausse Edition Sport, Koln (1994) p.41

Bassindale T., D.A Cowan, S. Dale, A.J. Hutt, A.R. Leeds and A.T. Kiernan, Disposition of androstenedione and testosterone following oral administration of mdrostenedione to healthy female volunteers: influence on the urinary TIE ratio, in Recent Advances in Doping Analysis (10), Proceedings of the 20th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport an:l Buch Straub, Koln (2002) p. 51

Becchi M., R. Aguilera, Y. Farizon, M. M. Flament, H. Casabianca and P. James, Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport, Rapid Commun. Mass Spectrom., 8 (1994) 304

Bosy, T.Z., Moore, K.A., and Poklis, A. (1998). The effect of oral dehydroepiandrosterone (DHEA) on the urine testosteronelepitestosterone (TIE) ratio in human male volunteers. J. Anal. Toxicol. 22 (6): 455.

Bowers, L.D. (1999). Oral Dehydroepiandrosterone supplementation can increase the testosterone /epitestosterone ratio. Clin. Chem. 45 (2): 295.

0-­ Page 6 of 11 \. <7"' WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

Carlstrom K., E. Palonek, M. Garle, H. Oftebro, J. Stanghelle and I. Bjorkhem, Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 alpha-hydroxyprogesterone, Clin. Chem., 38 (1992) 1779

Catlin D. H., C. K. Hatton and S. H. Starcevic, Issues in detecting abuse ofxenobiotic anabolic steroids and testosterone by analysis of athlete's urine, Doping in Sport Symposium, Clin.Chem.,43(7) (1997) 1280

Catlin D. H., C. K. Hatton, P. W. Straus and B. Starcevic, in D. A Cowan and AT. Kiernan (eds), Control of Doping with Anabolic Agents, Proceedings of the Scientific Meeting of the 4th Permanent world Conference on Anti-Doping in Sport, London (1993) p. 2

Catlin D.H., Leder BZ, Ahrens BD, Hatton CK, Finkelstein JS. Effects of androstenedione administration on epitestosterone metabolism in men Steroids. 2002 Jun;67(7):559-64.

Cowan D. A, AT. Kiernan, C. J. Walker and M. J. Wheeler, Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes, J. Endocrinol., 131 (1991) 14 7

Dehennin L. and A M. Masumoto, Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport, J. Steroid Biochem. Mol. Biol., 44 (1993) 179

Donike M., H. Geyer, M. Kraft and S. Rauth, Long-term Influence ofAnabolic Steroid Misuse on the Steroid Profile, in P. Belotti, G. Benzi, A Ljungqvist eds., Doping in Sport, Monte Carlo 1989, International Athletic Foundation, Monte Carlo ( 1990) 107.

Donike M., K.-R Barwald, K. Klostermann, W. Schanzer and J. Zimmermann, Nachweis von exogenem Testosteron in Sport: Leistung und Gesundheit, H. Heck, W. Hollmann, H. Liesen, R Rost eds, Deutscher Arzte Verlag Koln, (1983) 293;

Donike M., S. Rauth and A Wolansky, Reference Ranges of urinary endogenous steroids determined by GC/MS, Proceedings of the lOt Cologne Workshop on dope analysis, 111 to 12th June 1992, M. Donike, H. Geyer, A Gotzmann, U. Mareck-Engelke, S. Rauth eds, Sport und Buch Strausse Edition Sport, Koln (1993) p.69

Donike M., S. Rauth, U. Mareck-Engelke, H. Geyer and R. Nitschke, Evaluation of longitudinal studies, the determination of subject based reference ranges of the TIE ratio, Proceedings of the llt11 Cologne Workshop on dope analysis, 1h to 12th March 1993, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth eds, Sport und Buch Strausse Edition Sport, Koln (1994) p.33

Donike M., Steroid Profile in Cologne, Proceedings of the 10th Cologne Workshop on Dope Analysis, 1h to lib June 1992, M. Donike, H. Geyer, A Gotzrnann, U. Mareck-Engelke, S. Rauth eds, Sport und Buch Strausse Edition Sport, Koln (1993) p.47

Page 7 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

Donike M., U. Mareck-Engelke and S. Rauth, Statistical evaluation of longitudinal studies, part 2: the usefulness of subject based reference ranges, Proceedings of the 12th Cologne Workshop on Dope analysis, Koln 1995 p. 157

Falk 0., E. Palonek and I. Bjorkhem, Effect of Ethanol on the Ratio between testosterone and epitestosterone in urine, Clin. Chem., 34(7) (1988) 1462

Flenker U. and Schanzer W., Kinetic isotope effects during metabolism of delta-4-steroids, in Recent Advances in Doping Analysis (9), Proceedings of the 19th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (2001) p. 179

Leder BZ, Catlin DH, Longcope C, Ahrens B, Schoenfeld DA, Finkelstein JS. Metabolism of orally administered androstenedione in young men.J Clin Endocrinol Metab. 2001 Aug;86(8):3654-8.

Garle M., R. Ocka, E. Palonek and I. Bjorkhem, Increased urinary testosteronelepitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases, J. Chromatogr. B, 687 (1996) 55

Garle, M., and Palonek, E. (1998). Androstenedione: excretion studies from single and multiple dose experiments. In: Recent advances in doping analysis (6), Proceedings of the Manfred Donike Workshop, 16th Cologne Workshop on Dope Analysis, 15th to 20th March 1998, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke, (Eds,), Verlag Sport und Buch Strat:43, Edition Sport, p. 181. Koln, Germany.

Geyer H., U. Mareck-Engelke, W. Schanzer and M. Donike, The Cologne protocol to follow up high testosterone/epitestosterone ratios, in Recent advances in doping analysis (4), Proceedings of the 14th Cologne Workshop on dope analysis, 12th to 1?1h March 1996, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1997) p.139

Geyer H., W. Schanzer, U. Mareck-Engelke and M. Donike, Factors Influencing the Steroid Profile, in Recent advances in doping analysis (3), Proceedings of the 13th Cologne Workshop on dope analysis, 12th to 1~ March 1995, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1996) p.95

Hemmersbach P., K. I. Birkeland, J. R. Norli and S. H. Ringertz, Urine Storage Conditions and Steroid Profile Analysis, in Recent Advances in Doping Analysis (4), Proceedings of the 14th Cologne Workshop on Dope analysis, 1th to 1~ March 1996, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1997) p.99

Horning S., H. Geyer, M. Machnik, W. Schanzer, A. Hilkert and J. Oepehnann, Detection of Exogenous testosterone by 13 C/2C Analysis, in Recent Advances in Doping Analysis (4),

Page 8 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

Proceedings of the Manfred Donike Workshop 14th Cologne Workshop on Dope Analysis, 1th to 22nd March 1996, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1997) p. 275

Kazlauskas, R., Effects ofDHEA on urinary steroids, in Recent Advances in Doping Analysis (5), Proceedings ofKoln Workshop, (1997) p. 83

Kiernan A. T., H. Oftebro, C. Walker, N. Norman and D. A. Cowan, Potential use ofketoconazole in a dynamic endocrine test to differentiate between biological outliers and testosterone use by athletes, Clin. Chem., 39 (1993) 1798

Kiernan A. T., R. V. Brooks, S. C. Collyer, D. A. Cowan, M. N. Nanjee, G. H. Southan and M. J. Wheeler, Criteria to indicate testosterone administration, Br. J. Sport Med., 24 (1991) 253

Levesque J.-F. and Ayotte C. : The oral administration of DHEA : the efficiency of steroid profiling, in Recent Advances in Doping Analysis (7), Proceedings of the 17th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (1999) p. 213

Levesque J.-F. and Ayotte, C. : Criteria for the detection ofAndrostenedione oral administration, in Recent Advances in Doping Analysis (7), Proceedings of the 17th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (1999) p. 169

Liu X., Zhang Y., Wu M. and Zhang C., The steroid profiles after oral administration of testosterone undecanoate with different doses, in Recent Advances in Doping Analysis (7), Proceedings of the 1J1h Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (1999) p. 311

Mareck-Engelke U., H. Geyer and M. Donike, Stability ofSteroid profiles, Proceedings of the 10th Cologne Workshop on dope analysis, 1h to 12th June 1992, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth eds, Sport und Buch Strausse Edition Sport, Koln (1993) p.87

Mareck-Engelke U., H. Geyer and M. Donike, Stability of Steroid profiles (4): The circadian rhythm of urinary ratios and excretion rates of endogenous steroids in female and its menstrual dependency, in Recent advances in doping analysis (2), Proceedings of the lih Cologne Workshop on dope analysis, 10th to 15th April 1994, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1995) p.135;

Mareck-Engelke U., H. Geyer and M. Donike, Stability of steroid profile (2) : excretion rates from morning urines, Proceedings of the 11 th Cologne Workshop on Dope analysis, Koln 1994 p. 85

Page 9 of 11 . \p \ () WADA Technical Document-TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

Mareck-Engelke U., H. Geyer and M. Donike, Stability of steroid profiles (3) : ratios and excretion rates of endogenous steroids in male urines collected over 24 hours, Proceedings of the 12th Cologne Workshop on Dope analysis, Koln 1995 p. 121

Mareck-Engelke U., H. Geyer, U. Schindler, U. Flenker, R. Iffland and M. Donike, Influence of Ethanol on Steroid Profile Parameters, in Recent Advances in Doping analysis (3), Proceedings of the 13th Workshop on Dope Analysis, Ith to 17th March 1995, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, Sport und Buch Strau? ?dition Sport, Koln (1996) p.143

Mareck-Engelke U., U. Flenker and M. Donike, Stability of Steroid profiles (5): The annual rhythm of urinary ratios and excretion rates of endogenous steroids in female and its menstrual dependency, in Recent advances in doping analysis (3), Proceedings of the 13 th Cologne Workshop on dope analysis, 1th to 17th March 1995, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1996) p.177

Mareck-Engelke U., U. Flenker and W. Schanzer, Stability of Steroid profiles (6): The influence of oral contraceptives on steroid profiles, in Recent advances in doping analysis (4), Proceedings of the 14th Cologne Workshop on dope analysis, 12th to 1?1h March 1996, M. Donike, H. Geyer, A Gotzmann, U. Mareck-Engelke, eds, Sport und Buch Strausse Edition Sport, Koln (1997) p.139

Namba 0., Y. Miyachi, M. Irie and Y. Kuroda, Urinary testosterone and epitestosterone secretion in a doping positive subject, International Congress of Endocrinology, Kyoto, 1988, Abstract 16- 22-324

Palonek E. and M. Garle, Single Injection of Testosterone to 7 Volunteers : Results from this Study, in Proceedings of the 10th Cologne Workshop on Dope analysis, M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke and S. Rauth (eds), Sport und Buch Strausse, Edition Sport, Koln, 1993, p. 131

Raynaud E., M. Audran, J. F. Brun, C. Fedou, J. L. Chanal and a. Orsetti, False-positive cases in detection oftestosterone doping, Lancet (Letter), 340 (1992) 1468

· Schweizer C., C. Cardis, M. Cauderay, L. Rivier and M. Saugy, TIE ratio variations through puberty in male adolescents, Proceedings of the 14th Cologne Workshop on Dope analysis, Koln 1997 p. 159

Setiawati E., Suyatna F.D., Wiria, M.S. and Ulamsari D., Profile of urinary excretion in Indonesian volunteers after DHEA administration, in Recent Advances in Doping Analysis (9), Proceedings of the 19th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (2001) p. 287

Shackleton, C.H.L., Phillips, A., Chang, T., and Li, Y. (1997). Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids, 62: 379.

Page 10 of 11 WADA Technical Document - TD2004EAAS Document Number: TD2004EAAS Version Number: 1.0 Written by: WADA Laboratory Committee Approved by: WADA Executive Committee Date: 30 May, 2004 Effective Date: 13 August, 2004

Shackleton, C.H.L., Roitman, E., Phillips, A., and Chang, T. (1997). Androstanediol and 5- · androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: Potential use in gas chromatography isotope ratio mass spectrometry. Steroids, 62: 665.

Ueki, M., and Okano, M. (1999). Analysis of exogenous dehydroepiandrosterone excretion in urine by gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Commun. Mass Spectrom. 13: 223 7.

Uralets V. P., Gillette P.A. and Latven R.K., Over-the-counter anabolic steroids 4-androsten- 3,17-dione, 4-androsten-3,17-diol and 19-Nor-4-androsten-3;17-dione: excretion studies in men, Recent advance in doping analysis ( 6), Proceedings of the Manfred Donike Workshop, 16th Cologne Workslnp on Dope Analysis, 15th to 20th March 1998,W. Schanzer, H. Geyer, A. Gotzmann and U. Mareck-Engelke (eds.), Sport & Buch Strauss (1999) p. 147;

Uralets, V.P., and Gillette, P.A. (1999). Over-the-Counter anabolic steroids 4-androsten-3,17- dione; 4-androsten-3, 17-diol and 19-nor-4-androsten-3, 17-dione: excretion studies in men. J. Anal. Toxicol., 23: 357.

Uralets V.P. and Gillette P.A. (2002). New anabolic steroids available as nutritional supplements: 5-alpha-androstan-3, 17-diol, 1, 4-androstadien-3, 17-dione and 5 alpha-androst -l -en-17 -ol-3-one, in Recent Advances in Doping Analysis (10), Proceedings of the 20th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (2002) p. 73

Van Eenoo, P., Delbeke, F. R., Desmet, N., and De Backer, P. (1998). Excretion studies with 4- androstene-3,17-dione, Recent advances in doping analysis (6), Proceedings of the Manfred Donike Workshop, 16th Cologne Workshop on Dope Analysis, 15th to 20th March 1998, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke, (Eds,), Verlag Sport und Buch Stra~, Edition Sport, p. 171. Koln, Germany.

Van Eenoo P., F.T. Delbeke, Desmet N. and De Backer P., Excretion studies with 7-keto­ dehydroepiandrosterone, in Recent Advances in Doping Analysis (9), Proceedings of the 19th Cologne Workshop on Dope Analysis, W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (editors) Sport and Buch Straub, Koln (2001) p. 91

Wright F., J.P. Lafarge, J. Antreassian, M. Lagoguey and G. Peres, in P. Hemmersbach and K. I. Birkerland (eds), Long term Study of Steroid and Peptidic Hormones in the Plasma of Healthy Young Men under Controlled Testosterone Undecanoate Therapy, in Blood Sample in Doping Control, Second International Symposium on Drugs in Sports, Lillehammer, Norway (1993), p. 65

Page 11 of 11 ~ \ 0 EDMUND G. BROrVJV JR. State of CalUomia Attorney General DEPARTMENT OF JUSTICE RONALD REAGAN BUILDING 300 SOUTB SPRJNG STREET, SUITE 1702 LOS ANGELES, CA 90013 Public: (213) 897-2000 Telephone: (213) 897-8944 Facsimile: (213) 897-2804 E-Mail: [email protected]

October 4,2010 Sent by Facsimile and ~V First Class Mail

Howard L. Jacobs, Esq. Law Offices of Howard L. Jacobs 2815 Towns gate Road,· Suite 200 Westlake, CA 913 61

Re: CSAC v. CHAEL SONNEN

Dear Mr. Jacobs:

I am in receipt of your correspondence to California State Athletic Commissioner Executive Officer George Dodd dated September 29, 2010.(two letters) and September 30, 2010.

Your request for your client's appeal to be heard on the December 2, 2010 meeting calendar will be accommodated. Please be advised that the December meeting will be held in Sacramento, California, at a site to be detennined, and you will be notified.

I am faxing you along with this letter all the paperwork I have on this case. The paperwork from the lab indicates that Mr. Sonnen signed a declaration that he had taken 1 shot of Testosterone on August 5, 2010, so presumably you would not be challenging this specific laboratory finding.

However, should you be interested, as I indicated to you on the phone, you may request a litigation packet to be prepared by the laboratory, as we do not as a matter of routine order them. The lab will contact George to obtain his approval.

As far as the other items you have requested in your conespondence, items 1-8 would necessarily come directly from the lab.

To the extent that they exist, I will obtain and forward to you any documents from the Commission relative to your requests 1-7 September 29,2010 and items 1-5 September 30, 2010. Howard L. Jacobs, Esq. October 4, 2009 Page 2

The procedures for the conduct of the appeal have not changed since the last time you and l did one in Los Angeles. If you have any other questions, please do 11ot hesitate to contact me.

Thank you.

i~u-vf~KAREN B. CHAPPELLE j Supervising Deputy Attorney General

For EDMUND G. BROWN JR. Attorney General

Enclosures cc: George Dodd, Executive Officer, California State Athletic Commission

KBC:hg Callfomla State A:tnllltic: Commission c::ICa 2006 Evergreen Street. Suite 2010, Sacramento. CA, 95825 P B1f5..263-219S F 916-263-:2197 www.dce.Cil.gov1csac

September 16, 2010

Chae! Sonnen

Notice of Suspension and Fine

Dear Mr. Sonnen:

The results of your steroid test taken on August 6, .201 Owere received on September 2, 2010 and they were positive. Attached are the results from the Lab.

Tltle 4 California Code of Regulations, Section 303 states in part:

The administration or use ofany drugs, alcohol or stimulants, or injaations in any part of the body, either before or during a match, to orby any boxer is prohibited.

Based on the positive laboratory findings, your California license as a Mixed Martial Arts athlete is herby suspended for 1 year, beginning on September 2, 2010 and you are

fined $2 1500,

Per Business and Professions Code section 1B842, you have a right to .appeal this denial before the Athletic Commission. You mustsubmit your appeal request, in writing, within 30 days of the date of this letter. Upon receipt of your request, your appeal will be included on the agenda for the next available commission meeting.

If you, have any questltms, please feel free to contact me at any time (916) 263-2195.

Respectfully,

George Dodd Executive Officer California Athletic Commission 2005 Evergreen st. Suite 2010 Sacramento, CA 95815 Office (916) 263-2195 Fax (916) 263-2197

-·· "\ 6 1 /Z0 39\Jd l612';E9Z916 SS :z:1 010Z/1z;/60 "-" Sep. 3. 2010 6: 18 PM No. 4288 F. 4

' r. . UC2.A Olympic Analytical Laboratory AD!H;T ') UCLA S0h00l of Medicine . ■~alll!l'IM II l'I' D 2122 Granville Ave. Loa. An9eJe&1 CA 90025 ACCIU!t>l'l'lill \ ' ISO/IEC 170.26:2005 , . Phcme (310) 825-2635 Fax {310) 206-9077 ·. -, Chemical iesting • Certificate: 1420,01 . CONfJ:D)ffiTIAL D:RtJG fBSTING REPORT OSAC55 (RKI.,0.9)

Sept.ember 02, 2()10

California State Athletic Commission Attn, Sarah Waklee 200; Evergreen Street, Ste. 2010 Sacramento, CA 35815 Fax.; (915) 263-219?

Dear Ms. Waklee;

This is a supplemental report for CSAC 2487996 • UC!LA J.EL09, MMA, dollection date August os, 2010 and date received August 10, 2010.

Urine Qpecimen -number CSAC 2487996 = UCI,A JUCL09 ha• T/E ratib 0£ 16. 9 .:t 17% (k•.2) , The threshold T /E :r-atio iei 4, 0 . W11J1 :rec0:inrnen.d oai:bon , - i•otope rat~o analysis and/or lcngitu4ina1 follow-up.

Brian Ahrens Certifying Scientist , '~ure Date'

This report shall not be reproduced, e~oept in full, without tbe written. approval of the .laborato:ry. Pagel of l

E, l/E:0 39\;/d L5 tZ:E9Z:9 tE, Sep. 14. 2010 10:27AM No. 4326 P. 2/3

UCLA Olympic A:nalytioal Laboratory ~i;::H1""•N~ AC a . 2122_ ~ranv-iJle Ave, Lo.s Angeles, CA 90015 ACOREDITe Phone (31 O) 826-2630 Fax (S1 O} 206•9017 ISO/IEC 1'7'02512006 Ch111mlcal T•atiO(I Certifieste; 1420.01 CONFIDENTIAL Carbon lsot'ope .Ratio Report- CSAC55 (RKl,09)

September 14. 201°0

Califw:nia St&tt: Athl-:tic Commission Attn: Sarah Waklee 2005 Evergreen St1-ee~ Ste. 20 l 0 Sacramento~ CA 95815 Fax: (916) 263-2197

Sp-=~cn ntimbcr: 2487~96 UCLA Code: R.KL09 Sport: MMA Colleotion date: 0S/06/10 Date R.cccived &tLab: 08/10/10 Date of.Analysis: 09/07/10 Condition and custody of swple;, Ac0cptabk

A.Dalysis: The urine sample was analyzed using method 8001. ste1•oids by carbon isotope ratio by GC/IRMS.

Analytical Findings:

IRMS L11boratory Iusult: . A(fdiol~Btio) A

• Where 11Inconc:lu1iivc 11 or 11 Negative 11 indicates results are consistent with endogenous origin and '' A.d:verse" indicates results are consistent with adminisn:11.tion of a steroid. \,·. ''. Unit of measurement for the two values is 613C [°/0J. The Yalue after the :i: is the uncertainty of measurement (k=2),

Brian Ahrens Certifying Scientist Signature Date

This report shall not bi:: repi:oduced, ·except in full, withoui: the written approval ofthe laboratory. · Page 1 of 1 ·

51./P0 39'i:ld :l'i:1S8 L51.Z:E9Z915 99:z;i: 01.0Z:/1Z:/50 /), /\ ~ UCLA OLYMPIC ANALYTICAL LABORATORY DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE 2122 GRANVJL.l.f:: AVeNUE; LOS ANGEU!S, CA 90025 (310) 825•2635 FAX (310) 20&,,9077

LA80RATORY/SA.MPLE INFORMATION

sample Collection Date

TEST CONDUCTEP FOR THE CALIFORNIA STATE ATHLETIC COMMISSION Anabolic Steroids and Masking Agents

1~ /tt IBh J9 J9 I(p I I SAMPLE CODE NUMBER

SpecHic Gravity and PH levels within raoge? .--- 't"i!!! ____ NO Specfflc Gravit~: Grea1er than r;,r equal 10 1.005 PH: Not less tnan 5.0 ar,d not greater 1111111 7.5 ~~sa?r~c:..A Collection ite Name - City, State Sport

Event Narne &v-L ¼/lw·fE

Collector Signature

Oeclaration of any reeent blooel transtuaions, a& well as any medications and other sub~amins, miner11ls, herb$, and other dietary eupplemenl$ taken durin_g the preoeclin.g three (3) days (enter "NONE'' If none declared and dtaw a line through any unuaecl epac:es) (attaetl additional tntormatlan If necessary);

Dosage Name Dosage of Substance

tO

Consent for reaearch (optional): By checking •·1 Aocept''.and signing In the space provided, I agree that thi$ 1R1111ple may be used tor anti~doplng research purposes. When anatyaes Is completed and this sample would otherwise be discarded, It may than be used by any WADA approved iaboratory for anti-duping ras11arch .of any type provided that it can no longer be Identified r.as my aampla.

_ I Accapt Al Decline

COMPL.ETED BV DONOR: I deciare under penany of perjury under the laws o1 the State of Callfomia that the foregoing information I$ true nnd correct; further I realize thast aqy intentional misrepr-esentatlon may result in disciplinary tion against my llc::cn:ae, I certify that I provided my specimen to thi, coller;tor; that I have not adulterated It in any manntm ea specimen bottle used wa:s sealed with a tarnp~r-evident seal l't"1y pre11enc.e; and that the information and _ provl d on s form and a~ed{Yl ea~. h apeclmen ~ott~e are corrc;:ot.

~ OW\ ,/\_,e_.,,. o ----'--.-C.----~~...... -=--~ _--··· t{ , (t ( i (J ~ • r7f0 tv\_ Donor Name (Pl~$e print c.:iearty) Oate Time

COMPL.ETED BY DONOR'S WITNESS: I assisted the Donor in oompletlng this form and declare unQer penalty of perjury under the tawe of the state of California, that the foregoing Information is true and correct; further I realu:e tn8t · ny intentional misrepresentation may result in disciplinary action 7 E ·::.:..~.~m, -·~ w.... ,,~ 11fJ.:- ~J P I've WHITE • Dopins Control Officer Y5l.L.OW • L.aboratory !>INK - Donor 1629•006 (12/08) .J E.'t/90 39'i7d A UCLA OLYMPIC ANALYTICAL LABORATORY , .'."""Ii DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE 2122 GFIANVILI.E.AVBNUE LOS ANG1:;l.5S, CA 90D215 (310) 825-2635 F.A)( (310) 206,9077

LABORATORY/SAMPLE INFORMATION VJ·[Jfa;·~ Sample Collection Date Sarnple Collecton Time

TEST CONDUCTED FOR THE CALIFORNlA STATE'. ATHLETlC COMMISSION Anabolic Steroids and Masking ,Agents l&-1~ lre,111 ql 9 I~1 I SAMPLE CODE NUMBER

Specific Gravity and PH levels within -range? - Yes ---,-.-Ii&-/'-- ~,1iS'S~ $1)90lfic Gravity: Cireawr than or equal to 1,005 PH: Nat les& th1111 s.o and .not gremet than 7.5 ~ \~.('\ Per~~~ Collection Site Name - City, State C>-~\\'7 Event Name ·

Collectar Signature

Declaration of any recent blood transfusions, ai; well es any medications and other substances, Including Vltamins,·ml s, herbs, and other dietary supplements taken dur:l_n.s the prEtOedl11g three (3) day& (enter "NONE~ tt none Cl w a line through any unused space&) (attaoh,.additlonal Information If necessary):

•·· '•"' ,::.. Dos~ge •• Da~, . .Name Dosage Date. • • ,LasMaken of substance Last taken - - ConsenUor,,.resear.ch (optional): ~y;cheokin9.,'.'.LA0cept",:and,_slgnln9Jn-the .space,provldecl,d ~greethaUhis sample may-be used for anti.doping r.esearch•purposes. When,analyGeS I$ completed·and this sample~would:other.wlse-~ discar.ded, It may then be 1,.1$ed by 111ny WADAapproved•laboratory for amt-doping resear0h of.any type provieled that It can no longer be ldenUfiecl as my sample.

_ LA~pt _ Ai Q_ecline

COMPLETED BY DONOR: I declare uncier penalty cf perjury under th, laws of the Slate .of California that the toregolpg informatic,n is true and correct; further I realize that any intentional mlsrepre$entation may result in di$Clpllnary a0ti0n against my licena~. I certify that I provided my specimen to the collecior; that I h11ve not adulterated it in y m r; each specimen bottle used was sealed with a tamper-evident seal In ll'_IY presence; and thtrt the Information an ber. pr an this form and ~lxJ,d to each specimen bottle are correct. S o-(\ A a.. A ---+------~ rt.e /lo ~ Donor Name (Please print clearly) Dbnor Signature Date Time

COMPLETED BY DONOR'S WITNESS: I assisted tne Donor In oornpletlng this form and declare under penalty cf perjury under the laws of the State of Callf0rnla, 1hat the foregoing Information is true and correct; further I reattze that any intentional mlsreprNentation may result in dl&clplinary action against my license.

Witness Name (Please print olealjy) Qa.te Time

WHITE - Doping Control Officor Ve.LL.OW - Labormory PINK- Donor 1629-006 (12/08) 51/90 391:;;ld L51ZE9Z:915 LJ lOPY UNIVERSI'IT OF CALIFORNIA, LOS ANGELES UCLA

BERKELEY • DA\'!S • IRVINE • LOS ANGELES • MEHCED • HIVEHSIDE • SAN DlEGU • SAN FRANCISCO SANTA llARl-lAl\A • SANTA CHUZ

UCLA OLYMPIC ANAL)"rJCAL LABORATORY DEPAHTMENT OF PATHOLOGY AND LABORATORY MEDICINE 2122 GRANVILLE AVENUE LOS ANGELES, CALIFORNIA f/0025-6!0Ci CONFIDENTIAL PHONE,· 3I0-825-2(i35 FAX: 3W-20G-fi077

October 05, 2010

California State Athletic Commission Attn: Sarah Waklee 2005 Evergreen Street, Ste. 2010 Sacramento, CA 95815

RE: Specimen Numbe~'8"3/,~(9•,..:c UCLA RKL09

Dear Ms. Waklee:

Please find enclosed the documentation package for the A confirmation on the case identified above.

Enclosed are authentic photocopies of the original documentation supporting our conclusion and the drug testing report.

Please feel free to call if you have any questions.

Sincerely, [_ Brian Ahrens Certifying Scientist

Cc: Anthony Butch, Ph.D. Director CONFIDENTIAL DOCUMENTATION

IDENTIFICATION: Organization: CSAC Sample number 2487996 = UCLA RKL09 Substances identified: T/E>4, IRMS results consistent with administration of a steroid

TABLE OF CONTENTS Page

CORRESPONDENCE AND CHAIN OF CUSTODY: Drug testing report on "A" sample...... 5 Laboratory/Sample Information Form, lab copy...... 6-7 Courier Documentation ...... 8 Batch chain of custody documentation...... 9-10 Individual seals chain of custody documentation...... 11 List of staff involved in analysis ...... 12

ANALYTICAL DATA:

"A" SAMPLE SCREENING DOCUMENTATION Screening procedure ...... 13 "A" screen aliquot chain of custody documentation ...... 14-15

TMS derivative, SIM GC-MS data, IS = d3-Testosterone Negative urine OC An.alysis report ...... _...... 16 Extracted ion chromatograms...... 17 Positive urine calibrator (androgen free urine spiked with endogenous steroids) Analysis report...... 1 8 Extracted ion chromatograms...... 19 Sample urine aliquot Analysis report ...... 20 Extracted ion chromatograms...... 21

"A" SAMPLE CONFIRMATION DOCUMENTATION: Confirmation Procedure ...... 22-23 "A" bottle chain of custody documentation ...... 24 "A" confmnation aliquot chain of custody documentation ...... 25-26 Sequence verification data ...... 27

TMS derivative, SIM GC-MS data, IS= d4-19-Norandrosterone Ne2:ative urine QC Extracted ion chromatogram of IS ...... 28 Extracted ion chromatogram and SIM scan spectrum of Testosterone ...... 28 Positive urine OC (urine spiked with Testosterone glucuronide) Extracted ion chromatogram of IS ...... 28 Extracted ion chromatogram and SIM scan spectrum of Testosterone ...... 28 Positive calibrator (unextracted testosterone and epitestosterone standards at a ratio of 4: 1) Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 1...... 29 Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 2 ...... 29 Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 3 ...... 29 Sample urine aliquot Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 1...... 30 Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 2 ...... 30 Extracted ion chromatogram and SIM scan spectrum of Testosterone - replicate 3 ...... 30 Summary table showing ion ratio data...... 31 Summary of quantification, statistical analysis and uncertainty ...... 32

Analytical run instrument validation data Tune data...... ; ...... 33 Retention time check...... 34

GC/IRMSDATA Abbreviations frequently used in the documentation...... 3 5 Confirmation procedure ...... 36 "A" bottle chain of custody documentation (refer to page 24) "A" confirmation aliquot chain of custody documentation ...... 37-42 Sequence verification data...... 43-44

Negative urine OC Androsterone and Etiocholanolone Chromatogram of ion 44 ...... , ...... 45 Table of o13 C values ...... ·...... 45 Pregnanediol Chromatogram of ion 44 ...... 46 Table of o13 C values ...... 46. Positive urine OC (negative urine fortified with andro, etio and adiols) Androsterone and Etiocholanolone Chromatogram of ion 44 ...... 47 Table of o13 C values ...... 4 7 Pregnanediol Chromatogram of ion 44 ...... 48 Table of o13C values ...... 48 Sample urine aliquot Androsterone and Etiocholanolone Chromatogram of ion 44 ...... 49 Table of o13C values ...... 49 Pregnanediol Chromatogram of ion 44 ...... 50 Table of o13 C values ...... 50 IRMS HPLC data reading record...... 51 "A" Sample Confirmation Conclusion Data Negative urine OC Total ion chromatogram and spectra (etiocholanolone and androsterone) ...... 52 Total ion chromatogran1 and spectrum (pregnanediol) ...... 53 Positive urine QC Total ion chromatogram and spectra (etiocholanolone and androsterone) ...... 54 Total ion chromatogram and spectrum (pregnanediol) ...... 55 Sample urine aliquot Total ion chromatogram and spectra (etiocholanolone and androsterone) ...... 56 Total ion chromatogram and spectrum (pregnanediol) ...... 57 Identification data evaluated according to WADA TD2003IDCR...... 58

GC/IRMS run instrument verification data Instrument verification data summary ...... 59 Peak shape verification data...... 60 Linearity and precision verification data ...... 61-63 DSQII verification data ...... 64

"A" sample laboratory pH and Specific Gravity ...... 65 "A" sample Carbon Isotope Ratio Report ...... 66 2487996 .. -.. ,,.~,P 5

UCLA Olympic Analytical Laboratory II r~:i:gOPING ft. UCLA School of Medicine ~I:~~~; §]iEDFTJ ACCREDITED 2122 Granville Ave. Los Angeles, CA 90025 1S0/IEC 17025:2005 Phone (310) 825-2635 Fax (310) 206..;9077 Chemical Testing Certificate: 1420.01

CONFIDENTIAL DRUG TESTING REPORT CSACSS(RKL09)

September 02, 2010

California State Athletic Commission Attn: Sarah Waklee 2005 Evergreen Street, Ste. 2010 Sacramento, CA 95815 Fax: (916) 263-2197

Dear Ms. Waklee:

This is a supplemental report for CSAC 2487996 = UCLA RKL09, !"lM.~, collection date August 06, 2010 and date received August 10, 2010.

Urine specimen nUitlber CSAC 2487996 = UCLA RKL09 b.as T/E ratio of 16.9 ± 17% (k=2). Tb.e threshold T/E ratio is 4.0. We recommend carbon isotope ratio analysis and/or longitudinal follow-up.

Brian Ahrens Certifying Scientist Signature Date

This reoort shall not be reproduced, except in full, without the written approval of the laboratory. Page 1 o-F 7 2487996 p6

UCLA OLYMPIC AN"ii.LYTfCAL LABORATORY DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE 2122 GRANVILLE AVENUE LOS ANGELES, CA 90025 (310) 825-2635 FAX (310) 206-9077 RKL09

LABORATORY/SAMPLE INFORMATION

Sample Collection Date Sample Collection Time

TEST CONDUCTED FOR THE CALIFORNIA STATE ATHLETIC COMMISSION Anabolic Steroids' ~nd-Masking-AgentS'-' ld-17 I >rc;S~ Specific Gravity: Greater than or equal to 1.005 PH: Not less than 5.0 and not greater .than 7 .5 ~ \ ~ C"s. C)B-u ~~ Lr:\ Collection Site Name. - City, State Sport. · L>----~ \ 1';'· ---~:_\_c__ yV\J~fl- Event Name Collector-Name (Please print clearly) i~~v·._ ~ : _ Collector Signature. ..· :----~

.Declaration of any recent blood transfusions, as well as.any medications and other substances, including vitamins, minerals, herbs, and other dietary supplements taken during the preceding three (3) days (enter "NONE" if none declar.ed-Jnd-dravia7ine through any unused spaces) (attach additional information if necessary):

Name Dosage Date . Name -Dosage Date of Substance Last taken ; of Substance Last taken· \,sy--._o.;- Tr.::- c__~>c::__~Y\C-_ t,Jo//u- ~NJ~0r--. -1''--1:-,, ~£ ----. . \---..,_\__\', C"'. e: -

---~) C"1 ~ -- ~1-=- - Consent for research (optional): By checking "l Accept" and signin_g in the space provided, l agree that this sample may ,be i.J~ed to anti-doping research purposes. When analyses is completed and this sample would otherwise be discarded, it may then be used.by an! WADA approved laboratory tor anti-doping research of any type provided that it can no longer be identified as my sample.

-_.J Accept ·Xi Decline 2487996 p7

·------···-----L...... _. __ ~---- ·------~- -·-

UCLA OLYMPIC ANAi.iffCAL LABORATORY DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE 2122 G~J;,:NYILLE AVENUE LOS ANGELES, CA90025 (310) 825-2635 FAX (310) 206-9077 "/,:,:.;~·;::, 'ffi c:.rps · LABORATORY /SAMPLE INFORMATION vJC//10 Sample Collection Date Sample Collection Time

TEST CONDUCTED FOR THE CALIFORNIA STATE ATHLETIC COMMISSION '.~-:;::."!"'"~<(·:. Anabol\C Steroid$ atld [i/J.?._Sking~Agents·· . . :::.;_-- ... .,. ---., Id, 11 ! oh 19 l9 I (pl I SAMPLE COOE"NUMBER

Specific Gravity and PH levels within range? - . . . . ¥ES · .. - · NE>--'--- "::::.~~,, .. __ Spec1f1c Gravlty:.Greater than or equal.to 1.005 . / - \ C::-.....:::>~~C PH: Not less than 5.0 and not greater than 7.5

Sport

1 .,. ~J:t, :. 'f ",-·.:··- i:c ... c:~~ :~ L V\tt ;;: )/ Event Name' Colle;:tor-Name (Plea:!e ~prin! clearly) L:\ -.------Collector Signature

Declaration of any recent blood transfusions, as well as any medications and other substari-ces,including'vitamins, minerals, herbs, ,md other dietary supplements taken during the preceding three (3). days (enter "NONE" if none declared and draw a line through any unused spaces) (attach additional information if necessary): ....

Name Dosage Date Name Dosage Date of Substance Last taken .~ofSubstance Last taken Sls/10

.. -,·- - -· \ ; vo/..,c:__,-11 F;'c) / ,, • ~.., " '" , l " \. - '- Consent tor research (optional): By checking "I Accept" and signing in the space provided, I agree that this sample may tie used tor anti-doping research purposes. When analyses is completed and this sample would otherwise be discarded, it may then be used by any WADA approved laboratory for anti-doping research of any type provided that it can no longer be identified as my sample.

_.I Accept ,XI Decline -,"'-\ 2487996 p8

., ..):'.:~;;;;~:-\~-:~)-):

.. --=-f-1db -FeclExe,-US Airb/il Tr ■ akln, :tf1-f2 -~-:"\2b·2 6 · s 18 2 Expir.ess Number

From This pdrti~ CBII be removed tor Recipient's records. 4a Express Package Service .,._,...,.... Packages up la 150 lbs. · <- { (.,;1 '/ :--.. FadEx 8 7 2"326 26518 2 · r6,,Fl!dEx:Priority Overnigln O FedEx-Standard Overnight /J Oall! c> I .. / / u Tracking Number w NutbU1111111Smaming.•frio ■r NmctDUIUIUlllulmoon." □ ~~.2::2~: ::: ) ' IN1Jlffllnts wilt b• d■ 1111n.D ~II Monday S11111n1avDllffVWV NOT 1vaU1ble. . .. d9Wlll'1DS1leeflDGllunt.• w unlessSA.TURDAYD11wer,iuUlc11d. · - :: Phone EXP ..J w w Q. Comoany C ,\LI FOR hi I(:, STA TE ~THLET IC CDM 1 4b Eicpress'Freight Service "lofflDSlloclllliML Packages aver 150 lbs. ' -~t.:: :1 ~ 2 w Address 200:5. EVERGREEN ST STE 201 0 '0. u D1pt/i1Da1/Su1111Raom w -! (Ir. citv SACR--AMENTt) State C /::, ZIP 95815

2 Y~~~_intenial Billing Re!erence

.3 6 ~pecial:~~ndling an~ Delivery Signature Options -- .• ·,1· •.·'.iL

HDLD Weekday hldErJaCllion lddrus □ IIEllU1AED.Nlllanila ... m FedExAmllvomiOI>< _- HOLD Saturday n=~:..~or:lorhd&1Dcnonllld1a . fldb2Da,1JnlldlDclas. q ,,,,.., 'i ,;-­ ZIP L,V C"-J.· CO:NFIDENTIAL 2487996 p9 UCLA OLYMPIC ANAJ.,YTIC_U LABOR4'.TORY Anthony Butch, Ph.D, Director 2122 Granville Avenu.e, Los .Angeles, CA 90025 PH (310) 825-2635 FA-X (310) 206-9077 BATCH CHAIN OF CUSTODY

I Slffil~ RELRASED BY I TO I DATE/TIME I PUP~OSE I )8-10-2010 N:ui) /7£,,j)- E'><-, ~s. TRANSFER SIGN.A TURE - PRINT - COURIER FILl., OUT CTI ON RIGHT BELOW C,:7dqt,1/)

Said shipment consists of: Airbill # or Packa£e Tracking# or descrintion [] Bags N= 868962381183 NFL (Color)__ _ ~ GS· i2--to 869826017035 NC6 A.rt- 8 ll3 Iw 870719015270 NFL f t:8-12-iD 872388723604 NFL · l<.f 1'f '>./ro 869826331953 MBB ~- ~/2 /ro

868962381194 MBB li: ·0 t · I l ·I ~ ---:::::: N0 872388186290 MBB p:. /l ft'/.. I (D G26265!82(CSAC)0? I fo ·

[] EnYelopes N== __

rother](eA'])la:in: ______~------' Integrity of the sbipmen:t is ( check one): [qfud.amaged [ Jd.Bmaged (describe: ______~

CIRCLE Al'{D INITI.. 4,.L NEXT TO TBE )...JRBIT.,L # TO Th1DICATE THE BATCH. see re-verse side for continuation. Doco:m.ent ID Rev .#4008-000 2487996 JCiter i::isuectio-,, custodv offue sbipmem/batc1- indicated on uacre #1 is as followc:· p 10 - - J - b - -· I I i R FT P.A.....SED BY I TO I DATE I PURPOSE 11 STORAGE Har ScrniarnATG~ # 4,O 08-10-2010 / ! ACCESSION\\% AUOUOT .J !111:rnmau1Hrn # u~;-13-'..:'.o·i u ~S\NRM118 ·· 10 ~Delshad

I/ FREEZER 41. 08-13-2010 STORAGE yv/]1;110 ------Lfl--

I ! ' I

: :.:.. .. , . , I ~ f ' ., ' '

., ' ., ' .

'

:Baich specific :information: .

Client: cs~C Folder #_)!,,_~..,,..../--_ .UCLA CODE :_R...,,....,$'._,_, --1-..__- The munber of A samples is:-Z-- number ofB samples is:_:j___ The number of et_e Signature Forms/ ffi.cial Records is: J The number of pecimen Custody Documents (2624) is: ___ "5:L, r _jl _ r o

G:\SOP\LOGS&FRM\CUSBATCE.2005 FormAmmw£ov , 4 ~ !/!0/0< Docum~t ID Rev-.#4oef-ooo UCLA Olympic Analytical Laboratory 2487996 SAMPLE CUSTODY - DOCUMENTATION OF SEAL INTEGRITY p 11 FOLDER: CSAC 55

LabCode BottleNumber A B If not intact, describe below RKL0l 0 0

; RKL02 0 0

RKL03 2512278 X X

RKL04 2512279 ! X X ------~------,-- ,------RKL05 2512280 ! X I X , ----· r--.. -·--· ---'------RKL06 2512281 X I X ------RKL07 2487993 i X ! X . -·-· ---- .....------RKLOB 2487995 i X. jX ------; RKL09 2487996 l X J X r----- r-- RKLlO 2487997 ! X j X ;-:-- r--- RKLll 0 0

Verify by nx that the custody of each specimen is intact, If not intact, record "No". Entries for internal QC are listed as "0".

The above samples were received in the condition stated above.

Date 8/13/2010

c." Y If I .) 2487996 UCLA Olympic Laboratory p 12 Staff/Signature List

Receiving Signature Participated Chemist 1n anaoosm Tope Akintunji 7 Albert Ambeguia Brian Bishop Yvonne Chambers ✓ Rebecca Chan F ereshteh Delshad ✓ Nadiya Seleznova Raul Torres ✓ Assay Chemist Samira Ahantab -/ Yadira Bautista Konstantin Belevich Joey Espinosa ✓ Lisette Fernandez ./ Ronald Gonzalez Anabella Leung Jeannie Lin Annie Ramseyer Victoria Robinson Mihai Stoian Yousif Wahida Irina Yarema Instrumentation Analyst Eric Ho Martin Nocelotl Lei-Ana Ruebe ·✓ George Venegas ✓ Analyst Zhenghe Dai Joe Ramnarain Lorna Reyes Kathy Schramn ✓ Borislav Starcevic Shirley Taam Confirmation Analyst Louise Laden Andrea Miller ./ Tatiana Sergeeva Certifying Scientist Brian Ahrens ./ Anthony Butch Yulia Kucherova Sanja Starcevic ·✓ A" SAMPLE SCREENING DOCUMENTATION 2487996 p 13

SCREENING PROCEDURE FOR CONJUGATED STEROIDS-2

Extraction: Urine volume 2.5 mL urine sample aliqout is centrifuged for 5 minutes at 1500 rpm. Internal standards 20 µL of methanol cocktail containing: d3-testosterone, d3-epitestosterone, d4-androsterone glucuronide, d5-etiocholanolone,

Buffer Phosphate buffer (1 mL of 0.2M phosphate buffer at pH 7) Enzyme 50 mL ofE. coli Beta Glucuronidase are added to each aliquot. Deconjugation at 50°C, for 1 hour.

Extraction after deconjugation is performed using a Zymark Rapid Trace Vil ork Station Column Empore Extraction Disk Cartridge Conditioning: methanol (0.5 mL, 0.2mL/sec), and water (0.5 mL, 0.2 mL/sec) Rinsing: water (0.5 mL, 0.2 mL/sec), 10% methanol in water (0.5 mL, 0.2 mL/sec), hexane (0.5 mL, 0.2mL/sec) Drying: 3 min Collection: ethyl acetate (2 x 1 mL. 0.0167 mL/sec each) Drying under nitrogen at 65°C for 20 minutes, then in desiccator over P205 for 30 minutes.

Derivatization: MSTF A/NH4I , 50 µL, 15 min at 60°C

ANALYTICAL PARAMETERS (Method USADA09)

Instrument HP 5975 GC-MS Column HP Ultra 1, 17 m, 0.2 mm ID, 0.11 µm film thiclmess Flow parameter Carrier gas helium, flow rate 15 mL/min Injection Autosampler HP7683A, split ratio 1 :10, 2 µL, the temperature of the injection port 280°C. Oven program Initial temperature 180°C, 3°C/min to 230°C, 40°C/rnin to 31 o0c, 2 mm. MSD parameters SIM mode ALIQUOT CHAIN OF CUSTODY DOCUMENTATION 2487996 p 14 Please mark the appropriate box: AAS NAS Other Ontrak I(>( -CF PROCil DIURETIC THC LCMS AAS / AEA PROC I (TFAA deriv.) HCG AMPH Glucocorticoids NFL STIM. EPO BZE DFS (LIMITED) YIVAE :TRlAGE MORPH ·1, .. ' ; ; CFPENT.ANE Other: ZephyrAS Released-ro: □ R~frigerator #22 r-:::J Refrigerator #12 D Temp. Storage Fill in information as aliquots are released. (note: Each name must be printe~ast once ori this page.)

ALIQUOT(S) FOLDER NO. I RELEASED BY: DATE u.__:-·1 J-20'1 u -~Delshaa ·-=-

"' 'I CSAC 08-13-201 \J ~\(N\,Q) ;. ol.f .S'fa ) II JUA,,,,....___-----1

·-'~

·.,;. i

... :.:\ ..

':' . ..;\, •'

. :.\:·

,,;·

'

See reverse side for work-up Chain of Custody Form Approved By: r/j/ ,I/lo /-u>/o G\'- 1 ~I, 10/.,/,.~ 2487996 Chain of Custody for the work-up is as follows: p 15

Note: Each name mu.st be printed at least once on this page. I RELEASED BY: I T0: 1 I DATE; I PURPOSE: I r-• ·-•. i .,. ,. -.-,,··10.1·"'T'V. . . ·c,, i "_, '.~"~ ~ U i ~- ...,n (,~ ... L ·J 1.: \'-• San1ira ,L'.\..h ~nt;:ib AUG l 3 2010 ::'f:fn /\8s:~y -v l lncu1>> Analysis Report<<< p 16

Sample Name RKL Data File: RKL02.D Miscellaneous: WU:A 2.5 mL NH4I Analysis Time: 18 Aug 2010 21: 11 Equipment # MSDA16 Method File NUSADA.M ALS Bottle # 85

Compound RT RRT Peak Height Cone. (ng/mL) [d3]Testosterone--435 13.435 1.000 65768 48.0 Testosterone--432 13.481 1.003 37586 27.4 11-0H-Andro--522 13. 8'1 6 1.031 134284 4 70. l 11-0H-Etio--522 14.097 1.049 47917 198.2 11-Ketoetio--448 12.941 0.963 2753 4 04. l 5b-Pregnanediol--117 15.837 1.179 281753 120.0 DHEJ-\--432 12.095 0.900 5676 14 . 9 [d3]Epitestosterone--435 12.578 0.936 11720 8.0 Epitestosterone--432 12.627 0.940 19898 13. 6 [d4]Androsterone--438 10.689 0.796 445806 A 250.0 Androsterone--434 10.750 0.800 1941547 A 1088. 8 Mono-Androsterone--272 9.301 0.692 2162 [d5]Etiocholanolone--439 10.857 0.808 475494 A 250.0 Etiocholanolone--434 10.943 0.815 1129008 A 593. 6 5a-DHT--434 12.844 0.956 613 2.3 5a-3a,17B-diol--241 11.100 0. 8 2 6 11593 23. 6 5b-3a,17B-diol--241 11.239 0.837 15416 33.9 5a-Adione--275 0.000 0.000 0 40.0 5b-Adione--275 9.445 0.703 0 0.0

>> QC TIME RANGE FOUND<< TEST-EPIT 0.8250-0.9150 0.8543

>> RATIOS (CUT OFF VALUE) AND QUANTIFICATION<<

TESTOSTERONE / EPITESTOSTERONE (4) 2.02 ANDROSTERONE / ETIOCHOLANOLONE (3) 1.4 OH-ANDROSTERONE / OH-ETIOCHOLANOLONE 2.8 ANDROSTERONE / EPITESTOSTERONE 22.0 MONO-ANDROSTERONE/ DI-ANDROSTERONE (5) 0.5 % DHT / EPITESTOSTERONE (1.8) 0.2 5a-A-3a,17B-DIOL / EPITESTOSTERONE (10) 1.7 5a-A-3a,17B-DIOL / 5b-A-3a,17B-DIOL(3) 0.7 D4-Andro-gluc / D5-Etio (0.7 - 1.2) 0.9 DO-Testosterone / D3-Testosterone 0.6 Analysis Report for Data File= RKL02.D Graphics Page 1 [d3] & [dO] DHT [d5] & [dO] DHEA IS / T & E / OHA & OHE AbundanceLGCMS_ADC]lon 437.30,!AbundanceLGCMS_ADC]lon 437.30!AbundanceLGCMS_ADC]lon 435.30 (435.00 to 436.00): RKL02.D\data.ms ' ~ ~00 248799 1000 40000 :p 17 200 500 20000

01-.,--.--.-::;,=;'"4-"';-,---,-;=-r--~ o---~~~~~~- 0n--r-'Fl"-r.-=r-.--r=r--Y,.,....,FF-.-r-,=4--,L-,-+,=,===r=r=r-i=~ :Time--> 12.80 13.00 [Time--> 11.80 12.00 12.20 Time--> 11.50 12.00 12.50 13.00 13.50 14.00 AbundanceLGCMS_ADC)lon 434.30\1\bundanceLGCMS_ADC]lon 432.30:AbundanceLGCMS_ADC)lon 432.30 (432.00 to 433.00) RKL02.D\data.ms 3000 '. . . L(,l{._-. 30000 4000 /D/J/1[) 2000 20000

50000 50000

0 0t--r--,---,----,---,-,--,---,-,----,--,---,-i-,---,-,---+.,-r=r---.-r".--'--r'=:;:...+-'-,--,-- iTim e-> 10.50 10.60 10.70 10.80 10.90 11.00 11.10 Time--> 11.50 12.00 12.50 13.00 13.50 14.00 ANDROSTERONE & ETIOCHOLANOLONE [d3)5a & [d3)5b-Androstan-3a,17B~diols f.bundanceLGCMS_ADC]lon 434.30 434.00 to 435.00): RKL02.D\data.m~Abundance GCMS_ADC)lon 244.10 (243.80 to 244.80): RKL02.D\data.ms 400000 . 15000

10000 200000

5000

0 ' o+-,---,---,-,--;::::;,=;=-r--,-...,-;=,==t=r=..,.--,-,.J..,--r-r---r-r-r---,-,-,--,---,-.- rrime--> 10.50 10.60 10.70 10.80 10.90 11.00 11.10 iTime-0 > 10.90 11.00 11.10 11.20 11.30 11.40 ANDROSTERONE, Mono-TMS Sa & 5b-Androstan-3a,17B-diols \l\bundanceLGCMS_ADC)lon 272.20 (271.90 to 272.90): RKL02.D\data.m~AbundanceLGCMS_ADC)lon 241. 10 (240.80 to 241.BO): RKL02.D\data.ms , 20D0 9 01 ! 15000 LGCMS_ADC)lon 346.30 (346.00 to 3 DO): RKL02.D\data.ms ' I I

10000

1000 9.670 9.189 9.526 5000

0 oi=:.:-~-,-~--,--::;"'=;='=i"'--r-r-+--,-.:.-,~.,.....J,---,-~..,._-,--,-,=;~ !Time-> 9.00 9.20 9.40 9.60 9.80 Time--> 10.90 11.00 11.10 11.20 11.30 11.40 CORTISOL METAB VITAMIN E METAB 11-keto-ETIO Sb-PREGNANEDIOL \L\bunJtIBMLGCMS_ADCJlon 462.30)L\bundanceL GCMS_ADC]lon 422.30;AbundanceLGCMS_ADC]lon 448.00\l\bundance LGGMS_ADC]lon 117 .00 1 . 25 i 60000 9. 73 ' LGCMS_ADC]lon 433.00 LGGMS_AD Ion 269.00 . . . ~oo I I 200000 40000 l1 2000 20000 100000 20000 1000 f~ ~ 0.6P',~lc_=r-,.J..,-,-~~- Q-'=,-,-~,,--,1.:::., .,--,"S',===r:;::!· ~-~, ' I ' 0' '' " ' ~~ Time-> 17.00 17.50 Jime--> 8.60 8.80 9.00 9.20 9.40 Time-> 12.8Q 13.00 Time-> 15.70 15.80 15.90 CAL Used for this Sample: RKL0l.D PAUL ZIFFREN OLYMPIC ANALYTICAL LABORATORY 2487996 UCLA SCHOOL OF MEDICINE p 18 >>> Calibrator (CAL) l'.nalysis Report <<<

Sample Name RKL Data File: RKLOl.D Miscellaneous: WU:A 2.5 mL NH4I Analysis Time: 18 Aug 2010 20:36 Equipment # MSDA16 Method File NUSADA.M ALS Bottle # 84

Compound RT RRT Peak Height Cone. (ng/mL) [d3]Testosterone--435 13.412 1.000 58696 48.0 Testosterone--432 13.458 1.003 98575 80.6 ll-OH-Andro--522 13.846 1.032 101979 400.0 ll-OH-Etio--522 14.097 1.051 8 632 4 400.0 11-Ketoetio--448 12.917 0.963 608 100.0 5b-Pregnanediol--117 15.794 1. 178 209460 100.0 DHEA--432 12.070 0.900 47520 140.0 [d3]Epitestosterone--435 12.578 0.938 9243 8.0 Epitestosterone--432 12.602 0.940 257 67 22.3 [d4]Androsterone--438 10.709 0.798 453556 A 250.0 Androsterone--434 10.770 0.803 3337717 A 1839.7 Mono-Androsterone--272 9. 2 8 5 0.692 2639 [d5]Etiocholanolone--439 10.874 0.811 391688 A 250.0 Etiocholanolone--434 10.97.B 0.819 3278546 A 2092.6 5a-DHT--434 12.820 0.956 11959 50.0 5a-3a,17B-diol--241 11.100 0.828 43799 100.0 5b-3a,17B-diol--241 11.239 0.838 40576 100.0 5a-Adione--275 0.000 0.000 0 40.0 5b-Adione--275 9.381 0.699 15580 40.0

>> QC TIME RANGE FOUND<< TEST-EPIT 0.8250-0.9150 0.8556

>> RATIOS (CUT OFF VALUE) AND QUANTIFICATION<<

'J'ESTOSTERONE I EPITESTOSTERONE ( 4) 3.61 ANDROSTERONE I ETIOCHOLANOLONE (3) 1.0 OH-ANDROSTERONE I OH-ETIOCHOLANOLONE 1.2 ANDROSTERONE I EPITESTOSTERONE 28.9 MONO-ANDROSTERONE/ DI-ANDROSTERONE ( 5) 0.4 % DHT I EPITESTOSTERONE (1.8) *** 2.2 5a-A-3a,17B-DIOL I EPITESTOSTERONE ( 10) 4.5 5a-A-3a,17B-DIOL I 5b-A-3a,17B-DIOL(3) 1.0 D4-Andro-gluc I D5-Etio (0.7 - 1. 2) 1.2 DO-Testosterone I D3-Testosterone 1.7 Analysis Report for Data File= RKLOl.D Graphics Page 1 [d3] & [dOJ DHT [d5] & [dO] DHEA IS / T & E / OHA & OHE \A.bundanceLGCMS_ADCJlon 437.30~bundanceLGCMS_ADC Ion 437.30/AbundanceLGCMS_ADCJlon 435.30 (435.00 to 436.00): RKL01.D\data.ms

200 2487996 400 ) 40000 p 19

10 20: : ' :.\--r-,"-,.!;r.½-r-r--r-r'T""T"",::.,..,r-T 2000:+--r-.-.-r...,..C'r"'""T-.-4,-C;-l,.l,..,...<:,..l\.,....,.-,-~L..J-+---.-.-"i"'-,-_...... ,.~ Time--> 12.80 13.00 [rime-> 11.80 12.00 12.20 ffime--> 11.50 12.00 12.50 13.00 13.50 14.00 \A.bundanceLGCMS_ADC]lon 434.301.t\bundanceL GCMS_ADCJlon 432.301AbundanceLGCMS_ADC]lon 432.30 (432.00 to433.00): RKL01.D\data.ms

10000 40000

50000 . 5000 20000

0.L..,-...,....;,=<-r--,-,i..rr--r-r--,-,- i 0+-.-~-.-+...,...,_~;=;-,..,...,_., 0t--r--,-.,.-,--+-T"'-r--r-+-;><+-..,...._~~-...,....1...... ,_...:..,...... ,.,__-I--.-'...... _ rnme--> 12.80 13.00 rnme-> 11.80 12.00 12.20 ffime-> 11.50 12.00 12.50 13.00 13.50 14.00 . [ d 4 J AG/ [ d 5 J Et i o AbundanceLGCMS_ADC]lon 522.30 (522.00 to 523.00): RKL01.D\data.mS' bundanceLGCrvis)i,bcJlon'-438.30 (438.00 to 439:oof RKL6'1 :o,c1afu..ms 100000 LGCMS ADC]lon .30 (439.D 440.00): RKLD1.D\data.m~ 60000 - , i

40000 50000

20000

o.1..,..-~,....,..i;.,;...~.,...... ,..1-,__,....,,-,:=:,.-=;::::;-,-1.,-r..,...,....,..-,,'+,--,-,-,-,..,..-,-,...~, 0t--r.....--.-r--,-.,.....,.-,--,-,-,--,--,,-,-...,...... ,.....,...... ,.....,...... -'--,-'Y-f-+~ tnme-> 10.50. 10.60 10.70 10.80 10.90 11.00 11.10 ffime--> 11.50 12.00 12.50 13.00 13.50 14.00 ANOROSTERONE & ETIOCHOLANOLONE [d3]5a & [d3]5b-Androstan-3a,17B-diols bundanceLGCMS_ADC]lon 434.30 (434.00 to 435.00): RKL01.D\data.m~bundanceLGCMS_ADC]lon 244.10 (243.80 to 244.80): RKL01.D\data.ms

600000

400000

200000

o'-,-~~...... --~~--,-,....,..._,a,-,-__.~..,...,._,-,,._,-,,-.-,,-,-,-,--r-r-,- 0J.,-.....,.....,...... ,..-'=?-,-~-:r-...-+-.--.-,.-,-~...... -.-,-.,....,.-,-.,-,--,--, - ! ime--> 10.50 10.60 10.70 10.80 10.90 11.00 11.10 [fime--> 10,90 11.00 11.10 11.20 11.30 11.40 ANDROSTERONE, Mono-TMS Sa & 5b-Androstan-3a,17B-diols !AbundanceLGCMS_ADCJlon 272.20 (271.90 to 272.90): RKL01.D\data.m!iAbundanceLGCMS_ADCJlon 241.10 (240.80 to 241.80): RKL01.D\data.ms . 9 85 , 40000 LGCMS_ADCJlon 346. (346.00 to 3 7.00): RKL01.D\data.ms I .2000 9.654

20000 1000

oL,..:::;=,_,.4-...... :;L..,...~.,.....,.-1--..,L.,.....,..-'?".,.....,.-,-_,,,.,,._,,...,.....,...,=,=4 or;:::..,~~~.s,....,-'f":.,c...~~,....::;,4-,-,-...J,--,--,:;.,-,_,.~,_,.~ [Time-> 9.00 9.20 9.40 9.60 9.80 Time-> 10.90 11.00 11.10 11.20 11.30 11.40 CORTISOL METAB VITAMIN E METAB 11-keto-ETIO 5b-PREGNANEDIOL iAbundanceLGCMS_ADC]lon 462.3016,bundance L GCMS _ADC]lon 422.301\bundanceL GCMS_ADC]lon 448. OOAbundanceLGCMS_ADC]lon 117 .00 17. 67 j 9. 57 · LGCMS_ADC]lon 433.00, 200000 LGCMS_ C)lon 269.00 . 6000 I I 1000

50000 4000 100000

2000

0+-,----.-L-+-~.~,-,.-~-~ 0'n-,--n-r-~1-rn-n-n/-,-,-,~~ 0 ' 'I , :Time-> 17.00 17.50 [Time-> 8.60 8.80 9.00 9.20 9.40 Time-> Time-> 15.70 15.80 15.90 PAUL ZIFFREN OLYMPIC ANALYTICAL LABORATORY UCLA SCHOOL OF MEDICINE 2487996 p 20 >>> Analysis Report<<<

Sample Name RKL Data File: RKL09.D Miscellaneous: WU:A 2.5 mL NH4I Analysis Time: 19 Aug 2010 00:03 Equipment# MSDA16 Method File NUSADA.M ALS Bottle ,j/ 92

Compound RT RRT I Peak Height I Cone. I I (ng /mL) [d3]Testosterone--435 13.504 1.000 I 41496 I 48.0 Testosterone--432 13.549 1.003 I 159942 I 185.0 11-0H-Andro--522 14.029 1.039 I 602486 I 3342.7 11-0H-Etio--522 14.257 1. 056 I 357996 I 2346.4 11-Ketoetio--448 13.014 0.964 I 42548 I 9898.7 Sb-Pregnanediol--117 15.665 1.160 I 16423 I 11. 1 DHEA--432 12.167 0.901 I 29030 I 121.0 [d3]Epitestosterone--435 12.675 0.939 I 9394 I 8.0 Epitestosterone--432 12.699 0.940 I 17390 I 14.8 [d4]Androsterone--438 10.891 0.807 I 575016 A I 250.0 Androsterone--434 11. 013 0.816 I 18250736 A I 7934.9 Mono-Androsterone--272 9.366 0.694 I 11 , 27960 I [d5]Etiocholanolone--439 11. 048 0.818 I J/7:Yf:o1l~122~ A I 250.0 Etiocholanolone--434 11.256 0.834 I 18303697 A I ~l:i39. 7 Sa-DHT--434 12.917 0.957 I 5322 I )03i 9, :3 3 1 . 5 5a-3a,17B-diol--241 11.308 0.837 I 88374 I ,2 8 5. 4 5b-3a,17B-diol--241 11.413 0.845 I 212057 I 739.2 5a-Adione--275 0.000 0.000 I o I / o. o 5b-Adione--275 9. 4 62 0.701 I o I 0.0

>> QC TIME RANGE FOUND<< TEST-EPIT 0.8250-0.9150 0.8502

>> RATIOS (CUT OFF VALUE) AND QUANTIFICATION<<

TESTOSTERONE I EPITESTOSTERONE ( 4) *** 12. 4 9 ANDROSTERONE I ETIOCHOLANOLONE ( 3) 0.7 OH-ANDROSTERONE I OH-ETIOCHOLANOLONE 1.7 ANDROSTERONE I EPITESTOSTERONE 91.6 MONO-ANDROSTERONE/ DI-ANDROSTERONE ( 5) 1.8 % DHT I EPITESTOSTERONE (1.8) *** 2.1 5a-A-3a,173-DIOL I EPITESTOSTERONE ( 10) *** 19.3 5a-A-3a,17B-DIOL I 5b-A-3a, 17B-DIOL(3) 0.4 D4-Andro-gluc I D5-Etio ( 0. 7 - l. 2) -x * * 5.2 DO-Testosterone I D3-Tesc.osterone 3.9

! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! I ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! I ! ! ! ! ! I ! I The T/E Ratio for this sample is greater than 4 The Etio Concentration for this sample is above 10000 ng/mL ! ! ! I ! ! ! I ! ! ! ! ! ! ! ! ! ! ! ! I ! ! ! ! ! ! I I ! ! ! I ! ! ! ! ! ! I ! ! ! ! ! ! ! ! ! I! ! ! ! ! ! ! ! ! ! ! I

I Pi, 2487996 Analysis Report for Data File= RKL09.D Graphics Page 1 (d3] & [dOJ DHT [d5] & [dOJ DHE.A IS / T & E / OHA & OHE p21 AbundanceLGCMS_ADC)lon 437.30'AbundanceLGCMS_ADC]lon 437.301AbundanceLGCMS_ADC]lon 435.30-(435.00 to 436.00: RKL09.D\data.ms 40000

600

400 20000 500 \ 200 I "''--- I ' 0 '--r-~-=r-a--rl-.,.--,--,-~ Oh-rrl~/-rrl.-r-,-,--.--.-m oJ---,-?-.;:c=;=;::::;:::::;::.,.::;:::;:=;_.t;::;:::::,.:::,...::;:=;:::~-+.,:::;-----.___,/:::::;::::;._,~=,-;_IG- Time--> 12.80 13.00 Time--> 11.80 12.00 12.20 Time-> 11.50 12.00 12.50 13.00 13.50 14.00 Abun-LGCMS_ADC)lon 434.30!!\bundanceLGCMS_ADC]lon 432.301AbundanceLGCMS_ADC]lon 432.30 (432.00 to 433 OO)· RKL09.D\data.ms I I ' I 150000 I I I J./)J--- 4000 V ' 20000 100000 I I !DJs-;,

2000 /\___ I 10000 soooo \

~im,-> O 12.80 13. 00 l,m,-> ~ 1.80 12 00 12.20 mm-> 1I .so 12.00 12.50 1,;, 13.50 14 .00 (c::! 4}AG;/ [ d 5 J Et-i·o AbundanceLGCMS_ADC)lon 522.30 (522.DO to 523.00): RKL09.D\data.ms !Abundance[GCMs=Abcjion 438.30(438.oo to 43§:ooFRk:[oe.b\daia.m~ 5ooooo . LGCMS_ADC)lon 439.30 (439.00 110.00): RKL09.D\data.ms. I 40000 I 400000

20000 200000

i 0.L,...,...~-,,,;.:;:::,...,~m..,...,...,..,.J,..,...,..-r-r-,...,...,J~...,..,.-,--,--m..,.::;,.l-'?i..,_,..'F?:--, O+-,.~~~~~~~~~~~L;::>-,.....,..--~:..,_,.L:;:.~ irime-> 10.60 10.70 10.80 10.90 11.00 11.10 11.20 11.30 11.40 ffirne-> 11.50 12.00 12.50 13.00 13.50 14.00 ANDROSTERONE & ETIOCHOLANOLONE [d3]5a & [d3]5b-Androstan-3a,17B-diols bundanceLGCMS_ADCJlon 434.30 (434.00 to 435.00): RKL09.D\data.msAbundanceLGCMS_ADC]lon 244.10 (243.80 to 244.80): RKL09.D\data.ms 2000000 6000 l I I I 4000 I

1000000 2000

o..,..,.~--rr-,4,-r-rm--rr,--,-,...,..,--,--,--,-'r-,--,--,--,-,-r-r-r-m+rm-,-,--rm 0'-r-r-m-r-rm--,--,-!rn--r-,-m,-=.=;...r,--r-r-rrr-,--,-;:=rr.,.,..,=n<;:::;...,-,-.,-~ Time-> 10.60 10.70 10.80 10.90 11.00 11.10 11.20 11.30 11.40 rTime--> 11.15 11.20 11.2511.30 11.35 11.40 11.4511.50 11.5511.60 ANDROSTERONE, Mono-TMS Sa & 5b-Androstan-3a,17B-diols il\bundanceLGCMS_ADC]lon 272.20 (271.90 to 272.90): RKL09.D\data.msAbundanceLGCMS_ADC]lon 241.10 (240.80 to 241.80): RKL09.D\data.ms . 9. 6 . 200000 LGCMS_ADC]lon 346.30 (346.00 347.DO): RKL09.D\data.ms I I 20000 9.734 I 100000 10000

9.526 0 , 0 I, Time-> 9.10 9.20 9.30 .9.40 9.50 9.60 9.70 9.80 9.90 Time-> 11.15 11.20 11.2511.30 11.35 11.40 11.45 11.50 11.55 11.60 · CORTISOL METAB VITAMIN E METAB 11-keto-ETIO Sb-PREGNANEDLOL \tl.bundanceLGCMS_ADC)lon 462.30iAbuldanceLGCMS_ADC]lon 422.30AbundanceLGCMS_ADC Ion 448.00AbundanceLGCMS_ADC]lon 117.00 17. 47 , OOOOO 9.. 53 40000 LGCMS_ADC r433.00 LGCMS_ADC]lon 26°"1oo 200000 ' I \ I I

5 10000:, 20000~ 2000: \ (' IL oooo~ I ' , ' \

fTimE:-> ,'. ~-~O __, ,c _12.5~,.., ; C "';:1_::~-;"' .8.60 ::~. ;-~ □ _9;0 9.40 TimE:-> 12.80 13.00 Time-> 15.70 15.80 15.90 U\.,'\ "A" SAMPLE CONFIRMATION DOCUMENTATION 2487996 p 22

QUANTITATIVE PROCEDURE FOR TESTOSTERONE to EPITESTOSTERONE RATIO CONFIRMATION

Extraction: Urine volume 2.5 to 5mL urine sample aliquots (three replicates) Standard Curve: Unextracted calibrators spiked for Testosterone and Epitestosterone ratio of 6: 1 (three replicates of each) Quality Controls: Certified negative urine (Neg QC) and steroid free certified negative urine spiked with TIE ratio greater than 6: 1 (POS QC)

Internal standard: d4-19-Norandrosterone Column Varian Bond Elut C 18, elution with methanol

Buffer Phosphate buffer (lmL of 0.2M phosphate buffer at pH 7) Free Fraction extraction: pentane (SmL), separate tubes Conjugated Fraction: Enzyme 50 µL of E. coli Beta Glucuronidase are added to each aliquot Deconjugation 1 hour at so0c Extraction pentane Drying (separate fractions) under nitrogen at 65°C for 20 minutes, then in desiccator over P20 5 for 60 minutes

Derivatization: MSTF AINH4I, 50 µL, 15 min at 60°C

ANALYTICAL PARAMETERS

Instrument HP 5973 GC-MS Column HP Ultra-1, 17m, 0.2mm ID, 0.1 lµm film thiclmess Flow parameter Carrier gas helium, flow rate 15 rnL/min Injection Autosampler HP7683A, 2 µL, split ratio 10: 1, injection port temperature 280°C Oven pro gram Initial temperature 180°C, 3°C /min to 220°c, 40°C /min to 310°C, 2min. MSD parameters TESIM08-SIM mode 2487996 p 23

ST ATIS TI CAL ANALYSIS, CALIBR.A TION CUR VE Al\TD QUANTIFICATION

The relative peak heights of Testosterone TMS to Epitestosterone TMS for the sample are compared to those of the calibrator at the cut-off value, using the Student's t-test. This comparison is done using the data of the three replicate in the sample and the CAL. This test requires a determination of whether or not the variances of the samples and CALs are equal or unequal. The statistical pro gram generates a p value for the null hypothesis that the variances are equal. The decision regarding whether or not to report the case positive is based on the t-test and the associated value of p. If the p value for the comparison of the CALs to the sample is 0.01 or less, the case is reported positive. In the case that this p value is greater than 0.01, the sample is reported negative.

Expanded uncertainty is established by monitoring TIE positive control (QC) performance after QC pool is prepared. U = 2*standard deviation of QC fork= 2 (95% confidence level) . CHAIN OF CUSTODY DOCUI\1ENTATION 2487996 FOR BOTTLE(S) p 24

Circle: BOTTLE(S) csAC lo/0 0 R B CSAC Organization: ______UCLA folder no. ------If batch, UCLA Lab Code: ------~- Bottle no. ) l\ x+ 9 9 ~ UCLA code no. R\( L O 9 I

IT IS REQUIKED TO PRINT EACH NAME AT LEAST ONCE ON TlliS PAGE

Released by: To: Date Purpose:

08-2'/-?0'1 (, FREEZER # Lf'2- Aliquot Confirmation Jtr shteh Delshad ~ I Posltlve Freezer 11 J ll f3 - 2 ·7 - ':~ 0 ·1 D STOPLAGE IJIAJLr- ~ (rf}, ;_ n((){! / Juv·sitrve Freezer.:::#- / Aliquot Confirmation /Y)f0r1:l8 09-01-2010 ~ "-· ChambE;fS

Poslttve Freamc# / ,.,,c:<"'c"On,.·GE ! ,. ..-.. ·, .fTv' ~ (]L) V 09-01-2010 Tope Akintunji -l Rt"\S VPositive Freezer {to·\ ,1- ,_ SEP O7 2010 I . ~"·-~·0- Aliquot .Confirmation =· v" "Y\ c'9"'·-1 R ,r·•. c; E ,a.f~~~t)- Fositlve Freezer ! i SEP b7 2010 ,.)' l \.,., .,-,, ·-·

- .. "

1tJ From Approved by /C:;--0 - ~//lJ / th/' -...... ,-+---,'---,~- /

\ 'iJr,' CHArN OF· CUSTODY DOCUMENTATION 2487996 FOR COJ'\1FIRMATION ALIQUOT(S) p 25 Circle: ALIQUOT(S) QoRB UCLA folder no, eSAC j Organization: ______:C=S:L.JA!!.l!ll"Ct'..-- __ ------r; Bottle no. 1 Ld V J---q q C2 UCLA code no._,__,R~,\(-""'-\__ __,,0"'------1--~--- ;;:> I U ) \ l If multiple replicate aliquots indicate here N = _3__ Substance: __,_1__..E"'--1-)-lf-+•------IT IS P.EQ UIRED TO Pll.It•lT EA CH NAME AT LEAST ·ONCE ON THIS PA GE Released by: To: Date -Purpose_:

··- REFRIGERATOR #i 2 STORAGE

f V. . .. h Es2_inosa Refrigerator #i 2 ·__ AUG 2 7 ZDlD

Zyn,ark Dryer 08-27-2010

08-27-2010

08-27-'2010 Incubation

AUG 2 7 2010

Zyrr...ark Dryer AUG 2 7 ?OW Dry.ing

zyrn-ark Dryer 08-27-2010

oesiccat\on 08~27-2010

~ Ramnarain J~~ TRANSFER Heating· Block

/) ; From Approved by: Keu1{LJ'i) iVr rfi(rv .r \ o"- - 2487996 p 26

IT IS REOUI.RED TO PRINT EACH l\'Al,1E AT Lu...ST ONCE ON THIS PAGE

Released by: To: Date Pu_rpose Heating Block r Ramnarain TRAN:iFE~ ·. ~~ ~1/o AUTOSAMPLER Analysis, Then Storagt ,1&,~ MSDA /6 . 2/)lfo AUTOSAMPLER ~:z::ain 08-38-20'1 C MSDA / {. TRANSFEFli

AUTOSAMPLER 08-30-20'1 D ~z_ MSDA -i:A 1 Analysis, Then Storage lfiANSFe~ AUTOSAMPLER 'JS-31-20'10 nn 71_1')(;111 -MSDA A~ ~ ()(0.J(1'1\\ D . - cQ I V STORAGE Sa;-nple Stoiage Sh&tt OS-3'1-2010 0~ -:, .. -- - , - V ~ / 7o~ _)k 131 //lt).._t u> V . -'-i DISCARD k.r QLl °' rc; I Tu ~ ~~ ~ ______. ~ ~ ~~ '-.... '---...,~

~

. p "-...... ,, ......

G :\Rec\LOG S&FORJ\1S\CON.r lJ:U0 COC. wpd /). fJocumenr ID Rev t:4013-000 Side 2 o-fy,V" Sequence Name: K: \seq\aas\confirm\RKLTE..bJ\T. S 2487996 Comment: T/E 'A' CONFIPJvlATION Operator: p 27 Data Pa th: K: \ CHEM\l-'..A.S \ COHFIRM\MSD..b.21 \ Instrument Control Pre-Seq Cmd: Instrument Control Post-Seq Cmd: Method Sections To Run On A Barcode Mismatch (X) Full Method (X) Inject Anyway ( ) Reprocessing Only ( ) Don't Inject

Sequence file approved by (INITIALS/DATE):

CPU Time clock verified on PC by ( INITIALS/DP.TE) : GC/MS Autosampler loaded by (INITIALS/DATE) f~----- GC/!v1S Autosampler unloaded by (INITIALS/DATE)~ ------Line Type Vial DataFile Method Sample Name 1) MethPath - C: \MSDCHEM\l \METHODS\ 2) DataPath - K: \ CHEM\_A...P.S \ CONFIRM\M.SDA2 l \ 3) BatchRep - no 4) Overwrit - NO 5) Go Sub - BAKE 6) Sample 33 RKLTElN TESIM08 TE 4:1 STANDP~ 7) Go Sub - BJ-tKE 8) Sample 34 RKLPQNAC TESIM08 TE POS QC, CONJ T 9) Sample 35 RKLPQNJI.F TESIM08 TE POS QC, FREE T 10) Go Sub - BAKE 11) Sample 36 RKLNQNAC TESIM08 TE NEG QC, CONJ T 12) Sample 37 RKLNQNJtF TESIM0B TE NEG QC, FREE T 13) Sample 38 RKL09NCN TESIM0B RKL09-1 'A' CONF, CONJ T 14) Sample 39 RKL09NFN TESIM08 RKL09-1 'A' CONF, FREE T 15) Go Sub - BF.KE 16) -Sample 40 RKLTE2N TESIM08 TE 4:1 STANDARD 17) Go Sub - BAKE 18) Sample 41 RKL09OCN TESIM08 RKL09-2 'A' CONF, CONJ T 19) Sample 42 RKL09OFN TESIM08 RKL09-2 'A' CONF, FREE T 20) Go Sub - BAKE 21) Sample 43 RKLTE3N TESIM08 TE 4:1 STA.l'IDARD 22) Go Sub - BJ.1_KE 23) Sample 45 RKL09PCN TES IM OB RKL09-3 'A' CONF, CONJ T 24) Sample 46 RKL09PFN TESIM0B RKL09-3 IP.' CONF, FREE T 25) Go Sub - BAKE 26) End 27) Label - BAKE 28) OverWrit - YES 2 9) Blank 69 BAKE9 BPX.E EtOAC WASH 3 0) OverWrit - NO 31) Return

Paqe: l UCLA OLYMPIC ANP.LYTICAL LABORATORY 2487996 T/E P.nalysis Report P 28 Analyst~ Datafile: RKLNQNAC.D MSDA21 31 AUG 2010 1:03 AbundJl:lliir- Ion 409.00 (408.70 to 409.(Abundance Ion 432.30 (432.00 to 433.00): RKLNQIAbundanceScan 3138 (13.431 min): RKLNQNAC.d,data.ms (-3 ·• . 9. 30 ! 25000 Ion 432.30 (432.00 to 433.00): RKLNQI 412 . . I 13.431 i 20000 • 4000 i I ' 3500 20000 i 10000 i I I 3000 I 209 I i I 15000 I 0 2500 :111/z--> ...... 150 200 250 300 350 400 i ! 2000 i 12.595 M/Z REL% ABS T/E I ! 10000 2 09 15 3505 i 1500 i 417 13 2886 432 100 23069 2.17 1000 I i 5000 i Compound RT Height I 500 i d4-19-norandro 9.130 4447 23120 l::;:::;:::;:::;:'.:;:::;::::;:::;:::;:::;::;=:;:::;::::;::;:I /\. --, ~~:!;! 10640 0 • ~~I I !pe~~~:~~~~~~one Time--> 9.00 9.20 9.40 IT'ime-> 12.50 13.00 ..... 1.3.50 ...... - Dataf ile: RKLPQNAC.D MSDA21 31 AUG 2010 00:16 Abundance Ion 409.00 (408.70 to 409.iAbundance Ion 432.30 (432.00 to 433.00): RKLPQ\.£\bundance Scan--3139 (13.437 min): RKLPQNAC.d,data.ms (-3 . 9. 27 60000 Ion 432.30 (432.00 to 433.00): RKLPQI 4 2 3500 13.437 40000 50000 3000 : i 20000 I 2500 40000 I 209

I 0 2000 rn'z-> 150 200 250 300 350 400 30000 M/Z REL% ABS T/E 1500 209 15 8566 20000 417 13 7079 1000 432 .100 55653 9.02

I Compound RT Height d4-19-norandro 9 .127 3746 500.t;::::;:::;::::;::;:::;:::;:::::;::;;:::::;:::::;::::;::::;:::;:::;:: I 10000 ~ 2/:· I Testosterone 13.437 55674 Epitestosterone 12.589 6169 Time->... ~..... 9.oo ... __9_.2_0 __ 9_.4_0 _Jime-> ...... --12'.so .. _...... 13'.oo ...... __ 13.50 ...... : 2487996 ~ UCLA OLYMPIC Jl..NALYTIC.llli LABORATORY p 29 r· / T/E Jl.nalysis Report Jl.nal·y--~~-- / '/''---1 Datafile: RKLTElN.D MSDA21 30 AUG 2010 23:47 .. _ 1'- - Abundance Ion 409.00 (408.70 to 409.-1Abuncianceion.. 43;.30 (4~;·00 to 4;:°fOD} RK_L_T_~_}l\_b_u_~_"Scan-3-13-8~(-1_3 .. _.4_2_6_m_i_n)-: ______, 9. 24 , Ion 43 __ 30 (4-.,~.00 lo 4v3,00). RKL T _; : 13.426 . 4000 30000 20000 3500 25000 10000 3000 209 20000 2500 0, I • imfz ... > ____ 150 ______200. 250 300 ___ 350.. 400

2000 15000 M/Z REL% Ji.BS T/E 209 15 4451 1500 41 7 12 3718 10000 432 100 30327 4.62 1000 Compound RT Height 5000 500 d4 ...19 .. norandro 9.124 4395 Testoste:::-one 13. 426 30333 i ol:;::::;=,=,::::;:::=:;=:;::::;::::;==::;:: i Epitestosterone 12.578 6572 Time--> 9.00 9.20 9.40 !Time ... > ____ 12,.2Q_ .... _ 13.00 ...... J.~.50...... Datafile: RKLTE2N.D MSDA21 31 AUG 2010 2:25 Abundance Ion 409.00 (408.70 to 409.(Abundancelon 432.30 (432.00 to 433.00): RKLTE~bundanceScan.. 3137 (13.425 min): RKLTE2N.d\data.ms (·312( 3500 9. 23 i Ion 432.30 (432.00 to 433.00): RKL TE1 4 2 . ! 25000 13.425 . 20000 ! I 3000 l I 20000 / 10000 l 2500 : 209 I I lI ol-,.,~~,-,,...~~~~~~~~~~r-r-...+.,.._,__ 15000 2000 imlz-> 150 20.--=0---=2::.::5...:.0 _ __;;;3...:.0~0_...... c..35""'0__ 4""'0""0 __

M/Z REL% ABS T/E 1500 10000 209 15 3627 417 12 2952 1000 432 100 24204 4.57

5000 Compou..11.d RT Height 500 d4-19-norandro 9.123 3608 Testosterone 13.425 24252 ol:;::::;=~==;:::;:===:;: Epitestosterone 12.583 5312 Time-> 9.00 9.20 9.40 !Time .. -> 12.50 13.00 ...... 13.50 ...... Datafile: RKLTE3N.D MSDA21 31 AUG 2010 3:41 Abundance Ion 409.00 (408.70 to 409.1Abundancelon 432.30 (432.00 to 433-.0-0-):_R_K_L_T_E_3.l\_b_u_n_d_a_nc-eSca·r; 3137 (13.425 min): RKLTE3N.d\data.ms (-311 ' 9. 27 j Ion 432.30 (432.00 to 433.00): RKLTE~ 30000 4. 2 13.425 i 4000 30000 20000 I I 3500 I I I 25000 I I 10000 I I 3000 I 209 i I 20000 I 0 2500 I !mlz->_ 150 200 250 300 350 400 ···------···-·----- ·--·------···-· 2000 15000 M/Z REL% ABS T/E 209 16 4860 1500 417 13 3866 10000 432 100 30855 4.74 1000 12. 77 Compound RT Height 5000 500 d4 .. 19 .. norandro 9.127 4422 Testosterone 13.425 30860 \ Epitestosterone 12.577 6513 Q!:;,=;=:::::==1===,== ' i ' Time-•> 9.00 9.20 9.40 12.50 13.00 13.50 ······---··-·-·---· 2487996 ~ :/4 UCL.li. OLYlvIPIC ANALYTICAL LABORATORY p 30 12fJ() . ( T/E Jl.nalysis Repon: Analyst .· l1 Datel) :?;;1 /!' Datafile: RKL09NCN.D MSDk21 ____ 31 AUG 2010 ___ 1:39_____ Abunoancelon 409.00 (408.70 to 409.iAbundancelon 432.30 (432.00 to 433.00): RKL09l4'.bundanceScan------==- 3143 (13 461 mtn). ___RKL09NC-N-.d-,d--'a-ta [''( ___ m_s-{--3-1 9. 49 Ion 432.30 (432.00 to 433.00): RKLOS~ 4t2 3000 I 80000 13461 60000

70000 2500 40000

60000 20000 209 j 2000 i I 0t-r--r---c~r+-~--.---,-~,-,----,-,----.---,-~,-,----r-r...,....,----r-,-',-~ 50000 I jm/z--> 150 .. 200 ______250 -- 300 ___35_0 ____4~0~0 __ 1500 40000 M/Z REL% ABS T/E 209 16 13054 30000 1000 .41 7 13 10416 432 100 79205 19.98 20000 i i 500 i Compound RT Height i d4-19-norandro 9.149 3173 I 10000 I 12. 25 Testosterone 13.461 79308 ot;• ::::;::::;=;:::;::::;::::;:::;:::;:::;::;:::;::;:::;:::;: ! ,,.__/\ \ !. Epitestosterone 12.625 3 970 I Time--> .J.:QQ_ ____ 9.20 9.40 !Time-> 12.50 13.00 __ 13.50 ______; Datafile: RKL09OCN.D MSDA21 31 AUG 2010 2:55 Abundance Ion 409.00 (408.70 to 409.(Abundancelon 432.30 (432.00 to 433.00): RKL09Ql.\bundanceScan 3143 (13.461 min): RKL09OCh1.d\data.ms (-31 · 9. 45 ! Ion 432.30 (432.00 to 433.00): RKLosq 4 2 i 13.451 I 3000 i 80000 ; I I I I 50000 l 1 ! ro~ I 2500 l I I I 60000 I 209 I 2000 0h-~~r+--r-r~,-.----r-r,--~,~~r,---r-r--r-,----r-,-',-..,-"-.- 50000 i h"!!z-> 150 200 250 300 350 400

1500 40000 M/Z REL% ABS T/E 209 16 13028 30000 417 13 10435 1000 432 100 80411 19. 51 20000 500 Compound RT Height 10000 d4-19-norandro 9.145 3272 12. 25 Testosterone 13.461 80536 \ : 0 J:;;::::;:::;:::;::::;:::;;::::;::~:;:::;:::;:::;;::::;::::;::I !i Epitestosterone 12.625 4127 Time--> 9.00 9.20 9.40 ~ime--> ______12.50 __ 13.00 13.50 Datafile: RKL09PCN.D MSDA21 31 AUG 2010 4:11 Abundance Ion 409.00 (408.70 to 409.1Abundancelon 432.30 (432.00 to 433.00): RKL09PAbundanceScan 3143 (f:f461 min): RKL09PCN.d\data.ms (-3t ' 9, 49 [ Ion 432.30 (432.00 to 433.00): RKL09Pi 4 '2

: 90000 13.461 I 3000 I I I i l 80000 l l l 50000 2500 I l I 10000 ; I I I i 209 2000 ! 60000 I l l o~,~"T""T~~~-r---c~----r-~~~,-,---~--r-,~~~ 1 50000 h,12--> ___ _1_50 __2_0_0_ 250 300 350 400 I 1500 i I M/Z REL% ABS T/E I 40000 I I 209 16 14319 ' 417 13 11623 1000 30000 ! 432 100 86975 19.34 20000 500 Comp01.;md RT Height 10000 d4-19-norandro 9.149 3249 I 12./331 Testosterone 13.461 87049 \ ,/\, ___ /\./!\. 0, ! EpiLestosterone 12.631 4501 I I Time--> _ 9..:.QQ_ ____ ~?.9- .... 940 _____ !Ttme-> ...... 1..?:,5-9. 13.oo ___ Jb.~ __ . 2487996 p 31

UCLA Olympic Analytical Laboratory

'A' CONFIRMATION SUMMARY Identification data evaluated according to WADA TD20031DCR for: Client: CSAC Folder: 55 Bottle: 2487996 UCLA Labcode: RKL09

Substance: Testosterone

WADA ISL ISTD: d4-19-Norandrosterone CALIBRATOR TOLERA!\JCE RKL09 EVALUATION DatafHe RKLPQNAC LOWER UPPER RKL09PCN ISTD RT (min) 9.13 9.04 9.22 9.15 PASS Compound RT (min) 13.44 13.30 13.57 13.46 PASS Compound RRT 1.472 1.458 1.487 1.471 PASS Diagnostic Ion 1 432 100 NA NA 100 Diagnostic Ion 2 417 13 8 18 13 PASS Diagnostic Ion 3 209 15 10 20 16 PASS

CONCLUSION: Identification criteria are met for the following substance: Testosterone

RKL09 has a TE ratio of 16.9 +/- 17% (k = 2).

The threshold TE ratio is 4.0. 0.\11;_-) J\ . f]Jr 1.(Jlv 2487996 p 32

-RKL09 A-CONFIRMATION 24B7996 CSAC 55 9/1/2010 MSDA 21

CUTOFF REPLICATES ISTD T Eplt T/E Mean T/E SD Uncertainty RKLTE1N 4395 30333 6572 4.62 4.64 0.09 17% RKLTE2N 3607 24252 5312 4.57 RKLTE3N 4422 30860 6513 4.74

SAMPLE REPLICATES Conjugated Free Percent Corrected TIE ISTD T Epll T/E ISTD T Epit Free T Std@ 4 RKL09NCN 3173 79308 3970 19.98 3778 1140 34 1.2 17 .2 RKL09OCN 3272 80536 4127 19.51 4406 1333 43 1.2 16.8 RKL09PCN 3249 87049 4501 19.34 3875 1223 38 1.2 16.7 16.9 SD 0.3 CONTROLS RKLPQNAC 3749 55674 6169 9.02 3742 46 26 0.1 7.8 RKLNQNAC 4450 23120 10640 2.17 3784 94 28 0.5 1.9

F-Test Two-Sample tor Variances Hest: Two-Sample Assuming Equal Variances

Stcf@4 Sample Std@4 Sample Mean 4.6397 19.6104 Mean 4.6397 19.6104 Variance 7.9DE-03 1.DBE-01 Variance 7.9DE-03 1.DBE-01 Observations 3 3 Observations 3 3 df 2 2 Pooled Variance 5.81E-02 F 7.29E-02 df 4 P(Fc=f) one-tall 6.BOE-02 !Stat 76.0619 F Critical one-tall 0.0526 P(T c=t) one-tall 8.95E-08 t Critical on&-tail 3.7469 variances are equal significantly higher than cutoff

Conclusion: Sample T/E at 16.9 +/- 17% is significantly higher than cutoff. ry- ~\1\\0

LIA- 1I 1,1 1,

0 \. 0 2487996 5975 p 33 Mon Jl~ug 30 07: 20: 44 2010 Instrument: MSDJl~21 C:\msdchem\1\5975\mtucla.U Mass 69.00 Mass 219.00 Mass 502.00 P...b 159441 % 65.08 % 3.65 Ion Pol Pos MassGain -1101 PwS0 0.55 Pw50 0.52 Pw50 0.53 MassOffs -39 Emission 34.6 AmuGain 1076 EIEnrgy 69.9 AmuOffs 129.25 Filament 2 Wid219 -0.019 DC Pol Neg Repeller 19.90 IonFcus 7 8. 8 HEDEnab On EntLens 0.0 EMVolts 1353 EntOffs 18.07

Samples 8 PFTBA Ooen Averages 3 Stepsize 0.10

Temperatures and Pressures: MS Source 230 TurboSpd 100 MS Quad 150 HiVac 1.00e+l0 l/\ /\ I I I I I ' I 66 71 216 221 500 505

Scan: 10.00 - 701.00 Samples: 8 Thresh: 100 Step: 66 peaks Base: 69.00 Abundance: 154112 100 -

80- ) 6 0 -

40-

20 -

I i1 I I I I 0 I I I I ' I I I 100 200 300 400 500 600 700

Mass Abund Rel J.'-...bund Iso Mass Iso J:...b-:..1..-ri.d Iso Ratio 69.00 154112 100.00 70.00 1816 1.18 219.00 98512 63.92 220.00 4230 4.29 502.lCi 5500 3.57 503.10 535 9.73

Air/Water Check: H20~1.45% N2~0.91% 02-0.29% CO2~0.43% N2/H2O~62.78%

Ramp Crite:r-ia: Ion Focus Maximum 90 volts using ion 502; EM Gain 29057 Repeller Maximum 20 volts using ion 219;

MassGain Values(Samples): -1087(3) -J.083 (2) -1057 (1) -1024 (0) -980 (FS

TA..RGET MJl~SS: 5 0 6 9 131 219 414 502 1050

Amu Offset: 129.3 129.3 129.3 129.3 129.3 129.3 129.3 Entrance Lens Offset: 18.l 18.l 18.l 18.l 18.l 18.1 18.l Tarqet Jl...bund ( %) : l . 0 lo Ci . 0 5 5 . o 4 5 . o 3 . 5 2.5 ,,' 2487996 p 34 UCLA OLYMPIC .b.. N1'..LYTICP..L Ll'.cBORJl.TORY

Sample Name 4:1 STD Data File A2110O830C.D Miscella_neous: T/E 4:1, ISTD T4-047 Instrument MSDJl.21 Method File TETHIN04.M Jl..nalysis Time: 30 Aug 2010 7:53 P..LS Bottle# : 99

RT PEAK HEIGHT Testosterone ( 432) 13.430 93493 Epitestosterone (432) 12.579 21640

Testosterone/Epitestosterone Peak Height Ratio= 4.320

Peak Statistics for Testosterone 432 (Smoothed) :

RT Start = 13.22 RT Max = 13.43 RT Ends= 13.80 Area of first half = 106541 al,"' I I I l:, Area of second half = 86549 B/A = 0.8124 I q_ ?>p )~ iflt:- >YES The B/A Ratio is within the tolerance range of 0.7 to 1.1 >>YES

) bundance LGCMS_ADC]*lon 432.30 (432.00 to 433.00): A21100830C.D\data. 1 . 0 40000

30000

20000

10000

0 I ime--> 13.10 13.20 13.30 13.40 13.50 13.60 13.70 13.80 Abundance LGCMS_ADC]lon 432.30 (432.00 to 433.00): A21100830C.D\data.m 13. 30

50000

40000

30000

20000

12.579 10000 n ) \ . I,-'-r-~~~~,-.~~~_.L~---'-~-,-.~~,-.~~ \ '1240 '12.60 12.80' ':3.00 13.20 13.40 12.60 '13.80 ,,\ 2487996 p 35

ABBREVIATIONS FREQUENTLY USED IN THE DOCUMENTATION

Andro Androsterone (5a-androstan-3a-ol-17-one)

Etio Etiocholanolone (5fJ-androstan-3o.-ol-17-one)

Pdiol Pregnanediol (5~-pregnane-3a,20a-diol)

AB STD Unextracted standard containing androsterone, etiocholanolone and retention time standard (5a-androstan-3fJ-ol)

QCP4 Positive urine QC, HPLC region 4 fraction (andro, etio)

QCPS Positive urine QC, HPLC region 5 fraction (pdiol)

QCN4 Negative urine QC, HPLC region 4 fraction (andro, etio)

QCN5 Negative urine QC, HPLC region 5 fraction (pdiol)

Blank4 Reagent blank, HPLC region 4 fraction

Blank5 Reagent blank, HPLC region 5 fraction 2487996 p 36

PROCEDURE FOR IRMS ANALYSIS OF STEROIDS

SAMPLE PREPARATION:

Urine volume: 10-20 rnL urine sample aliquot Hydrolysis: Phosphate buffer: (2 mL of l.OM phosphate buffer at pH 7) Enzyme: 200 µL of ~-Glucuronidase (E.coli source) Conditions: 50°C, 1 hour SPE Extraction: Bond-Elut cartridge (Varian C18, 500 mg) Methanol and water conditioning Water rinse, Methanol/ethyl acetate elution HPLC: Instrument: HP 11 00 Autoinjection 90 µL, Phenomenex Onxy Monolithic Cl 8 100 x 4.6 mm, Mobile phase Water(A) and Acetonitrile(B), Flow rate 3 rnL/minute HPLC Cleanup 1: Grad.ient:0.0 minutes 30% B Time-based fractions 6.0 minutes 50% B 6.5 minutes 95% B 8.5 minutes 95% B region 4:---4.5-5.5 (Andro, Etio) 9.0 minutes 30% B region 5:~5.8-6.2 (Pdiol) 12.0 minutes 30% B Derivatization: Fractions: Pdiol Reagents: Acetic anhydride/pyridine Conditions: ·60°C, 3 hours

Reconstitution: Cyclohexane with Scx-androstan-3~-ol retention time standard

GC-IRMS AND GC-MS ANALYSIS: Instrument: Thermo Electron Trace GC Ultra, Delta V Plus IRMS, DSQII Injection: Autosampler GC Pal, 0.3-3µ.L PTV splitless at 280°C, Helium carrier Column: Agilent-J&W HP-50+ GC column (30 m x 0.25 mm x 0.15 µm) GC oven program: Initial: 80°C, hold 1 minute Ramp: l5°C/minute to 270°C, hold 6 minutes Ramp: 30°C/minute to 300°C, hold 4 minutes DSQII parameters: Scan mode over 50-450 m/z range Delta V Plus: o13C assignment via ISODAT, CO2 reference gas

."). '\..,; \.. 2487996 CH.AJJ\: OF CUSTODY DOCUIY.I:ENTATION p 3.7 FOR

IRMS _,1\,..NDRO/ETIO - IRMS DIOLS (CIB.CLE ONE)

EACH NAlvfE },£UST BE PRINTED AT LEAST ONCE ON THIS PAGE Fill rn. m . f ormati on as a lilquo t s are rel ease d t 0 R e f ne-era . t or #1 -'J f orst orae-e. ALIQUOT(S) .FOLDER NO. RELlfASEDH Y : DA"Tit I I I I I Tope Aki ntu nj i \~?1°13 rt ? LlSADA SEP O7 2010 R{t:J _'.) i·~~Or F:\ ~ VJ

~&1 [[J~ CSAC 5-5 r . -~ i( K- L -~'.q)(J SEP O7 2010 ,,...- - '-'' l. _,,_-. ~ 11\ NFL SEP ct 7 2010 1\JD21- ~ 31+ !"I·. ,. , -'. ~ ! .-,'"'W)~J " =· ·Y NCDF \ eo 4 ~ i , t· . -i SEP O7 ZD10 ' R_!✓ J._ ~& ~~o-• -·-..,,. ,_, 9 ·= ., , a.s NCDF I lPf5J . SEP O' 72010 K.N~ ~~ T-~ t-?·~q·it: . - ·11 ~-l'J ¢-·v lf NFL t~ l OJ SEP O7 2010 ~~e-~ !op_e AkintunJi Kl\(f l.~f NF.L ~ 3 t0' SEP O7 2010 ~,t}-- .. --::,.. ~

-- . ... . -·· ·- .. ··------·-- ·------·------..

... - -· --· . ·-- ·-·-········. -- ·-···. - ·······- ··- -- -- ·- . - --- . ---- -·· - ·- .. ·-. -· .. _____ .., ___ -- ··-- ··-- . ------··-··-- .. --

'

:·-· !"~

See reverse side for work-up Chain of Custody

n-\C:(YP\T nn.~~FRlvf\f'TT.C:T-TRM.~ Vi'Tld 2487996 p 38 EACH NAll{E lvfl.JST BE PR.fl\TTED AT LEAST ONCE ON I'.dIS PAGE

CHAIN OF CUSTODY FOR THE 'WORK-UP IS AS FOLLO"WS: I RELEASED BY: I TO: j .. DATE I PURPOSE I ¼~·\l?\~ Kf~ll- q.~·ID ~O;L.\,~ ·-Jc,,~C',f U( t t1t K', \I hU.IJ 2- ,.-._

--~-sd~t~ \h~b"'l'fD\- 9-~· \0 ti~ ~A,tl.r.'ltt s"fv

\Y\ \:AA0C'rtt) Y- ~~\celQ q·tr[D . ~),~ Ill'"! +:,so,f

. r ... ,.. :-\,•-.. ~~,~\O~ d,1,,'t,- 1-S- t'fi 1·•<.'.·-~- . dtv ,\ ·1 ·\::)

[o. ~+fl'\VJ· ctri\t,\r Ltit~1Q .. q.~· --1-~~t;t Y

D[-ft·(O L{'YvlCPvlQ _- !'S1 rr-o•) th °V'J:.U \ ~vf11rc3 '

Ni~'1JjJJ, v0\~~\ 4¼~~lQ q-~--[o . ~~hi-~ h~v~f

.. ~)\,\~0~ tt ? l G ~-~- \0 ~~~Hnv M?LG L.('4CJ2\U. ~-q.1.0 ~\tLS,fv-

~0sAU~ aviu- 1·'1 ·\D JV'{l Ylj .

~\r\t,)r 4.v~C{la .1·c1· l"D 'lY'c'\\'l'S-t"L. y- AI £

~>cilf\Q d·es, vtA~1~ 'J,q .\D ~(tiU:P~EYv

~ I cfos'i ('.;Vlfor 4){;lcel0 q.q. \0 Gmttt1V.f ¾~~{ ..

~ 0 ~Jt\V1 \oQ..f 4f 2-b ~-~·.ID . ('.-hJ rtt{O I - --:7 /l V - SEP ·o 9 2010 Refrigerator #26 ✓'7JITAhreh TRANSFER

f· -~•r-~ ("I t''\l!'\l f}"" \r i-rt~~. SEP Og 2010 F~UtJ~';:)~\~ i }·;l'-d t'• 1 .;._; /L_ L AN~lY"-'~_, ·, . ~ } Form approyed by f- :Jv/!'d' G: \SOP\LOGS&FPJ\-1\CtJST-IPJ\1:S. wpd Document ID Rev .. #:4010-000 Side. 2 of 2, "\,,,. 2487996 p 39 EACH NAlv.fE MUST BE PRniTED AT LEAST ONCE ON I'rlIS PAGE

CR4. ..IN OF CUSTODY FOR THE WORK-UP IS AS FOLLO-WS: I RELEASED BY: I TO: I DATE I PURPOSE I

r,, u{, cr.3., PT k' ms /-:/ /~ L /,-'I \, 'I... a. nnI \-. lJ ~·._,. /~ j/ ' SEP 1 3 2010 TRANSFER - _,ne.r1 Ah1-r1ns , ~ L TRMt.H SEP 1 3 2010 Dl~ARD

,.

-

~\ S:~, Ci:\'1, 110 Form approved by · f- ;f.0/0c? G:\SOP\LOGS&FRM\CUST-IRMS.-wpd ilnc:1rn,~nt ffi Rev. #:4010-000 Side. 2 0£ 2 , "l..,"'\J 2487996 CHAIN OF CUSTODY DOCUMENTATION FOR p 40

IRMS Al\'DRO/ETIO - IRMS DIOLS (CIRCLE ONE)

EA CH NAl/iE JvfUST BE p JWvTED AT LEAST ONCE ON THIS PA GE F,.rn in -rnformat:wn as a liiquots are release d to R ef ngerator . #1 2 f or storage. ALIQUOT(S) .FOLDER NO-.-1------,,~SEifB'i': DA""Tlt -1 I I I " u; }, Tope Akintun,ii USADA \ ~ ·? j fJJ j ( SEP O7 2010 ~:]) i/,1 ~'if\''':''f\1 ~..

~ VJ jj Q_ L ~ t'.J I (b 0) CSAC ~ ·,, \l , ~{)~ SEP O7 Z010 - '-;,' _}'-- - A ·(.~ i NFL ~{)if,j SEP ~ 7 2010 RJ°l2 ~-~oJ--- -, ... ,, .,;.• =· NCDF i ~04 ~& \Gt£ SEP O7 2010 ' 'f~~~o-...,. - '· NCDF , I- - ¾ RN iS a.s 1 (p fsJ rP,~m~,J- SEP o-72010

T-ft C·?•[!(it'. -= 11 NFL t~ l OJ SEP O7 2010 l('N rt v \ ~~e- ~op~ Akintunji i_~· ·nK 1\f. '/ 1 NFL 0) 3 t~ ~~t}- SEP O7 2010 -=· -

.. •-··--· -·--·-··--·-·· -·-- ·-·----•-··-•--•-·- --·--•--··· -·

- - .. - . - --· . -·· - . - . -- - . ·-· ·- - .. - . - . - ... --····

- - ·-· ------· ··•·-· -

'

See reverse side for work-up Chain of Custody \U.-:· , ~J _c.:, t., > 1 r 0

G:\SOP\LOGS&FRlvf\CUST-IRlvf.S.v,,pd 2487996 p 41 EA CH NAJ1fE AfUST BE PRINTED AT LEAST ONCE ON THIS PAGE

CHAIN OF CUSTODY FOR THE WORK-UP IS AS FOLLO"WS:

I RELEASED BY: I TO: I DATE I PURPOSE I ~St\~,\\u)c Jr 1-f f :W' I 2- 9-~·ID Bio; l\'1 --/ts s. 0 f _ l1vJ:\-c Tu 11 ho.,1 · 2-- ,,-, ·1 · 4~~CRUu1 \\-'\ lM \::."'11t11- 9-~ \0 \l'I Gu,l,(.\11 G"f\,,

\ \'\l,v,~r:tt()\'" 4St\ eel O~ 1·D·[D Lontt \71'~ -fcr:;s0-f

~~\\Q\~\ d,1,i't1- c1.~ rd· [\\t '\ ·1 ·nj

l, ciri~t\r lt:rdt;\Q ·- 1-~· [o. ~r,t{h V,,i: -~~S.n f

·l{sth\Q Nit,~Dy_,h vJ;.u \ 1-~ [O i,lv{I hJ '

c[ ,~ !o \\I ·1 ~-o JJJ1 \/\JhQJ:.\ · 4vJ~l0. ~"tih\-~ k~P-f

•. ~)c\cA~ tt ? L G 1-'6· \0 &~~-tibJ'V M?le ✓ ~<4re\O ~-C\-\D ~~sfcJ~ 4zt~L~ &v·i ir- 1·'1·\D dv'fl''j · '

~ \f\Q._,\',.. ~v~caQ .1·cl ID Tt'\\%-fcJ~ f! .J;: IQ I 4~Cf\Q 1✓ ·; 11' ~5 tl1 Vvku\ 1·1-\0 ciH \nJ '·

\D ~1tt~\/{ ~[_,5,0v~ ll 1 'f11Jz), \1·0\Vt \ tfy~~\Q q-~-

J.+ .\i • •• \ _\xy~u\U_ . .. 1\QI\ no - . ~}✓~ 0 --· .. ... /2f,_\1'1\Ci1bL,?~ f.n/ - I ~1JJ01t:: - l I ' I - ~~l\_f01j G\dt~ UYc1(CflQ q.ltO VJi'l-tih~ h~~~{

G. y- \,,., .~) 1 ;): l u,_~\ o~,, \J .\ \\, oo t\r\ \I\J \'St\ Gt-1,ID (l Vi\ l·Lj

Form approved by · f ~ :,f0/0d G:\SOP\LOGS&FRl½\C'LJST-IPJi-1:S.wpd

"~a"<=> r) of 2 n Documen~ ID Rev. ;/¢:4010-000 0~ -.L - ,"\.,"t:; 2487996 p 42 EACH NA111E JifUST BE PRINTED AT LEAST ONCE ON THIS PAGE

CHAIN OF CUSTODY FOR THE WORK-UP IS AS FOLLOWS: I RELEASED BY: I TO: -· I DATE I PURPOSE I 4)c\cql4 1' C\· \D ~'(\ \fJ\ lf-R_ s [;, ,~ 11\"Cj'l I~ v~ku \ ) 1~1/-r{'. \::C,it/'1()_l,,JC i -¼ ✓

~~c\lQ\Q 1'\Q f ~ ZG 01q \0 s'i1>'vP1,j v .---J /) /(/ ~ SEP O9 2010 Refrigerator #26 TRANSFER .-, {,/ '@r~hmns

- ~Al.. 1'\< ... YG..t,S s · f \ t{•oo~rn,c)l\ Ar trr~~>(' f~'t,~'.,_,.-v.,l.'j,.1U' ,11!!-..J SEP O9 2010 11 ~ L - /"/ !\utosa~er Inns SEP 1 3 2010 TRANSFER n /L L SEP 1 3 2010 /L_ L TRA8.H l""l~'fo:0Dt..11 1...., .._,, ~,t'i.

'

Form approved by f- ,to/o

Row 11, Peak Center GC Method AS Sample AS Method Identifier 1 Comment Preparation I11\ethod

1 X Disabled 1 >Internal No 7 AE STD#? method2landro]ptvO2.met 2 X Disabled 1 >Internal No 7 AE STD#? method2l andro]ptvO2.me! 3 X Disabled 1 >Internal No 7 AE STD #7 method2Iandro}ptvO2.met 4 X Disabled 1 >Internal No 7 AE STD#? method2landro]ptvO2.met

5 X Disabled 2 >Internal No 6 Pdiol method2Iandro]ptvO2.me!

6 X Disabled 3 >Internal No 6 Pdiol diacetate method2[androjptvO2.met 7 X Disabled 4 >Internal No 6 QCP4 AE method2[androjptvO2.met

8 X Disabled 5 >Internal No 7 QCP5 PDIOL method2[andro]ptvO2.met

9 X Disabled 6 >Internal No 5 QCN4 AE 0.3 UL method2[androjptvO2.met

10 X Disabled 7 >Internal No 7 QCN5 PDIOL method2[andro}ptvO2.met

11 X Disabled 8 >Internal No 6 BLAhlK4 AE method2IandrojptvO2.met 12 X Disabled 9 >Internal No 7 BLANKS PDIOL method2[andro]ptvO2.me!

13 X Disabled 10 >Internal No 7 RHD03-4 AE 1.0 uL method2IandrojptvO2.met

14 X Disabled 11 >Internal No 7 RHD03-5 PDIOL method2[androjptvO2.met

15 X Disabled 12 >Internal No 7 RKLOB-4 AE 1.0 uL method2[andro]ptvO2.me! 16 X Disabled 13 >Internal No 7 RKLOB-5 PDIOL method2[andro]ptvO2.me\

17 X Disabled 14 >Internal No 7 RKLOS-4 AE 1.0 UL method2(andro}ptvO2.me!

18 X Disabled 15 >Internal No 7 RKLOS-5 PDIOL method2[andro]ptvO2.met

19 X Disabled 16 >Internal No 6 RM211-4 AE method2fandro]ptvO2.met

20 X Disabled 17 >Internal No 7 RM211-5 PDIOL method2[andro]ptvO2.mel

21 X Disabled 18 >Internal No 6 RNA06-4 AE method2[andro]ptvO2.met

22 X Disabled 19 >Internal No 7 RNA06-5 PDIOL method2[andro}ptvO2.me\

23 X Disabled 20 >Internal No 6 RNE25-4 AE method2[andro]ptvO2.met

24 X Disabled 21 >Internal No 7 RNE25-5 PDIOL method2[andro]ptvO2.met

.25 X Disabled 22 >Internal No 6 RNV14-4 AE method2[andro]ptvO2.met

26 X Disabled 23 >Internal No 7 RNV14-5 PDIOL method2[andro]ptvO2.met

27 X Disabled 24 >Internal No 6 RNYZ0-4 AE method2[andro]ptvO2.met

28 X Disabled 25 >Internal No 7 RNYZ0-5 PDIOL method2[andro)ptvO2.me! 29 X Disabled 1 >Internal No 7 AE STD #7 method2landrojptvO2.rne!

Autasarnpler k"!Tts (D2U ~7 - Dlt 1/c;/v

C'-.i\ [ 11 {/- 1/1 J )1() rU1·r- 1 ··as" a., mi')\ ·r'..,. pr inn-;,, ,.:;, .i;,J:J 17 Vial List---C:\Xcalibur\methods\ 100909.sld 2487996 p 44 i Position/ Sample Type Level Sample ID ISample Name 11 Unknown AESTD #7 12 Unknown Pdiol

i3I Unknown Pdiol diacetate :4 Unknown QCP4 i5 ! Unknown QCPS ·1 i6 Unknown QCN4 7 Unknown QCNS 8 Unknown BLANK4 9 Unknown BLANKS irnI Unknown RHD03-4 i11 Unknown RHD03-5 12 Unknown RKL0B-4 13 Unknown RKL08-5 14 Unknown RKL09-4 /15 Unknown RKL09-5 i 115 I Unknown RM211-4

Ih1 Unknown RM211-5 18 Unknown RNA06-4 19 Unknown RNA06-5 20 Unknown RNE25-4 21 Unknown RNE25-5 22 Unknown RNV14-4 23 Unknown RN\/14-5 124 Unknown RNY20-4 !2s Unknown RNY20-5

S:) · 'l I 1> I 1 .;) 2487996 p 45 I Friday, September 10, 2010 01 UCLA Olympic Analytical Laboratory GC RI-Ill Interface Results Row AS Sample AS Method Identifier 1 Identifier 2 Comment Preparation lvtethod 9 6 >Internal .No 5 QCN4 AE 0.3 :ul method2[andro]ptvO2.met C:\Windows\Temp\100909-0008.dxf II 45/44 - 1.190 - 1.180 - - 1.170 - - 1.160 - _Jr ,- ,- ,.. - 1.150 - - - - - 1. 140 - 1.135 - ' l l 250 500 750 1000 1250 144E 11 44 111 45 Iii 46 7000 ::: ..... ~ ::' g 6000- "' "' "' "' "' ~ ~ .. 5000- ,.. ,..."' .. ... - ., 4000- - co ~ 3000-

2000- I;{ 1000- 1 " ....__ ' l ' l 250 500 750 1000 1250 144E Component Start Rt End Ampl. 44 BGD44 BGD45 BGD46 Area All d 13C/12C [s) [s] [s] [mV] [mV] [rnV) [rnV] [Vs] [per rniij VS. VPDB

WMG BP1 154.2 174.7 182.9 4644 1.3 1.2 2.3 91.603 -29.864 WMG BP2 303.5 324.0 332.9 4644 1.5 1.4 2.4 91.829 -30.120 WMG BP3 452.9 473.4 481.7 ·4619 1.5 1.4 2.4 S1.D42 -30.090 ·- : 721.5 742.0 i 748.6 . -4668 : 9.5 10:8 17.8 i :92:599 -30,657 - 797.1 801.5 "813.4 785 13.5 15.6 25.1 2.074 -30.604 - 925.7 930.7 946.1 3020 20.6 23.9 37.0 7.876 -21.729 - 946.1 950.7 966.0 5552 20.6 23.9 37.0 15.003 -20.061 - WMGP2 1224.1 1244.6 1249.6 4686 18.1 ·21.1 • 34:5 .92.890 -30.:657 WMG BP4 1348.5 1368.9 1376.3 4629 1.8 1.7 4.0 91.946 -30.449

S\, C5 \n \10 2487996 p 46 I Friday, September 10, 201 O 0~ UCLA Olympic Analytical Laboratory GC 11-111 Interface Results Row AS Sample AS Method Identifier 1 Identifier 2 Comment Preparation Method 10 7 >Internal t\Jo 7 QChJ5 PDIOL method2[andro]ptv02.met C:\Windows\Temp\100909-0009.dxf Ii 45/44 1.185 - 1.180 - 1.175 - 1.170 - 1.165 - 1.160 'r ~_J~ f------1.155 - 1 .150 - - - - c- 1.145 - - U40 - -4 1.135 - ' ' ' ' ' 250 500 750 1000 1250 144E ■ 44 ~ 45 ~ 46 7000-·,------~t------,,------,_------,;:.. ::: 6000- "~ "' '" 0 "' '" M"' "' 5000 - ~ ~ ~ .. ~ ~ ,-, ·- 4000- "' "~ 3000- 2000- 1000 - ~,.,, _..______L ~ ' ' 250 500 750 1000 1250 144E Component Start Rt End Amp!. 44 BGD44 BGD 45 BGD46 Area All d 13C/12C [s) [s) [s] [mV) [mV) [mV] [mV] [Vs) [per mil] vs. VPDB WMG BP1 154.2 174.7 183.7 4651 1.4 1.2 2.2 91.675 -30.321 WMG BP2 303.5 324.0 332.5 4651 '1.5 1.4 2.4 91.796 -30.383 WMG BP3 452.9 473.4 48U 4619 1.5 1 .4 2.4 91.232 -30.231 - 721:5 742.2 ' 747.8 4664 , 53.2 61..2 . 79.8 · 92.890 -30.,657 - 785.0 801.7 806.5 3767 55.8 64.3 85.D. 7.254 -29.919 - 1135.9 1143.2 1161.0 1966 45.8 53.1 73.7 B.077 -22.921 WMG P2 1224.1 1244.6 1251.3 4685 35.8 41.6 59.7 93.116 -30;657 WMG BP4 1348.7 1369.2 1376.7 4637 1.8 1.8 4.1 91.840 -30.337 2487996 p 47 j Friday, September 10, 2010 1J UCLA Olympic Analytical Laboratory GC 11-111 ln·terface Results Row AS Sample AS lv'iethod Identifier 1 Identifier 2 Comment Preparation Method 4 >lnterna! I\Jo 5 QCP4 AE 0.3 ul method2landro]ptvO2.me1 C:\Windows\Temp\ 100909-0029.dxf rm 45;44 1.185 - 1.180 - 1.175 - 1.170 - 1.165 - 1.160 1.155 - - 1.150 - - - ,- .... 1.145 - -~ - 1.140 - 1.135 -· ' ' 250 500 750' 1000 1250 144E lfl 44 Ill 45 ~ 46 6955 ,;. ::- "' - 6000 a, a, "'a, "' "' ~ .., 5000 - ~ ~ ,,.... ~ ,.,"' - .., - - 4000 - g~ 0 0, 3000 -

2000 - "'a, 0 1000 - "' ( '.J - ' 250 500 750 1000 1250 144E' Component Start Rt End AmpL 44 BGD44 BGD 45 BGD46 Area All d 13C/12C [s) [s] [s) [m\/] [mV] [m\/] [m\/] [Vs] [per mil] vs. VPDB

Wlv1G BP1 154.2 174.3 i84.1 4573 1.3 1.1 1.8 90.D58 -30,372 Wlv1G BP2 3D3.7 324.0 333.4 4574 1.4 u 1.9 90.136 1-30.282 WMG BP3 452.9 473.4 483.0 4558 1.5 1 .4 2.1 89.814 1-30.D94 . · 720.2 742.0 , 749.i 4581 10.8 12.2 17..D .91 .D54 ~30.657 . 797.8 801.9 814.1 767 17.3 19.8 26.8 1.943 I -30.519 . 925.7 931.3 946.6 2235 27.8 31.9 42.4 5.967 1-26.124 . 945.6 950.7 966.2 3177 27.8 31.9 42.4 8.582 -26.075 . WMGP2 1224 ..1 1244.6 1249.6 4645 23.6 .27.2 38.1 92J34 -30:657 WMG BP4 1348.7 1368.9 1376.7 4627 1.8 1.7 3.3 91.653 -30,327

;). C\ \ \;, \l'\,A '--v 248799( p 48 I Friday, September 10, 2010 1\ UCLA Olympic Analytical Laboratory GC 11-111 Interface Results Row AS Sample AS Method Identifier 1 Identifier 2 Comment Preparation h/iethod 2 5 >Internal I\Jo 7 QCP5 PDJOL method2[andro]p\v02.met C:\Windows\Temp\100909-0030.dxf liE 45/44 1187 1.180 - 1.170 - 1. 160 I - 1150 - ~ - - _Ur~-~ f-- 1.140 - 1.130 - ' 250 500 750 1000 1250 144E II 44 ~ 45 ~ 46 8861 .; m 8000 ~ - ...."' "' "' ..,,: ~ i 7000 - ~ el .... - m "' 6000 "' 5000 - 5 .... ~ C ,- - ~ - 4000 - - ~ 3000 - 2000 - 1000 - -L -" ~ ' '" 250 500 750 1000 1250 144E Component Start Rt End Ampl. 44 BGD 44 BGD45 BGD46 Area All d 13C/12C [s) [s] [s] [mV] [mV] [mV] [mV] [Vs] [per mil] VS, VPDB

WMG BP1 154.2 174.7 183.7 4573 1.4 1.2 2.1 90.292 -30.074 WMG BP2 303.7 324.2 332.5 4565 1.5 1.4 2.2 90.171 -30.040 WMG BP3 452.9 473.4 482.0 4558 1.5 1.4 2.3 89.921 -29.934 ·- 721.5 742.2 746.5 · -4605 56,7 65;2 83.5 91.473 ,30,657 - 797,1 801.7 806.1 5886 60.9 70.2 90.6 10.732 -30.131 - 1135.7 1144. i 1168.5 3146 54.9 63,5 844 13,170 -23.452 WMGP2 1224.3 1244.6 1250.2 4670 . 42.4 49.1 66.9 92.630 -30,657 WMG BP4 1348.7 1369.2 1376,3 4633 1.9 1.8 3.9 91.961 -30.385

fs • s In /10 248799 p 49 i Friday, September 10, 2010 1~ UCLA Olympic Analytical Laboratory GC 11-111 Interface Results Row AS Sample AS Method Identifier 1 Identifier 2 Comment Preparaiion Method

4 14 >Internal l ✓ o 6 RKL09-4 AE 0.5 UL method2[andro]ptvO2.met C:\Windows\Temp\100909-0032.dxf 11 45/44 1.185 - 1.180 - 1.175 - 1.170 - 1165 - 1.160 1.155 - ,...., ,_ ,_ .... >-- 1.150 - 1.145 - ~~ 1.140 - 1.135 - ' ' ' 250 500 750 1000 1250 144E 111 44 Ill 45 ~ 46 9000 - ;;; O• N 8000 - 0, tc ~ "' ~ ~ 7000 - o,"' ~ " w 6000 - "'.., o,~ ~ 5000 - ,... -·~ ~ 4000 - - - ~" 3000 - 0 ~ 2000 - 1000 - l l ~ I ' ' ' IL 250 500 750' 1000 1250 144e Component Start Rt End Ampl. 44 BGD 44 BGD45 BGD 46 Area All d 13C/12C [s) [s) [s] [m\/] [m\l] [m\/] [mV] [Vs] [per mil] VS. VPDB WMG BP1 154.5 174.7 183.3 4565 '1 .4 1.3 2.3 90.D04 -29.730 WMG BP2 303.7 324.2 33'1 .9 4590 1.5 1.5 2.5 90.642 -29.865 WMG BP3 452.9 473.4 480.9 4598 1 .6 1.5 2.5 90.724 -29.877 - : 720.4 742.0 748.4 . 4656 13.8 15.8 23.4 92.451 C3Q.657 - 796.9 8D1.5 819.7 2107 19.6 22.7 33.2 4.659 -30.343 - 925.0 931.9 946.6 6347 31.7 36.8 5'1.9 17.321 -26.035 - 946.6 951.2 965.4 6219 31.7 36.8 51.9 17.344 -24.950 I WMGP2 1223.3 1244.6 . 1250.4 4648 24.7 28.7 43.1 . '.92.350 -30,657 WMG BP4 1348.7 1369.2 1376.1 4600 1 .8 '1 .B 4.D 91.300 -30.426

(J · 7 \ \-, I '\:::J 248799 p so j Friday, September 10, 2010 1q UCLA Olympic Analytical Laboratory GC 11-111 Interface Results Row AS Sampie AS Method Identifier 1 Identifier 2 Comment Preparation Method 18 15 >Internal No 7 RKL09-5 PDIOL method2fandro]ptv02.met C:\Windows\Temp\100909-0017 .dxf II 45/44 1.185 - 1.180 - 1.175 - 1.170 - 1.165 - 1.160 LJ -¼ - 1.155 - ,_ ,- 1.150 - ,- t- 1.145 - .,- r +~ 1.140 - 1.135 - ' ' 250' 500 750 1000 1250 144E 11 44 lll 45 ~ 46 ..;~ ~ ~ "' !::! 7000- ::: ~ ID 6000- ., a, a, ., "~ 5000- 5 5 ,.. ,.,. ~ 4000- - 3000- 2000- .,0 ~ 1000- d ~ - ' ' 250 500 750 1000 1250 144E Component Start Rt End Ampl. 44 BGD44 BGD45 BGD46 Area All d 13C/12C [s) [s) [s) [mV] [mV] [mV] [mV) [Vs) [per mil] vs. VPDB

WMG BP1 · 154.2 174.7 183.3 4637 1.4 1.2 2.4 91.298 -29.787 WMG BP2 303.5 324.0 332.7 4646 1.5 1.4 2.5 91.665 -29.916 WMG BP3 452.9 473.4 482.2 4651 1.6 1.4 2.5 91.735 -29.930

- 720.4 : 74j,5 747.4 · -4734 ; '52.9 60.7 .. · 7-9.8 · .94.184 . -30;657 - 798.0 801.9 813.8 4975 70.1 80.8 105.3 10.283 -30.772 - 1135.9 1142.6 1156.6 706 46.1 53.6 74.6 2.866 -21.676 WMGP2 1222.9 1244.6 1250.2 4772 : 37.2 43.1 62,0 :94.680 ~30.657 WMG BP4 1348.7 1369.2 1376.5 4696 1.9 1.8 4.3 93.296 -30.356

s:) , 0 \ I --i, I \ 0 !RMS_HPLC _report_ 100909_RKL09 .xis

IRMS HPLC DATA READING RECORD FOR SEQUENCE: Criteria 3.9 3.8 4.0 4.0 -29 -29 5b-diol 5b-diol 5a-diol 5a-diol Pdiol Pdiol Observation l\6Etio l\6Andro l'.\65bcliol M5adiol Finding Elio Andra di-acetate Corrected di-acetate Corrected di-acetate Corrected RKL09 - 7.0 5.9 Adverse -26.035 -24.950 -21.676 -19.012 2 3 4 5 G 7 8 9 10 11 12 13 14 15 16 17 rn 19 20

Brian Ahrens // 1(:/rv N /L "O ~ Certifying Scientist Signature L Date 00 Ul --.J I-- \0 \0 0\

/ ~eP UCLA Co11fidenlial P8ge 1 Datafile Y \D2ta\HPLC\100909\2010090908 Date 9/10/2010 5:04 4', AM Miscellaneous. 2487996 Sample ID QCN4 Comment V1ai Position: 6 Method• C:\Xcalibu r\methods\method2[ andro ]ptv. meth p 52 RT: 10.00 - 20.00 No errors during acquisition.

L') NL• lO l[) 1.85E7 TIC MS 201009090 8

(I) u CG "D C :::, Ll< ID .2: E ID 0::

Time (min) 2010090908#31',-313 RT: 15.16-15.20 AV: 3 SB: 2 14.50, 16.50 NL: 1.21E5 2010 0 9 0 9 0 8 #311 - 313 RT : T .... c Full ms [50.00-450.00] SB: 2 14.50 1 16.50 290 T: + c Full ms [SO. 00-450. 00] 10~ 244 ?.57 J ml z = 2 4 3- 2 91 j m/z :Intensity Relat.ive 80 ID (.) 244" 113871.7 94.27 C 272 uCll 246: 47093.7 38.99 C 1 :::, 257 111863.2 92.61 .a < 272 79624.0! 65.92 Q) .2: 290 120786.Bl 100.00

i I 50 100 200 250 300 350 400 mlz 290 c Full ms [50.00-450.00) 244 2_57 + 101 272 50 228 _?_91

I I I ' I I I I I 50 100 150 200 250 300 350 400 mlz 2010090908 #331-335 RT: 15.50-15.56 AV: 5 SB: 2 14.50 , 16.50 NL: 8.06E5 2010090908f331-335 RT: T: + c Full ms [50.00-450.00] SB: 2 14 . 50 I 16.50 290 T: + C Full ms [50.00-450.00) m/z= 243-291 m/z !Intensity Relative 10180 Q) 24 6 [ 297192.6! 36.88 ~ co 257 259822. 9: 32.24 "Cl C :::, 60j 272 210437. O, 26 .11 .D < 108 275 179643.6! 22.29 Q) 246 290 805901. 5 1 100.00 £ .?.57 ~ 40~ 0) 79 93 239 0:: ?_91 21 I ol I I i I I 50 100 150 200 250 300 350 400 mlz

290 .,. C Full ms [50.00-450.00] 100"] j

::,-o-=J I 108 246 257 1]/r 1/n/r o 7 239 I r-- J 147 --~I I r·291- -' I I j! 0 ' ' I I I ' I I I 0nr, ,:,,;n ,nn '.-l'iO 400 f~' c-;. \ \ >} (u \ ~ Jataf:le Y:\Dala\HPLC\ 100909\2010090909 Date. 9.110/20105364"1 .ll..M lvliscellaneous · 248799( Sample ID OCN5 Comment: Vial Position 7 p 53 Method: C:\Xcalibu r\methods\method2[ andro jptv .meth RT 10.00 - 20.00 No errors aur~ng acqL:isition. NL lI) 0 1.33E7 r'l TIC MS Avalon 201009090 ·1003 9 .J 90-::J --j BO~ -I

OJu ro 60 "O 7~ C ,:..: ::, .0 0::: <( 5 OJ .2 ~ 401 OJ c::: 301

"j10 t.'\ 0 , 1 I I I I I ' I I I I I I I I I I I I I I I I I I I I I I I I I I I ' I I I I I I 10 11 12 13 14 15 16 17 18 19 20 Time (min) 2010090909 #524-528 RT: 18.71-18.78 AV: 5 SB: 2 18.68 , 19.83 NL: 3.58E5 2010090909#524-528 RT: T: + c Full ms [50.00-450.00] SB: 2 18. 68 , 19. 8 3 284 T: + c Full ms [50.00-450.00] m/z= 269-34 5 m/z ;Intensity Relative 269: 247442.1 69.08 270: 59276.5 16.55 284 358172,7: 100.00 269 285 93580.3; 26.13 344 77828.1[ 21.73 CJ Ll C rn 6 'Cl C ::, .0 <( CJ 230 :5 ro ai c:::

3 93 1_07 __121 22.~. 81 255 344 7~-- 215 J.22 67

I I I I I I 50 100 150 200 250 300 350 400 mlz 2010090909 #524-528 RT: 18.71-18.78 AV 5 I\JL: 3.61 ES 2010090909 Start S1/: 524 End S#: 528 T + c Full ms [50.00-450.00] Sta.re Time: 18.71 End Time: 18.78 284 + c Full ms (50.00-450.00j 100:i aJ j ~ so1 269 ~ 60~ 2. ~ 230 ru 40..J ~ ~ ·93 285 ~ 22~1 255 344 a; I r· Cc'. I ,11, i I· I I I I I I I ! I I I Data1iie Y \Data\HPLC\10090912010090929 Date 9/10/20·IG 4 53:56 PM Miscellaneous· 2487996 Sample ID: OCP4 Comment. Viai Position. 4 p 54 Method: C:\Xcalibur\methodslmethod2[ and ro )ptv .meth RT 10.00 - 20.00 No errors during acquisitio~. NL: 1.14E7 100 TIC MS 201009092 9

QJ 80 u Cru u C ::, 60 .D <( LI:) 0 Cl) 40 C') ~ ~ QJ 0:: ,1

0 I ' I I 10 11 12 13 14 15 16 17 18 19 20 Time (min) 2010090929#311-316 RT: 15.16-15.25 AV 6 SB: 2 14.50, 16.50 NL: 1.15E5 2010090929#311-316 RT: T: + c Full ms [50.00-450.00] SB: 2 14. 50 , 16. 50 24-5 257 290 T: + c Full ms [50.00-450.00] 100] m/z= 2 4 3-291 m/z ;Intensity'Relative 80 (I) 272 u 244: 113237.0 98.58· ruC u 107 246 57129.5 49.73 C 6 ~;, ::, 79 J08 257 113910.2 99.17 .D <( 272 83821.0 72.97 Cl) -~ 67 119 290 114868.5 100.00 iii ai J.21 0:: 2 1.91

I I I I 100 150 200 250 300 350 400 mlz 290 + c Full ms [50.00-450.00] 244 2_57 272 228 9;, 107 16.1 176 201 0,-4,IJ...,_....,._.'l"--,IIIWIL,JJJIIJI-JJIUIW-"-,-""""-1-"'!W,.....,.., ....,...."f-1 ____"-'JLW"'r'""'-,-_,...__,.__~--~~~~.,..-",.....,~ 50 100 150 200 250 300 350 400 mlz 2010090929#331-335 RT: 15.50-15.56 AV: 5 SB: 2 14.50, 16.50 NL: 4.62E5 2010090929fr331-335 RT: T: + c Full ms [50.00-450.00] SB: 2 14 . 50 , 16. 50 290 100 T: + c Full ms [50.00-450.00J m/z= 243-291 m/z Intensity!Relative 8 (I) u 246 170754.9( 36.95· C (tl 257 152408.8: 32.98 · u I C 60 272 114625.Zi 24.80 _g 108 < 275; 105308.1 1 22.79 Cl) -~ 246 257 290 462129.0i 100.00 iii ai 41 79 93 2:w -- 212 Q'.'. 291 I~ -

l l I l I l I ' I I 50 10_0 250 300 350 400 mlz 290 + c Full ms [50.00-450.00) 1001

7 5~ ~ 67 0/ n J, I. /n)r~ \ I i ! .... ~ Data;'ile: Y:\DutalHPLC\ 100909\2010090930 Date: 9/10/2010 5:22:25 PM Miscellaneous: Sample ID: QCPS Comment: Vial Position. 5 2487996 Method: C :\Xcaliburlmethodsimethod2[ andro ]ptv. meth 55 RT: 10.00 - 20.00 No errors during acquisition. NL: 2.75E7 TIC MS Avalon 201009093 0

Time (min) 2010090930 #524-528 RT: 18.71-18.78 AV: 5 SB: 2 18.68, 19.83 NL: 5.34E5 2010090930*524-528 RT: T: + c Full ms [50.00-450.00) SB: 2 18.68 , 19.83 284 10 T: + · c Full ms (50. 00-450. 00] m/z= 269-345 m/z Intensity Relative 269 344173.8 64.42 270 76539.8 14.33 284 534230.2 100.00 285 139722.7 26.15 7 344 118368.1 22.16 269 Qlu C ro u § .0 <( 5 QJ £ 230 ro ai 4 c:'.

93 197 _L21 22JL 344 7~ 81 215 255 __122

I 100 150 200 250 300 350 400 mlz 2010090930 #524-528 RT: 18.71-18.78 AV: 5 NL: 5.39E5 2010090930 Start S#: 52 4 End S#: 528 T· + c Full ms [50.00-450.00] Start Time: 18.71 End Time: 18.78 284 + c Full ms [50.00-450.00] 100:1

QJ <) C Cu 80] 269 ~ 60 , i5 < 230 (!) 40~ i .2: f_85 3 229 J 255 344 iii 20-{ c::'" I I ~ I : -! ' ' I I ' I Datafile Y:\D2,ta\HPLCI 100909\2010090932 Date 9/10/2010 6:26:12 PM Miscellaneous Sarnple ID RKL09-4 Comment: Vial Posiilon 1" 2487996 Metnod: C \Xcaliburlmethods\method2[ and ro jptv. meth p 56 RT: 10.00 - 20.00 No eYro~s durins acquisi~ion.

LO NL: LO 2.22E7 M LO 100, N~ TIC MS LO 201009093 j ~ 2

Q) (.j 80~ C cu "D C 60 :, .D < (I) .2 40 "iii o:'."' 20

0 10 11 12 13 14 15 16 17 18 19 20 Time (min) 2010090932 #311-316 RT: 15.16-15.25 AV: 6 SB: 2 14.50, 16.50 NL: 3,69E5 20100909321311-316 RT: T + c Full ms [50.00-450.00] SB: 2 14 .50 , 16.50 290 T: + c Full ms [50.00-450.00] mo 244 257 m/z= 243-291 m/z 'Intensity Relative 8 (I) u 244: 343130.2: 93.09 iii 272 246! 169970,3 46.11 D 107 C: 228 :, 9;.3 257' 3450~4.S! 93.61 .::, .108 < 7;) 272: 236659.7i 64.20 a, 290! 368619.71 100.00 .? 67 119 "iii 0::"'

300 350 400 mlz 290 + c Full ms [50.00-450,00)

272 5 ?_91

50 100 150 250 300 350 400 m/z 2010090932 #331-335 RT: 15.50-15.56 AV: 5 SB: 2 14.50, 16.50 NL: 9.98E5 20100909321331-335 RT: T: + c Full ms [50.00-450.00] SB: 2 14. 50 I 16.50 290 T: + C Full ms (50.00-450.00] 100~ m/z= 243-291 m/z :intensity Relative 80 a, u 2 4 6' 340562.5 34 .13 C ro J 257 294291.5. 29.49 "D C :, 272 242083.7 24.26 .n < 108 275 214253. 0: 21. 4 7 a, 290 997966.11 100.00 .2 :J 246 '?c,57 (I) 93 23_9 Ct'."' 291 20~ r·- I I 01 I I I ' 50 100 200 250 300 350 400 mlz 290 + c F·ull ms [50.00-450.00j 100-:J ~ 108 50~ 246 257 232_ ,1_s1 147 [.- // ~ 1/11/1° 11.1· \,I ' \J.! ""I.. i I I I I I ' I I I ' I i i I ~rn ;nn \'7' Data'ile Y:\Data\HPLC\100909\2010090917 Date 9/10/2010 9:52:15 Alv1 lv11scellaneous: 2487996 Sample ID RKL09-5 Comment: Vial Position 15 lv1ethod: C:\Xcalibur\methods\method2[andro]ptv.meth p 57 RT: '10.00 - 20.00 Ne e=rors during acquisition. NL: LO D 2.14E7 r0 TIC MS i:-: Avalon 0:: 201009091 10D~ 7

I 90..J ::J I so-=I 7

(I) 7~ 0 C rn 6~ ~ ::, .0 < 5~ (I) :;::,> ~ 4~ (I) a: ,1 2C] 10 L_J __ _, I I I I 10 11 12 13 17 18 19 20 Time (min) 2010090917#524-528 RT: 18.71-18.78 AV: 5 SB: 2 18.68, 19.83 NL: 1.29E5 2010090917#524-528 RT: T: + c Full ms [50.00-450.00] SB: 2 18.68 , 19.83 284 T: + c Full ms [50.00-450.00] m/z= 269-345 m/z 'lntensity'Reiative 269 93845.1 72.48 270 17443.7 13.47 284 129481.41 100.00 269 285 36119.71 27.90 344 24016.41 18.55

230

)~85 121 255 7;l B1 344

100 150 200 250 300 350 400 m/z 2010090917 #524-528 RT 18.7'1-18.78 AV 5 hll: 1.31 E5 2010090917 Start: s~: s2 4 End S#: 528 T: + c Full ms [50.00-450.00] Sta.rt Time: 18. 71 End Time: 18. 78 284 + C Full ms [50.00-450.00) 100"] _J (l) _J u C 801 269 ro -0 C ::, 6G~ .D J < _J 230 (I) 40-j :.S J J-85 ro _J 81 22.;l_/ 255 ru 3tµ; a: 2~~5 I rs It- 1/u/r 0 _J I I C· . J I I I I I I I ' I I I A l'>I'> '\~ 2487996 p 58

UCLA Olympic Analytical Laboratory

'A' SPECIMEN SUMMARY Identification data evaluated according to WADA TD2010lDCR for: Client: CSAC Folder: 55 Bottle: 2487996 UCLA Labcode: RKL09 Analysis: A-Specimen

Substance: Etiocholanolone !STD 5a-androstan-30-ol QCP4 TOLERANCE RKL09 EVALUATION Datafile 2010090929 LOWER UPPER 2010090932 ISTD RT (min) 13.05 12.95 13.15 13.03 Compound RT (min) 15.21 15.11 15.31 15:23 PASS Diagnostic Ion 1 290 100 NA NA 100 Diagnostic Ion 2 244 98.58 88.58' 108.58 93.09 PASS Diagnostic Ion 3 257 99.17 89.17 · 109.17 93:61 PASS

Substance: Androsterone ISTD: 5a-androstan-30-ol - QCP4 TOLERANCE RKL09 EVALUATION Datafile 2010090929 LOWER UPPER 2010090932 ISTD RT (min) 13.05 12.95 13.15 13:03 Compound RT (min) 15.55 15.45 15.65 15.55 PASS Diagnostic Ion 1 290 100 . NA NA 100 Diagnostic Ion 2 246 36.95 29.56 44.34 34.13 PASS Diagnostic Ion 3 257 .32.98 26.38 39.57 29.49 PASS

Substance: Pregnanediol -diacetate !STD: Sa-androstan-30-ol QCP5 TOLERANCE RKL09 EVALUATION Datafile 2010090930 LOWER UPPER 2010090917 ISTD RT (min) 13.05 12.95 13.15 13.05 Compound RT (min) 18.79 18.69 18.89 18.76 PASS Diagnostic Ion 1 284 100 NA NA 100 Diagnostic Ion 2 269 64.42 54.42 74.42 72.48 PASS Diagnostic Ion 3 344 22.16 17.16 27.16 18.55 PASS

CONCLUSION: Identification criteria are met for the following substances: Etiocholanolone Androsterone Pregnanediol 2487996 p 59 GC/IRMS RUN INSTRUMENT VERIFICATION DATA SUMMARY

PEAK SHAPE (High voltage scan over 2.98-3.03 kV range) m/z 45 peak center within m/z 44 plateau m/z 45 peak center within m/z 46 plateau

LINEARITY cPC(%o) vs. background subtracted m/z 44 (V) slope magnitude <0.066%0/V

STABILITY o13 C%o standard deviation <0.06%0

DSQII RF Frequency test passed Detector gain test passed Mass calibration test passed Leak Check test passed 2487996 p 60

/

I 5000~ / \ I \ i / \I \ i / "---, \ I I \\ \ I \ \

400~ I / \\ \ I \ I \ i \ I I I i \ ~A- 1/1/ro ' I i ! II I \ I 3001 \ I ! \\\ \1 \\ \\ 2000--;

' ;/ l\' i I I ! \\ I 1000~ I ! ! / i / \\ I \\ i \' I I ./ \\ I \,, ; "" I ,<·-.. . / ~, ----- / ~---- 2487996 p 61

LINEARITY ANALYSIS (%JV)

Analysis Date: 12/29/2009

Datafile: 091229_CO2 OnOff Linearity 1

N 44(m\/) 44 (V) BGD 44 (mV) BGD 44 (V) BGD sub 44 (V) lt'c%. 1 630 0.630 14.7 0.0147 0.615 -29.889 2 1227 1.227 14.5 0.0145 1 .213 -30.250 3 2022 2.022 14.6 0.0146 2.007 -30.529 4 2827 2.827 14.7 0.0147 2.812 -30.657 5 3722 3.722 14.8 0.0148 3.707 -30.759 6 4912 4.912 15.0 0.0150 4.897 -30.746 7 6380 6.380 15.2 0.0152 6.365 -30.766 8 7648 7,648 15.8 0:0158 7.632 -30.901 9 9051 9.051 15.8 0.0158 9,035 -30.793 10 10289 10.289 16.1 0.0161 10.273 -30:698

SUMMARY OUTPUT

Regression Statistics Multiple R 0.713 R Square 0.509 Adjusted R Square 0.447 Standard Error 0.228 Observations 10

ANOVA df ss MS F Significance F Regression 1 0.431 0.431 8.289 0.021 Residual 8 0.416 0.052 Total 9 0.848

Coefficients Standard Error t Stat P-value Lower 95"/4 Upper 95% Lower 95.0% Upper 95.0% Intercept -30.282 0.131 -230.379 0.000 -30.586 -29.979 -30.586 -29.979 !X Variable 1 0.023 -2.879 0.021 -0.117 · -0.013 -0.117 -0.013 / Tuesday, December 29, 2009 1/ UCLA Olympic Analytical Laboratory 2487996 GC Ii-Ill Interface Results P 62 Row AS Sample AS Method Identifier 1 · Identifier 2 Comment Preparation Method < •··• •· :. > ) , )F:~O~¼"~? G)QZ, :~~~i~2~f C :\Thermo\lsodat NT\Global\User\GC 11-111 lnterface\Results\Maintenance\091229\091229_CO2 OnOff Linearity 1.dxf ■ 45/44 1.196 -,------, 1.190 1.180 1.170 1.160 1.150 J 1.140 1.130 ' ' 100 200 300 400 500 539 ■ 44 ■ 45 ■ 46 11096------,,,----=~----, 10000 ;i ~ .., ITT~ § a • 7.500 i;,; ;g 6250 ~ 5000 3750 2500 1250

100 200 300 400 500 539 Component Start Rt End Ampl. 44 BGD 44 BGD 45 BGD 46 Area All d 13C/12C [s] [s] [s) [mV] [mV] [mV] [mV] [Vs) [per mil] VS. VPDB 35.5 55.8 60.0 630 14.7 18.9 · 25.5 12.553 -29.889 85.3 105.8 107.6 1227 14.5 18.6 24.9 24.100 -30.250 135.0 155.5 158.4 2022 14.6 18.7 25.3 40.094 -30.529 >.::'t .. ?:: .,;:::.-:,; ~:~1~1t~i::~:i~!:;,<:1i!i •i.i~:IIl~il¥li~i:~i ~]l:~~lil~t~ ~~~~l!.4i1~i~~ ~~·~7 t,r ~, ,?:e',;::::r, 1:12s.isi:i~:!'fi}1li~~~~1~rt\1~1t s:~~iW;m~:~:ii:?:'.i11i:i 234.7 255.0 264.4 3722 14.8 18.9 25.5 71.900 -30.759 284.4 304.9 313.3 4912 15.0 19.1 25.7 94.857 -30.746 334.2 354.7 365.8 6380 15.2 19.3 26.0 123.679 -30.766 382.7 404.4 411.7 7648 15.8 19.9 26.8 153.486 -30.901 433.7 454.2 466.9 9051 15.8 19.9 26.8 175.851 -30.793 483.4 504.1 517.3 10289 16.1 20.3 27.2 199.557 -30.698 2487996 p 63 I Tuesday, December 29, 2009 1j UCLA Olympic Analytical Laborato.ry GC 11-111 Interface Results

Row AS Sample AS Method Identifier 1 Identifier 2 Comment Preparation Method 7 Disabled CO2 OnOff 7 PZOAL GC CO2 std onoff Z:\Results\fv1aintenance\091229\091229_CO2 OnOff 7 .dxf 11J 45/44 1,185 1.180 1.175 1.170 1 .165 1.160 1.155 1.150 1.145 ---J J 1.140 1.135 ' 100 200 300 400 500 539' 11 44 ~ 45 ~ 46 7000-~------~------,,,N~------=.,------~

6000- :: 0 g i 5000- "' 4000- 3000- 2000- 1000-

100 200 300 400 500 539 Component Start Rt End AmpL 44 BGD 44 BGD45 BGD46 Area All d 13C/12C [s] [s] [s] [m\/] [m\/] [mV] [mV] [Vs] [per mil] VS, VPDB - 35.5 56.0 66.0 4691 14.0 18.6 25.7 90.932 -30.519 - 85.3 105.8 115.6 4692 14.7 19.3 26.7 91.042 -30,631 - 135.0 155.5 165.1 4697 14.8 19.5 26.9 9'1.086 -30.682 - 185.0 205.2 , .214.4 4695 ' j4.8 ,19:5 26.9. ·, .91.006 . -30.657 - 234.7 255.2 264.0 4701 14.9 19.5 26.9 91.016 -30.614 - 284.4 304.9 314.3 4697 14.9 19.5 26.9 91.068 -30.572 - 334.2 354.7 363.9 4695 14.9 19.6 27.0 90.955 -30.629 - 383.9 404.4 4'14.4 4693 '14.9 19.6 26.9 91.044 -30.609 - 433.7 454.2 464.2 4693 14.9 19.5 27.0 91.074 -30.665 - 483,6 504.1 514,1 4697 14.9 19,5 26.9 91,042 -30.588

- ]a.~ 6,DLff' Iz,/ 2-1(0/ 2487996 p 64

Tune Report Source: EI Thu Sep 09 15:31:30 2010 Instrument: PATH3235900L Rod DC: B DC/RF: 0.930 Operator: DSQ m/z 69 m/ z 131 m/z 219 ml z 414 ml z 502 ,------. ------~ ~------\

)\~_ \\__

Theorv Actual Apex Intensity % Base Pk Isoto2e Rac.io 69.0 69.0 69. 1 1208653 100.0 1.2 131.0 131.0 131. 1 873793 72.3 3.2 219. 0 218. 9 219.0 836092 69.2 4 . 1 414.0 414.0 414. 0 114255 9.5 9.5 502.0 502.0 502.0 13034 2 10.8 10.2 Automatic Tune Calibration Result Parameters Last Calibrated RF Frequency Passed 1098.5 kHz Sep 09 / 2010 03:20 PM Dete.ctor Passed 3e5 @ 1343 V Sep 09, 2010 03:23 PM Mc.SS Passed 44.82, -42.91 Sep 09 / 2010 03:31 PM -0.73, 0.33 Resolution (+) Passed 0.0240, 0.0245 Sep 09 / 2010 03:31 PM 0.3542, 0.3567 9.4964, 4.9816 Leak Check Passed 5.9% of reference Tune file: pzoall - Tune Completed Lens 1 -25.00 V Ion Source Temp (250) 250 C Lens 2 -7.03 V Fore Pressure 14 mTorr Lens 3 -25.00 V Electron Lens 15.00 V Electron Energy -70.00 V Prefilter Offset -5.00 V Emission Current 100.00 µA

Tune Factors Mass 25.0 Start 10 0 0 End 1000 Mass 51. 5 Start 321 End 321 Mass 78.5 Start 436 End 436 Mass 132.5 Start 216 End 216 Mass 220.5 Start 683 End 683 Mass 4 15. 5 Start 779 End 77 9

Mess-Resolution Tuning Factors Mass 1. 0 Ion Offset 2. 9 Res. Factor 1.62 Mass 1050.0 Ion Offset 5.0 Res. Factor 3.22 2487996 p 65

"A" Sample Laboratory pH and Specific Gravity

UCLA Specimen Lab Lab Code # pH SG

RKL09 2487996 5.5 1. 029 2487996 p 66 ■ WORLD UCLA Olympic Analytical Laboratory ANTI-00PIHG AGENCY UCLA School of Medicine play-true 2122_Granvil!e Ave. Los Angeles, CA 90025 Phollle (310) 825-2635 Fax (310) 206-9077 Chemical Testing Certificate: 1420.01

CONFIDENTIAL Carbon Isotope Ratio Report - CSAC55 (RKL09)

September 14, 2010

California State Athletic Commission Attn: Sarah W aklee 2005 Evergreen Street, Ste. 2010 Sacramento, CA 95815 Fax: (916) 263-2197

Specimen number: 2487996 UCLA Code: RKL09 Sport: :M:MA Collection date: 08/06/10 Date Received at Lab: 08/10/10 Date of Analysis: 09/07 /10 Condition and custody of sample: . Acceptable

Analysis: The urine sample was analyzed using method 8001, steroids by carbon isotope ratio by GC/IRMS.

Analytical Findings:

IR.MS Laboratory Result: fl (Pdiol-Etio) fl (Pdiol-Andro) Result* 7.0± 0.9 5.9± 0.8 Adverse

* -where "Inconclusive" or "Negative" indicates results are consistent with endogenous origin and "Adverse" indicates results are consistent with administration of a steroid.

0 Unit of measurement for the two values is cPC [ / 00]. The :value after the::!:: is the uncertainty of measurement (k:=2).

Brian Ahrens L Certifying Scientist Signature Date

This report shall not be reproduced, except in full, without the written approval of the laboratory. Page 1 of 1 EDMUND G. BROWN JR. State of California Attorney General DEPARTMENT OF JUSTICE RONALD REAGAN BUILDING 300 SOUTH SPRING STREET, SUITE 1702 LOS ANGELES, CA 900I~ Public: (213) 897-2000 Telephone: (213) 897-8944 Facsimile: (213) 897-2804 E-Mail: [email protected]

October 6, 2010 Sent by Facsimile and by First Class Mail

Howard L. Jacobs, Esq. Law Offices of Howard L. Jacobs 2815 Townsgate Road, Suite 200 Westlake Village, CA 91361

Re: CSAC v. CHAEL SONNEN

Dear Mr. Jacobs:

As I promised yesterday, here is the licensing application packet of Chael Sonnen. f~ (Jvt~~ KAREN B. CHAPPELLE Supervising Deputy Attorney General Licensing Section

For EDMUND G. BROWN JR. Attorney General

Enclosures

cc: George Dodd, Executive Officer, California State Athletic Commission

KBC:hg LAW OFFICES OF H D WA R D L. _J AC D B 5

NOVEMBER 3, 2010

VIA E-MAIL [[email protected]] AND REGULAR MAIL

Anthony Butch, Ph.D. Director UCLA Olympic Analytical Laboratory 2122 Granville Ave. Los Angeles, CA 90025

Re: CSAC 2487996 / UCLA RKL09, MMA (collection date 8/6/201 OJ

Dear Dr. Butch:

Please be advised that I represent the athlete in the above-referenced matter. Request is hereby made for a "litigation packet," consistent with what would be expected under the USADA Protocol for Olympic Movement Testing, related to the above-referenced sample, limited to that testing that relates to the TIE ratio testing that was performed on the sample. At this time, no request is being made for any documentation related to the carbon isotope ratio testing that was performed on the sample.

This request is made subsequent to my request made to the California State Athletic Commission ("CSAC"), and at the direction of the CSAC who instructed that my request should be directed to the laboratory. If possible, it is requested that the documents be produced electronically to the e-mail address listed below, as opposed to mailing the documents.

Should you have any questions regarding this matter, please do not hesitate to contact me.

cc: George Dodd, California State Athletic Commission (via e-mail and regular mail)

2815 Townsgate Road, Suite 200 Cell. 818.422.0508 [email protected] Westlake Village, California 91361 Fax. 805.418.9899 "wv. ,;':lic1s:,;:i-11vc· un: Tel. 805.418.9892 Tel. 818.292.8735 lc:sRc:ICALIFORNIA STATE ATHLETIC CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 11 Subcommittee Report Muay Thai Subcommittee Update Summary of Meeting Muay Thai Subcommittee Meeting Van Nuys, California October 18, 2010

Meeting was called to order at 2: 10 p.m. Present were Commissioners John Frierson and Christopher Giza, Executive Officer George Dodd, and Anita Scuri, legal counsel.

Commissioner Giza indicated to members of the audience that he would be asking them to present their concerns for their sport, the priority of those concerns, and their suggestions for possible solutions to the issues they raise. He indicated that a summary of the meeting will be posted online, with the ability for audience participants to suggest corrections, in order to ensure accuracy.

Attendees introduced themselves: JT Steele CAMO Jeremy Lappen CAMO Bryan Dobler Thai Boxing Association Walter Michalowski Thai Boxing Association Robin Hart Cohen Stand Up Promotion Montri Shnpanich MTAA Jeff Saco 9 Diamonds Kickboxing Shannon Rainey Thai Boxing Association Steve Fossum International Fight Sports Anthony Lin United States Muay Thai Dej Sri-Ampki CSAC

Mr. Dodd indicated that the muay thai rules were missed between kickboxing and MMA rules-the sport is similar to MMA but no action took place on the ground.

The primary concerns by those in attendance (and their suggested solutions) are presented below.

Brian Dobler stated that his organization's primary concern was that, since amateur "smoker"-i.e. unregulated-events had been shut down, there is no path by which an amateur can progress to the professional rank and the inter-gym tournaments are not safely regulated. He presented the following options and comments: 1. Delegate the entire amateur portion of muay thai regulation to a nonprofit group. This does not address inter-gym tournaments but the delegation would have to address it. 2. Delegate "B" and "C" class (pre-amateur) to a nonprofit organization while the commission continues to regulate semi-pro and pro events. If regulation is inexpensive, then he thinks those responsible for such events would all go along and submit to the regulatory entity's jurisdiction. 3. Delegation should be to an absolutely neutral organization, with no ties to any group or to any product manufacturer. The classes delegated would have padded intergym fights with headgear for athletes just starting out. "C" class would permit punches, kicks, and knees but no elbows. Athletes would wear headgear and shin guards. "B" class would permit punches, kicks, knees, and elbows. Athletes would wear same equipment as "C" class and elbow pads. "A" class would permit punches, kicks, knees, and elbows. Athletes would

/ . ...A wear elbow pads but no shin guards or headgear. Athletes should be separated into these categories by age, weight, and experience. 4. There should be a pathway to licensure for officials. 5. There should be one set of standardized rules.

Jeff Baco supported the three classes because the sport needs a path to the pros. He believes the rules are unclear or inconsistently enforced (re equipment, weight of gloves, etc.). He has provided Mr. Dodd with a copy of the rules proposed by New Jersey State Athletic Commission and and urges adoption of those proposed rules. Another concern is that referees and judges are not knowledgeable about the sport of muay thai. They may understand boxing and kickboxing very well but not muay thai. There are many officials who want to do muay thai events and would be eager for training.

Anthony Linn expressed the following concerns: 1. There should be one set of standardized rules. They have submitted a set of rules to Mr. Dodd. 2. Improper training and improper equipment are the biggest causes of injury. 3. Referees and judges need training in the basics of the sport. 4. The rules are applied inconsistently. 5. There needs to be a path to gain experience in the use of elbows before turning pro-for the development of the sport. 6. Regulation needs to be accomplished so as to permit the sport to be financially viable. 7. Commission is doing a good job. Just need to tweak the rules, training the officials, and improve communication. 8. The commission should be the central data collection point. It can start by gathering information from all relevant databases.

Steve Fossum commented as follows: 1. Delegation is not the answer because it lacks the power of the state's authority to enforce laws. 2. The system is working in California-just need some training of officials and to improve consistency in applying the rules. 3. Cost can be reduced by using "inspectors in training" and other lower-cost personnel.

Robin Hart Cohen commented that safety of the fighters is the highest priority. 1. They need the same safety features as are applied to the pros. She agreed with other comments regarding inconsistency in applying the rules. She believes a data base of amateur athletes is extremely important.

\-:: Stakeholder Concerns and Suggestions: 1. Safety of Amateur Muay Thai (AMT) athletes (see #2, #3 below) - Concerns: It was recognized by all present that proper safety for AMT athletes was a unifying goal. There were many avenues proposed to improve AMT safety, including adoption of consistent AMT rules, standard AMT equipment, proper training for AMT officials, education of AMT stakeholders, providing more opportunities for supervised competition in the amateur ranks, establishing an accurate database(s) of AMT combatant records. Within this context there was discussion about having different 'levels' of amateur competition, perhaps with different levels of safety equipment. There was also discussion about unsanctioned "Smoker" events and how they were handled (see #6 below - currently, if CSAC is notified about such events, they dispatch an inspector with local law enforcement to deliver a 'cease and desist' order).

Proposed solutions: Standardization of the rules and equipment, more AMT-specific training, combining or using multiple AMT databases were all suggestions as to ways of improving AMT fighter safety. See below {#2, #3, #4) for specific suggested actions to promote AMT safety.

2. Lack of consistent rules for AMT, differences with amateur kickboxing and MMA - Concerns: Many commented on uncertainty regarding which rules pertained to AMT with regards to fighting, equipment and even the ring/venue.

Proposed solutions: EO Dodd indicated that some of these inconsistencies were currently being corrected by careful review of the existing law, including education of both CSAC personnel and stakeholders as to the appropriate regulations.

a. Fighting rules - many differences between AMT and kickboxing, including 8 legal striking areas vs only 4 for kickboxing. MT fits better under the existing general rules for MMA.

Proposed solutions: Two versions of proposed AMT rules were provided to the AMT subcommittee to review and compare with the existing CSAC rules. Once CSAC staff have compiled these different versions, a comprehensive standard rule set will be drafted and provided for public comment. Given the challenges with rule modifications that require legislation, it is desirable to work within the existing rule structure and only propose legislative changes where necessary.

b. Equipment- many specific inconsistencies were raised, particularly with regards to AMT, including use of shin guards, head protection and booties.

Proposed solutions: Again, equipment requirements will be clarified and more consistently enforced under currently existing rules. In addition, areas where existing regulation may need modification will be identified and pursued. c. Venue/setting - several stakeholders indicated fighting arenas/rings that were unacceptably close to walls or other features with the potential to cause injury.

Proposed solutions: Clearly, any unsafe features will not be permitted at supervised events. The starting point for this is existing regulation, but changes will be pursued when necessary.

3. Variable qualifications of officials, proper training to officiate AMT - Concerns: Comments were made regarding lack of knowledge of specific MT/AMT rules/regulations, and/or inconsistent application of existing regulations. Officials with expertise in other combatant disciplines but limited knowledge of MT/AMT were reportedly being assigned to these AMT events.

Proposed solutions: Review and modification of existing rules to create a standard set of rules for AMT will help. EO Dodd also indicated a desire to move ahead with specific MT training for officials in the near future. Multiple stakeholder organizations generously offered assistance in training officials for Muay Thai.

4. Proper advancement of AMT athletes - Concerns: Multiple items were raised, including inaccurate record keeping, lack of a legitimate path to pros and lack of opportunity for experience at the amateur level. Overall there is a recognition that these problems put US AMT athletes at a disadvantage, as they often have less than 10-15 fights when competing internationally, against individuals from other countrtes who may have 20-40 amateur matches. There are substantial challenges to accurately determining an athlete's record so that they may be matched appropriately. There is no single fight database and different organizations have shown variable levels of cooperation when accepting fighter credentials. It is also recognized that relying solely on the fighter's statement without some independent verification of his/her record would be inaccurate and could lead to mismatches.

Proposed solutions: Multiple actions were proposed to improve this, including #2, #3, #5. The stakeholder organizations present have also offered use of1heir existing fight record databases for review by CSAC licensing staff. Licensing staff may need to review several sources to confinTI fight records; in addition, the upcoming implementation of a computerized database at the CSAC will eventually allow confirmation of matches that occur within-state.

5. Making AMT matches affordable and desirable for promoters - Concerns: Promoters emphasized the importance of ensuring affordability of AMT matches to encourage them to schedule these events. Once the costs of registration/licensure, medical personnel, officials, etc. are tabulated, it is important for these events to be financially viable. Estimates of $5000-9000 were cited as the range of potential costs for an AMT event. Proposed solutions: Consider using some officials-in-training at AMT events to reduce costs. Review CSAC fees for amateur events. Clarification of licensing, equipment and venue requirements might also help reduce expenses.

6. Unsanctioned "Smoker'' events - enforcement - Concerns: There were differing levels of concern regarding the degree to which unlicensed 'smoker' events were now occurring; however, all agreed that such unlicensed and unsupervised events raised potential health and safety risks for the athletes.

Proposed solutions: Several opinions were expressed as to how the number of these unsanctioned events might be reduced. These included creating a legal regulated pathway for gaining experience in AMT, reducing licensing costs to encourage promoters to host more AMT events and stricter enforcement of 'cease and desist' orders when illegal matches are disc~vered. Some felt that enforcement of AMT rules for these events would best be served by delegating authority to a third party, others felt that the authority of the state (namely through the CSAC) was a more effective means of enforcement. Many stakeholders felt that the current system was already working pretty well but could be improved.

7. Inconsistent communication between CSAC and promoters/trainers re: AMT - Concerns: Several stakeholders mentioned inconsistent information and enforcement regarding the rules for AMT from different CSAC staff and officials. This includes when stakeholders contact the office for advice/information regarding an AMT event, but may also include circumstances when CSAC personnel are not familiar with the rules/regulations related to AMT.

Proposed solutions: EO Dodd indicated that we could immediately begin working on this through staff and stakeholder education. This would be an ongoing process as rules were clarified and/or modified in the future.

The meeting was adjourned at 4:15 p.m. lc:sRc:ICALIFORNIA STATE ATHLETIC: C: CJ NI NI ISSI CJ N

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 12 USA Boxing Northern California Report CALIFORNIA STATE

ATHLETIC:: C::CIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 13.a Bout Appeal Adam Rothweiler Vs. Nick Garcia

...______./"},

\~ CALIFORNIA STATE

ATHLETIC CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 13.b Bout Appeal Ryan Roy Vs. Joe Schilling CALIFORNIA STATE

.ATHLETIC CCIMMISSICIN

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 14 Neurological/Boxer Pension Fund Report to Legislation STATE OF CALIFORNIA-----STATE AND CONSUMER SERVICES AGENCY ARNOW SCHWARZENEGGER, Governor

STATE OF CAL.IFCRNIA California State Athletic Commission 2005 Evergreen Street Suite 2010 Sacramento, CA 95815 c:::1ca www.dca.ca.gov/csac/ DEPARTMENT OF CONSUMER AFFAIRS (916) 263-2195 FAX (916) 263-2197

December 2, 2010

The Honorable Gloria Negrete McLeod, Chair Senate Committee on Business, Professions and Economic Development State Capitol Room 2053 Sacramento, CA 95814

The Honorable Mary Hayashi, Chair Assembly Committee on Business, Professions, and Consumer Protection State Capitol, Room 3013 Sacramento, CA 95814

Madame Chairs:

This report is submitted pursuant to the California Business and Professions Code Section 18618, which was enacted in Assembly Bill 329/Nakanishi (Chapter 2, stats. of 2007).

This bill requires the Commission to report to the Governor and the Legislature with findings and recommendations concerning the State Athletic Commission Neurologic Examination Account on or before July 30, 2010. Please accept our sincere apology for the delay in this report. This report shall include the amount collected from each promoter pursuant to Section 18711, the purpose for which moneys in the account are expended, and findings and recommendation on the amounts, appropriateness, and effectiveness of these assessments. Additionally, this report will discuss the condition of the Boxers' Pension Fund. It will include a recommendation on whether the fund should be continued and, if so, whether it should be expanded to include all athletes licensed under this chapter and appropriate fees paid into the funds.

As shown in attachment A, the Neurologic Examination Account is well funded and in a healthy state to fund the necessary expenditures as dictated by the Commission. For FY-10, the Athletic Commission collected $157,000 from 205 events regulated by the Commission, reflecting $616,000 as the current balance. Given the size of the balance, the Commission recommends suspending the Neurologic Fund. The Commission would like to revisit the funding ofthis account annually. At this point, no funds have been released from this account.

The Commission recommends utilizing this fund to assess the neurologic effects related to combative sports. Some of these funds will be used to create a medical data base that would track · and identify trends in neurologic and other injuries including catastrophic brain injuries. Additionally, the fund would allow for the re-development of a neuropsychological testing program for its athlete licensees. Years ago, the Commission utilized a neuropsychological test as a condition of licensure. This test was especially designed for the California State Athletic Commission. Some time ago, that test was abandoned and replaced with a mini-mental status examination (MMSE). The MMSE was not designed for concussion evaluation in athletes, but for diagnosing dementia. Recently, computerized neuropsychological testing has become available. It has been widely used in other athletic programs, including professional football and hockey, but has only been used on a limited basis for professional boxers and other combative athletes. Computerized testing has many advantages over other forms of neuropsychological testing. These advantages include availability in multiple languages, minimal test - re-test learning, and digitized storage/retrieval of results. In other sports, these computerized tests are used to supplement clinical evaluations for determining retum­ to-play. Computerized testing has two potential applications for athletes licensed by the California Athletic Commission. First, the exam may be used to assess the appropriateness and safety of licensure. Secondly, the computerized test may be used to assist in developing improved retum-to­ competition guidelines. Because of the novelty of this form of neuropsychological testing, an extended trial period followed by careful analysis of the results will be necessary. The Commission estimates that a one year trial period would be necessary to understand the benefits and limitations of this form of testing. Currently, the Commission is seeking bids from various vendors who operate these computerized neuropsychological tests, and a subcommittee has been formed to develop an appropriate study design and analytical plan for this data.

Regarding the Boxers' Pension Fund, California is the only state that provides a pension program for retired professional boxers at age 50. This fund is a defined contribution plan that is paid by each professional promoter and Indian tribes that hold events in California. The boxer does not have to be a resident of the State of California to participate in the fund. The only requirement is that the athlete become vested into the fund by fighting in at least 10 scheduled rounds per calendar year during each of the four calendar years without an intervening break in service and has fought in at least 75 scheduled rounds without a break in service. The distribution of the funds is conducted in one of three ways: 1) one lump sum at the age of 50, 2) upon death, 3) Vocational Early Retirement once the athlete reaches age 36 and retires from boxing. Recently, the Athletic Commission extended the service contract of Raymond James Financial Services, Inc. to act as a discretionary investment advisor, an independent fiduciary, and a,n investment manager with our strict oversight to conservatively invest within the contract guidelines. Again, as with the Neurological fund, the Boxer Pension Fund remains in a healthy status, with over 5.2 millions dollars available for the fund. In July~ 2005, an audit was conducted on the Boxer Pension Fund that listed some areas of concern for the continuation of funding this program. In response to those concerns, the Athletic Commission has made changes which allow more individuals to become vested in this pension program. Currently, out of 1,046 boxers, 472 are vested. The California State Athletic Commission is currently debating the expansion of this program to other athlete licensees. At this point, expanding the program has not been recommended.

Respectively,

George Dodd Executive Officer

2 CALIFORNIA STATE

ATHLETIC C CJ l'V1 l'V1 I Ei Ei I CJ N

DEPARTMENT OF CONSUMER AFFAIRS

CALIFORNIA STATE ATHLETIC COMMISSION

Agenda Item 15 Agenda Items and Meeting Date for Future Meetings